| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 4001 |
Recovery of Renal Function and Independence from Dialysis in Newly Diagnosed and Relapsed Multiple Myeloma Patients - A Single Instituition Experience.
|
Ravindranathan, Girish
|
|
|
110 |
11 |
p. 4847
|
artikel
|
| 4002 |
Recovery of Renal Impairment by Bortezomib-Doxorubicin-Dexamethasone (BDD) in Multiple Myeloma (MM) Patients with Acute Renal Failure. Results from an Ongoing Phase II Study.
|
Ludwig, Heinz
|
|
|
110 |
11 |
p. 3603
|
artikel
|
| 4003 |
Recovery of the NK Cells and Its Intending Clinical Roles after Unmanipulated Haploidentical Blood and Marrow Transplantation.
|
Huang, Xiao Jun
|
|
|
110 |
11 |
p. 2984
|
artikel
|
| 4004 |
Recruitment of Rad50 and MCM Complexes on the Human Beta Globin Locus Control Region (LCR): A Novel Role for LCR Hypersensitive Site 4 (HS4).
|
Karmakar, Subhradip
|
|
|
110 |
11 |
p. 273
|
artikel
|
| 4005 |
Recurrence and Mortality of DVT-Associated PE Is Greater Than Isolated PE Alone: Results of the 7532-Patients Prospective OPTIMEV Cohort Study.
|
Bosson, Jean Luc
|
|
|
110 |
11 |
p. 700
|
artikel
|
| 4006 |
Recurrence of Severe ITP Following Administration of G-CSF: Remission Following Platelet and Vinca-Alkaloid Infusion.
|
Ahn, Eugene R.
|
|
|
110 |
11 |
p. 3222
|
artikel
|
| 4007 |
Red Blood Cell Alloimmunization Is Affected by Depletion of Donor White Cell Subsets.
|
Campbell-Lee, Sally A.
|
|
|
110 |
11 |
p. 456
|
artikel
|
| 4008 |
Red Blood Cell Derived Microparticles Are Thrombogenic in Mouse Models of Atherosclerosis.
|
Isobe, Hirotaka
|
|
|
110 |
11 |
p. 3624
|
artikel
|
| 4009 |
Red Blood Cell Exchange Transfusion (RBCET) in the Management of Acute Hemolytic Transfusion Reaction (AHTR).
|
Rose, Shelonitda S.
|
|
|
110 |
11 |
p. 4021
|
artikel
|
| 4010 |
Red Blood Cell Variables in Young and Mature High-Trained Football Players
|
Grudeva, Janet G.
|
|
|
110 |
11 |
p. 3749
|
artikel
|
| 4011 |
Red Cells Release Microparticles Heterogeneous in Phenotypes, Procoagulant Activities, and Size under Different Conditions.
|
Jy, Wenche
|
|
|
110 |
11 |
p. 1726
|
artikel
|
| 4012 |
Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).
|
Brito-Babapulle, Finella
|
|
|
110 |
11 |
p. 3310
|
artikel
|
| 4013 |
Redistribution of Recombinant Activated Factor VIIA into Platelets and Vascular Bed: Implications on Bioavailability and Hemostatic Mechanisms.
|
Galan, Ana Maria
|
|
|
110 |
11 |
p. 3957
|
artikel
|
| 4014 |
Reduced Bone Mineral Density in Hemophilia.
|
Alrustamani, Ahmad
|
|
|
110 |
11 |
p. 3958
|
artikel
|
| 4015 |
Reduced Cyclophosphamide Combined with Etoposide and Total Body Irradiation as a Conditioning Regimen for Patients with Impaired Cardiac Function Undergoing Allogeneic Stem Cell Transplantation.
|
Yoshimi, Akihide
|
|
|
110 |
11 |
p. 2000
|
artikel
|
| 4016 |
Reduced Dose Lenalidomide Is Safe and Effective in Deletion (5q) MDS Patients with Severe Renal Impairment: Report of Two Cases.
|
Knop, Stefan
|
|
|
110 |
11 |
p. 4624
|
artikel
|
| 4017 |
Reduced Dose of Non-Pegylated Liposomal Doxorrubicin with Cyclophosphamide, Vincristine and Prednisone ± Rituximab for Elderly Patients with Aggressive Lymphoma Non Candidates to Standard Chemotherapy.
|
Gimeno, Eva
|
|
|
110 |
11 |
p. 4464
|
artikel
|
| 4018 |
Reduced Effect of Inotuzumab Ozogamicin (CMC544) on P-Glycoprotein Positive Malignant B Cells and Its Restoration by Multidrug Resistance Modifiers.
|
Takeshita, Akihiro
|
|
|
110 |
11 |
p. 2378
|
artikel
|
| 4019 |
Reduced Fibrinolysis in the Hepatic Venous Occlusive Disease: Effect of Defibrotide on Plasmin Activity.
|
Echart, Cinara
|
|
|
110 |
11 |
p. 1992
|
artikel
|
| 4020 |
Reduced Genotoxic Risk Using Foamy Viral Vectors for the Treatment of Canine Leukocyte Adhesion Deficiency
|
Bauer Jr, Thomas R.
|
|
|
110 |
11 |
p. 3744
|
artikel
|
| 4021 |
Reduced HSPA9B Expression, a 5q31.2 Candidate Gene, in Primary Human CD34+ Cells Recapitulates Features of Ineffective Hematopoiesis Observed in MDS.
|
Chen, Tim H.
|
|
|
110 |
11 |
p. 116
|
artikel
|
| 4022 |
Reduced Incidence of Acute Graft Versus Host Disease (GVHD) and Transplant-Related Mortality (TRM) with the Addition of Short-Course Mini-Dose Methotrexate (MTX) to Cyclosporine (CSA) as GVHD Prophylaxis Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).
|
Srinivasan, Ramaprasad
|
|
|
110 |
11 |
p. 2990
|
artikel
|
| 4023 |
Reduced Incidence of Severe Acute GVHD in Patients Transplanted from Donors with IL23R (Arg381Gln) Gene Variant.
|
Elmaagacli, Ahmet H.
|
|
|
110 |
11 |
p. 1061
|
artikel
|
| 4024 |
Reduced Intensity Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome: Does the Conditioning Matter?.
|
Terriou, Louis
|
|
|
110 |
11 |
p. 4924
|
artikel
|
| 4025 |
Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901.
|
Shea, Thomas C.
|
|
|
110 |
11 |
p. 486
|
artikel
|
| 4026 |
Reduced Intensity Allogeneic Transplant in Patients Older Than 55 Years: Unrelated Umbilical Cord Blood Is Safe and Effective for Patients without a Matched Related Donor.
|
Majhail, Navneet S.
|
|
|
110 |
11 |
p. 331
|
artikel
|
| 4027 |
Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Using Oral Fludarabine as Part of the Conditioning Regimen.
|
Delgado, Julio
|
|
|
110 |
11 |
p. 4925
|
artikel
|
| 4028 |
Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation (SCT) with Fludarabine and Intravenous Busulfan Is Associated with Improved Toxicity Profile and Longer Survival Than Conditioning with Fludarabine and Melphalan in Patients with Chemo-Sensitive Hematological Malignancies.
|
Shimoni, Avichai
|
|
|
110 |
11 |
p. 2002
|
artikel
|
| 4029 |
Reduced-Intensity Conditioning for Allografting Following Autografting for Myeloma: Lower Relapse Rates Compared with Single or Double Autografting but Similar Overall Survival. The Genoa Experience in 74 Patients.
|
Carella, A.M.
|
|
|
110 |
11 |
p. 5095
|
artikel
|
| 4030 |
Reduced-Intensity Conditioning Is Associated with Shorter Duration of Chronic GVHD Than Myeloablative Conditioning and Provides Very Good Quality of Life for Long-Term Survivors after Allogeneic Stem Cell Transplantation.
|
Shimoni, Avichai
|
|
|
110 |
11 |
p. 1668
|
artikel
|
| 4031 |
Reduced Intensity Conditioning Is Safe and Effective for Transplantation of Patients with Shwachman Diamond Syndrome.
|
Bhatla, D.
|
|
|
110 |
11 |
p. 2004
|
artikel
|
| 4032 |
Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Acute Myeloid Leukemia (AML): Long Term Results of a “Donor” Versus “No Donor” Comparison.
|
Mohty, Mohamad
|
|
|
110 |
11 |
p. 1090
|
artikel
|
| 4033 |
Reduced Intensity Conditioning (RIC) with Fludarabine, Busulfan and Cyclophosphamide for High Risk Patients with Thalassemia Major Undergoing Allogeneic Bone Marrow Transplantation Results in High Rejection Rates.
|
Chandy, Mammen
|
|
|
110 |
11 |
p. 1998
|
artikel
|
| 4034 |
Reduced Intensity (RI) Allogeneic Hematopoietic Cell Transplantation (HCT) Improves Outcomes for Older (≥ 60 Yrs) Patients (Pts) with Acute Myeloid Leukemia (AML).
|
O'Donnell, Margaret R.
|
|
|
110 |
11 |
p. 1089
|
artikel
|
| 4035 |
Reduced Intensity Stem Cell Transplantation and Donor Lymphocyte Infusion after Imatinib Induction To Eradicate Residual Disease in Chronic Myeloid Leukaemia.
|
Heaney, Nicholas
|
|
|
110 |
11 |
p. 1097
|
artikel
|
| 4036 |
Reduced Oxidative Stress and Enhanced Nitric Oxide (NO) Bioavailability in Transgenic-Knockout Sickle Mice Expressing Fetal Hemoglobin (HbF) Is Mediated by Decreased Sickling and Hemolysis.
|
Dasgupta, Trisha
|
|
|
110 |
11 |
p. 842
|
artikel
|
| 4037 |
Reducing Iron Stores Lowers Cancer Risk in Patients with Peripheral Arterial Disease.
|
Zacharski, Leo R.
|
|
|
110 |
11 |
p. 2665
|
artikel
|
| 4038 |
Reducing MCM Loading Causes Chromosomal Aneuploidy.
|
Orr, Stephen J.
|
|
|
110 |
11 |
p. 3349
|
artikel
|
| 4039 |
Reduction in Immunoglobulin (IVIG or Anti D) Use in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Receiving AMG 531: Results from Two Phase 3 Randomized Placebo-Controlled Trials.
|
Pullarkat, Vinod
|
|
|
110 |
11 |
p. 1304
|
artikel
|
| 4040 |
Reduction of Prion Infectivity in Packed Red Cells by Separation of Whole Blood and Washing of the Red Cell Fraction.
|
Morales, Rodrigo
|
|
|
110 |
11 |
p. 2890
|
artikel
|
| 4041 |
Reduction of Prothrombin in Mice Carrying a Conditional Knockout Allele Attenuates the Development of Paralysis Associated with Experimental Encephalitis.
|
Mullins, Eric S.
|
|
|
110 |
11 |
p. 407
|
artikel
|
| 4042 |
Re-Establishment and Characterization of an Extinct Line of Sheep with a Spontaneous Bleeding Disorder That Closely Recapitulates Human Hemophilia A.
|
Almeida-Porada, Graça
|
|
|
110 |
11 |
p. 1144
|
artikel
|
| 4043 |
ReFacto AF Is Effective and Safe in Previously Treated Patients with Severe Hemophilia A: Final Results of a Pivotal Phase III Study.
|
Recht, Michael
|
|
|
110 |
11 |
p. 1151
|
artikel
|
| 4044 |
Refractory Autoimmune Hemolytic Anemia Following Unrelated Cord Blood Transplantation for Acute Lymphoblastic Leukaemia: A Case Report and Review of the Literature.
|
Liu, Huilan
|
|
|
110 |
11 |
p. 5031
|
artikel
|
| 4045 |
Refractory Hemorrhagic Cystitis after Hematopoeitic Stem Cell Transplantation: Clinical Benefit of Factor XIII.
|
Chaumard, N.
|
|
|
110 |
11 |
p. 4935
|
artikel
|
| 4046 |
Refractory Thrombocytopenia Due to Allo-Immune Anti-CD36 Complicating Unrelated Donor Bone Marrow Transplant in a CD36-Negative Recipient.
|
Broderick, William R.
|
|
|
110 |
11 |
p. 4951
|
artikel
|
| 4047 |
Registry of RadioImmunoTherapy: Analysis of Outcomes of Recurrent or Refractory Non-Hodgkin Lymphoma Patients Treated with 90Y Ibritumomab Tiuxetan.
|
Giraldo, Pilar
|
|
|
110 |
11 |
p. 4476
|
artikel
|
| 4048 |
Reguatory T-Cell Subsets Demonstrate Quantitative Differences but Not Functional Abnormalities in Patients with Multiple Myeloma (MM) Compared with Healthy Controls.
|
Feyler, Sylvia
|
|
|
110 |
11 |
p. 3511
|
artikel
|
| 4049 |
Regular Follow-Up of MGUS Allow Early Detection of Malignant Transformation Before Severe Complications Occur.
|
Decaux, Olivier
|
|
|
110 |
11 |
p. 4774
|
artikel
|
| 4050 |
Regulation and Function of NOTCH2 in B-CLL Cells.
|
Hubmann, Rainer
|
|
|
110 |
11 |
p. 1138
|
artikel
|
| 4051 |
Regulation of Bim Expression by IGF-1 in the 5T33MM Murine Model for Multiple Myeloma.
|
De Bruyne, Elke
|
|
|
110 |
11 |
p. 3512
|
artikel
|
| 4052 |
Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (TAFIa) and Platelets.
|
Du, Xiao-Yan
|
|
|
110 |
11 |
p. 408
|
artikel
|
| 4053 |
Regulation of Chronic Lymphocytic Leukemia Cell Proliferation by CTLA4.
|
Mittal, Amit K.
|
|
|
110 |
11 |
p. 1140
|
artikel
|
| 4054 |
Regulation of Erythrocyte Volume by Cell Surface Associated Protein Disulfide Isomerase.
|
Romero, Jose R.
|
|
|
110 |
11 |
p. 149
|
artikel
|
| 4055 |
Regulation of Hematopoietic Stem Cell Quiescence - A Novel Role for p53.
|
Liu, Yan
|
|
|
110 |
11 |
p. 92
|
artikel
|
| 4056 |
Regulation of Hox Genes by Polycomb Group Protein EZH2 Plays a Critical Role in Diffuse Large B-Cell Lymphoma Cells.
|
Velichutina, Irina
|
|
|
110 |
11 |
p. 1562
|
artikel
|
| 4057 |
Regulation of αIIbβ3-Signaling by Myomesin Family of Proteins.
|
Reddy, Kumar B.
|
|
|
110 |
11 |
p. 3893
|
artikel
|
| 4058 |
Regulation of Microparticles and Adhesion Molecules in Pregnancy. Diagnostic and Pathophysiologic Implications.
|
Hoppensteadt, Debra
|
|
|
110 |
11 |
p. 1639
|
artikel
|
| 4059 |
Regulation of miR-210 Generation in Response to Hypoxia in Erythrocytic Cells.
|
Kosaka, Nobuyoshi
|
|
|
110 |
11 |
p. 1247
|
artikel
|
| 4060 |
Regulation of Platelet Functions by Targeting STAT3 with a g-Quartet Oligonucleotide.
|
Zhou, Zhou
|
|
|
110 |
11 |
p. 3640
|
artikel
|
| 4061 |
Regulation of Progenitor Cell Proliferation and Granulocyte Function by microRNA-223.
|
Camargo, Fernando D.
|
|
|
110 |
11 |
p. 507
|
artikel
|
| 4062 |
Regulation of the New CXCR7 Receptor in Plasma Cell Dyscrasias.
|
Moreau, Anne-Sophie
|
|
|
110 |
11 |
p. 3527
|
artikel
|
| 4063 |
Regulation of Tissue Factor Activity: Conformational Changes in Tissue Factor Associated with Cleavage of the Cysteine 186-Cysteine 209 Disulfide Bond.
|
Ngo, Jacky Chi Ki
|
|
|
110 |
11 |
p. 270
|
artikel
|
| 4064 |
Regulation of TLR Expression and Activation in Human Mesenchymal Stromal Cells by IFN-a, IFN-g and TNF-a.
|
François, Moïra
|
|
|
110 |
11 |
p. 1790
|
artikel
|
| 4065 |
Regulation of TLR Signaling by USP7.
|
Tan, Yaohong
|
|
|
110 |
11 |
p. 2300
|
artikel
|
| 4066 |
Regulators of Erythrocyte Volume as Modifiers in Sickle Cell Disease: The Gardos Channel.
|
Tian, Charles
|
|
|
110 |
11 |
p. 3387
|
artikel
|
| 4067 |
Regulatory T Cells Do Not Affect Human Hematopoietic Stem Cell Engraftment and Prevent T Cell Alloreactivity Against CD34+ Cells: A Preclinical Study.
|
Mahmud, Dolores
|
|
|
110 |
11 |
p. 4870
|
artikel
|
| 4068 |
Relapsed and Primary Refractory Diffuse Large B-Cell Lymphoma: Improving Outcome by Incorporating Involved Field Radiotherapy into a Comprehensive Second-Line High-Dose Therapy Strategy.
|
Hoppe, Bradford S.
|
|
|
110 |
11 |
p. 1893
|
artikel
|
| 4069 |
Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide/Dexamethasone Who Achieve a Complete or near Complete Response Have Longer Overall Survival and Time to Progression Compared with Patients Achieving a Partial Response.
|
Harousseau, Jean-Luc
|
|
|
110 |
11 |
p. 3598
|
artikel
|
| 4070 |
Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype.
|
Vose, Julie M.
|
|
|
110 |
11 |
p. 3430
|
artikel
|
| 4071 |
Relapse of Acute Myeloid Leukemia after Allogeneic Stem-Cell Transplantation (SCT) with Myeloablative Conditioning Is Associated with Longer Survival Than Relapse after Reduced-Intensity Conditioning (RIC).
|
Shimoni, Avichai
|
|
|
110 |
11 |
p. 1650
|
artikel
|
| 4072 |
Relapse Prediction in AML Patients in Complete Remission Using WT1 as a Molecular Marker: Development of a Mathematical Model To Predict Time from Molecular to Clinical Relapse and Define Optimal Sampling Intervals.
|
Ommen, Hans B.
|
|
|
110 |
11 |
p. 3495
|
artikel
|
| 4073 |
Related Versus Unrelated Donor Transplantation for High Risk (HiRi) Acute Myeloid Leukemia (AML) in First Complete Remission (CR1).
|
Kienast, Joachim
|
|
|
110 |
11 |
p. 169
|
artikel
|
| 4074 |
Relation between FLT3 Mutations, High Flow Cytometric FLT3 Expression and CXCR4 Expression in CD34+ Cells in Adult Acute Myeloid Leukemia.
|
Yang, Li
|
|
|
110 |
11 |
p. 4080
|
artikel
|
| 4075 |
Relation between JAK2 V617F Mutation and Chronic Myeloproliferative Disorders.
|
Xiao, Zhjian
|
|
|
110 |
11 |
p. 4638
|
artikel
|
| 4076 |
Relationship between Clinical/Hematological Response and Increase of Plamacells in the Bone Marrow of Patients with Chronic Myelogenous Leukemia Imatinib Mesylate Treatment (631).
|
Poggi, Alessandro
|
|
|
110 |
11 |
p. 4552
|
artikel
|
| 4077 |
Relationship between Procalcitonin Levels and Severity of DIC Induced by Bacterial Infection.
|
Kawasugi, Kazuo
|
|
|
110 |
11 |
p. 3976
|
artikel
|
| 4078 |
Relationship between the Hematopoietic Phenotype and the Subtype of Fanconi Anemia Mice.
|
Navarro, Susana
|
|
|
110 |
11 |
p. 2447
|
artikel
|
| 4079 |
Relationship of Stem Cell Transplant and Risk of Atrial Fibrillation in Multiple Myeloma: A Case-Control Study.
|
Gertz, Morie Abraham
|
|
|
110 |
11 |
p. 3001
|
artikel
|
| 4080 |
Relevance of HLA-C Epitopes C1 and C2 for the Survival of Patients with AML and CML after Allogeneic Blood Stem Cell Transplantation.
|
Bruns, Ingmar
|
|
|
110 |
11 |
p. 1974
|
artikel
|
| 4081 |
Relocation of Cell Iron. A Mode of Chelation with Application to Diseases of Regional Iron Accumulation.
|
Cabantchik, Zvi I.
|
|
|
110 |
11 |
p. 708
|
artikel
|
| 4082 |
Removing the Covalent Links between GP Ibα and GP Ibβ Hampers Binding of von Willebrand Factor to GP Ib-IX Complex in CHO Cells.
|
Mo, Xi
|
|
|
110 |
11 |
p. 3641
|
artikel
|
| 4083 |
Renal Dysfunction Does Not Affect Clinical Response in Multiple Myeloma (MM) Patients Treated with Bortezomib-Based Regimens.
|
Ailawadhi, Sikander
|
|
|
110 |
11 |
p. 1477
|
artikel
|
| 4084 |
Repeated Courses of Bone Marrow-Derived Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor (G-CSF) in Amyotrophic Lateral Sclerosis: Interim Analysis of a Prospective Multicenter Trial.
|
Tarella, Corrado
|
|
|
110 |
11 |
p. 4065
|
artikel
|
| 4085 |
Repeat Treatment with Iodine-131-Rituximab Is Safe and Effective in Patients with Relapsed Indolent B-Cell Non-Hodgkin Lymphoma (NHL) Who Had Previously Responded to This Therapy.
|
Bishton, Mark J.
|
|
|
110 |
11 |
p. 3413
|
artikel
|
| 4086 |
Repetitive Busulfan Administration Uncovers a Competitive Advantage for Hematopoietic Clones with a Retrovirus Insertion Near the HDAC7A Locus
|
Xie, Jianjun Xie
|
|
|
110 |
11 |
p. 3745
|
artikel
|
| 4087 |
Report of a Phase1/2 Study of 5-Azacitidine and Cytarabine in Patients with Relapsed, Refractory Acute Myelogenous Leukemia.
|
Borthakur, Gautam
|
|
|
110 |
11 |
p. 911
|
artikel
|
| 4088 |
Repression of ROCKII by GATA-1 Inhibits Cell Proliferation during Erythroid Maturation.
|
Ma, Peilin
|
|
|
110 |
11 |
p. 3345
|
artikel
|
| 4089 |
Requirement for p85α Regulatory Subunit of Class IA PI3Kinase and Rac2 GTPase in Myeloproliferative Disease Driven by Activation Loop Mutant of KIT.
|
Munugalavadla, Veerendra
|
|
|
110 |
11 |
p. 89
|
artikel
|
| 4090 |
Requirement of the E2F3 Transcription Factor for BCR/ABL Leukemogenesis.
|
Eiring, Anna M.
|
|
|
110 |
11 |
p. 33
|
artikel
|
| 4091 |
Requirements for Retroviral Targeting of a Suicide Gene to Alloreactive Memory Stem T Cells for Adoptive Immunotherapy of Leukemia.
|
Bondanza, Attilio
|
|
|
110 |
11 |
p. 2176
|
artikel
|
| 4092 |
Research of Synergetic Reversal in Adriamycin - Resistance by the Application of Magnetic Nanoparticle of Fe3O4 and Tetrandrine in K562/A02 Leukemic Cells.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 4173
|
artikel
|
| 4093 |
Research on Biological Characteristics of Chronic Myelogenous Leukemia Patients' Bone Marrow Mesenchymal Stem Cells.
|
Chen, Xiao Chen
|
|
|
110 |
11 |
p. 4535
|
artikel
|
| 4094 |
R-ESHAP as Salvage Therapy for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Spanish GEL-TAMO Multicenter Study.
|
Martin, Alejandro
|
|
|
110 |
11 |
p. 3438
|
artikel
|
| 4095 |
Residual Lymphocytes in GM-CSF and IL-15 Differentiated Monocyte-Derived Dendritic Cells Enables Cytotoxic T Lymphocyte Responses.
|
Hardy, Melinda Y.
|
|
|
110 |
11 |
p. 4907
|
artikel
|
| 4096 |
Resolving the Riddle of Obscure Iron Deficiency Anemia.
|
Hershko, Chaim
|
|
|
110 |
11 |
p. 371
|
artikel
|
| 4097 |
Resource Use and Costs Associated with Routine Management of Febrile Neutropenia in German Hospitals.
|
Ihbe-Heffinger, Angela
|
|
|
110 |
11 |
p. 3338
|
artikel
|
| 4098 |
Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
|
Schubert, Joerg
|
|
|
110 |
11 |
p. 788
|
artikel
|
| 4099 |
Response and Survival Rates in Patients with Peripheral T-Cell Lymphoma Treated with Anthracycline-Based Regimens: A Comprehensive Meta-Analysis.
|
AbouYabis, Abeer N.
|
|
|
110 |
11 |
p. 3452
|
artikel
|
| 4100 |
Response of Hodgkin Lymphoma Patients of Different Ethnic Groups to Standard ABVD with or without Involved Field RT.
|
Ofori-Ntow, Samuel
|
|
|
110 |
11 |
p. 4444
|
artikel
|
| 4101 |
Response of the Erythroid Lineage to Irradiation.
|
Wenger, Jesse
|
|
|
110 |
11 |
p. 3660
|
artikel
|
| 4102 |
Response Predictive Factors to Anagrelide in Essential Thrombocythemia Diagnosed Patients.
|
Besses, Carlos
|
|
|
110 |
11 |
p. 4649
|
artikel
|
| 4103 |
Responses and Disease Progression in CML-CP Patients Treated with Nilotinib after Imatinib Failure Appear To Be Affected by the BCR-ABL Mutation Status and Types.
|
Hughes, Timothy
|
|
|
110 |
11 |
p. 320
|
artikel
|
| 4104 |
Responses and Outcome Following Immunosuppressive Therapy in Large Granular Lymphocyte Leukemia-Associated Pure Red Cell Aplasia: A Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
|
Fujishima, Naohito
|
|
|
110 |
11 |
p. 1688
|
artikel
|
| 4105 |
Response to Bortezomib Therapy for Multiple Myeloma (MM) in Actual Clinical Practice: Preliminary Effectiveness Findings of an International Observational Study.
|
Delforge, Michel
|
|
|
110 |
11 |
p. 4837
|
artikel
|
| 4106 |
Response to Dasatinib in Patients with Aggressive Systemic Mastocytosis with D816V Kit Mutation.
|
Rondoni, Michela
|
|
|
110 |
11 |
p. 3562
|
artikel
|
| 4107 |
Response to Imatinib or Imatinib Containing Regimens of Secondary Clones in Chronic Myeloid Leukemia Patients with Additional Chromosomal Abnormalities.
|
Luzi, Debora
|
|
|
110 |
11 |
p. 4574
|
artikel
|
| 4108 |
Response to Oral Forodesine in Refractory Cutaneous T-Cell Lymphoma: Interim Results of a Phase I/II Study.
|
Duvic, Madeleine
|
|
|
110 |
11 |
p. 122
|
artikel
|
| 4109 |
Restoration of Peroxiredoxins and Catalase Is Closely Correlated with the Level of Philadelphia Chromosome during Imatinib Therapy in CML.
|
Lee, Kyoung-Eun
|
|
|
110 |
11 |
p. 4539
|
artikel
|
| 4110 |
Restoring Oxygen Carrying Capacity of Sickle Erythrocytes with Nitric Oxide Donors.
|
Hrinczenko, Borys
|
|
|
110 |
11 |
p. 3785
|
artikel
|
| 4111 |
Restricted Oligo-Clonal Usage of Monoclonal Immunoglobulin λ Light Chain Germline in POEMS Syndrome.
|
Nakaseko, Chiaki
|
|
|
110 |
11 |
p. 2483
|
artikel
|
| 4112 |
Results from a Phase II Study of Lenalidomide Oral Monotherapy in Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma.
|
Witzig, Thomas E.
|
|
|
110 |
11 |
p. 2560
|
artikel
|
| 4113 |
Results of Alternative Donor Search in Adult Patients with Severe Sickle Cell Disease (SCD) Eligible for Hematopoietic Stem Cell Transplantation (HSCT).
|
Hsieh, Matthew M.
|
|
|
110 |
11 |
p. 2260
|
artikel
|
| 4114 |
Results of an Exploratory Study of Oral (po) and Intravenous (iv) Clofarabine in Patients with Myelodysplastic Syndrome.
|
Faderl, Stefan
|
|
|
110 |
11 |
p. 1455
|
artikel
|
| 4115 |
Results of a Nonrandomized, Open-Label, Phase II Study of Combined Gemcitabine, Mitoxantrone, and Rituximab in Relapsed or Refractory Mantle Cell Lymphoma.
|
Garbo, Lawrence E.
|
|
|
110 |
11 |
p. 4452
|
artikel
|
| 4116 |
Results of a Phase I/II-Study on PCR-Based Pre-Emptive Therapy with Valganciclovir or Ganciclovir for Active CMV Infection Following Reduced Intensity Allogeneic Stem Cell Transplantation.
|
Lim, ZiYi
|
|
|
110 |
11 |
p. 5011
|
artikel
|
| 4117 |
Results of a Prospective Phase II Trial of Limited and Extended Rituximab Treatment in Nodular Lymphocyte Predominant Hodgkin's Disease (NLPHD).
|
Horning, Sandra J.
|
|
|
110 |
11 |
p. 644
|
artikel
|
| 4118 |
Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.
|
Wingard, John R.
|
|
|
110 |
11 |
p. 163
|
artikel
|
| 4119 |
Results of a Randomized Phase II Trial of Pegfilgrastim Versus Filgrastim To Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkin's Lymphoma (NHL).
|
Rifkin, Robert
|
|
|
110 |
11 |
p. 4936
|
artikel
|
| 4120 |
Results of Haploidentical Stem Cell Transplantation after a Conditioning Regimen without Total Body Irradiation in Elderly Patients with Advanced Myeloid and Lymphoid Malignancies.
|
Selleslag, Dominik L.D.
|
|
|
110 |
11 |
p. 3074
|
artikel
|
| 4121 |
Results of Immunosuppressive Therapy in Children with Severe Aplastic Anaemia (SAA). Report Polish Pediatric Hematology Group (Warszawa, Lublin, Krakow, Wroclaw, Zabrze, Bydgoszcz, Poznan, Lodz, Bialystok, Szczecin, Gdansk).
|
Pawelec, Katarzyna
|
|
|
110 |
11 |
p. 3768
|
artikel
|
| 4122 |
Results of the AFR07 Prospective Study in De Novo Philadelphia Positive ALL Patients Aged over 55 Years: Efficacy and Safety of a Glivec® Based Induction Followed by Maintenance Therapy with Glivec® and Pegasys®.
|
Rousselot, Philippe
|
|
|
110 |
11 |
p. 2816
|
artikel
|
| 4123 |
Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza®) in Patients with Myelodysplastic Syndromes (MDS).
|
Lyons, Roger M.
|
|
|
110 |
11 |
p. 819
|
artikel
|
| 4124 |
Resveratrol Exerts Antiproliferative Effect and Induces Apoptosis in Waldenstrom's Macroglobulinemia.
|
Roccaro, Aldo
|
|
|
110 |
11 |
p. 1383
|
artikel
|
| 4125 |
Retention of Thrombin Generation Capacity of Therapeutic Apheresis Plasma Prepared with Amotosalen and UVA Light (INTERCEPT) Pathogen Inactivation.
|
Cazenave, Jean-Pierre
|
|
|
110 |
11 |
p. 4027
|
artikel
|
| 4126 |
Retinoblastoma Protein and the Leukemia-Associated PLZF Transcription Factor Interact To Repress Target Gene Promoters.
|
Petrie, Kevin R.
|
|
|
110 |
11 |
p. 1240
|
artikel
|
| 4127 |
Retinoic Acid Blockade Increases Primitive Blood Cell Formation in cdx4 Mutant Zebrafish Embryos, Murine Yolk Sac Explants and Differentiated Embryonic Stem Cells.
|
de Jong, Jill L.
|
|
|
110 |
11 |
p. 201
|
artikel
|
| 4128 |
Retreatment with Alemtuzumab after a First, Successful Alemtuzumab Treatment in B-CLL.
|
Fiegl, Michael
|
|
|
110 |
11 |
p. 4714
|
artikel
|
| 4129 |
Retrospective Analysis of Post-Remission Modalities in AML Patients with Normal Karyotype.
|
Chae, Yee Soo
|
|
|
110 |
11 |
p. 4258
|
artikel
|
| 4130 |
Retrospective Comparison of Lymphocyte Subsets in the Different Stage of Patients with Chronic Graft-Versus-Host Disease after HSCT for Possibility of Early Diagnosis.
|
Xing, Haizhou
|
|
|
110 |
11 |
p. 4967
|
artikel
|
| 4131 |
Retrospective Comparison of Transplant Outcomes in Patients with Multiple Myeloma According to Induction Therapy with Thalidomide/Dexamethasone (TD) with or without Bortezomib (VTD).
|
Giralt, Sergio
|
|
|
110 |
11 |
p. 948
|
artikel
|
| 4132 |
Retrospective Review of Hypercoagulability in Minority Populations at an Inner City Hospital's General Hematology Clinic.
|
Patel, Pritesh R.
|
|
|
110 |
11 |
p. 3973
|
artikel
|
| 4133 |
Retrospective Survey of Children Treated for Relapsed Acute Lymphoblastic Leukemia (Complete Remission (CR) Rates): A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.
|
Ko, Richard H.
|
|
|
110 |
11 |
p. 854
|
artikel
|
| 4134 |
Retroviral Insertion and Temozolomide Selection Promote T-Cell Lymphomas in Tumor-Prone Mice.
|
Sweeney, Colin L.
|
|
|
110 |
11 |
p. 2593
|
artikel
|
| 4135 |
Retroviral Vector-Producing Mesenchymal Stem Cells for Tumor Tracking and Therapeutic Gene Amplification in Suicide Cancer Gene Therapy.
|
Uchibori, Ryosuke
|
|
|
110 |
11 |
p. 1917
|
artikel
|
| 4136 |
Revalidation of the Flipi Score in the Era of Immunotherapy.
|
Stemmelin, German
|
|
|
110 |
11 |
p. 4437
|
artikel
|
| 4137 |
Reversal of Complications Following Intensive Combined Chelation in β-Thalassemia Major Patients.
|
Farmaki, Kallistheni
|
|
|
110 |
11 |
p. LB4
|
artikel
|
| 4138 |
Reversal of Low Chimerism Following Nonmyeloablative (NM) Hematopoietic Cell Transplantation (HCT) Using Pentostatin and Donor Lymphocyte Infusions (DLI).
|
Thakar, Monica
|
|
|
110 |
11 |
p. 480
|
artikel
|
| 4139 |
Reversal of New-Onset Type 1 Diabetes in Mice and Induction of FoxP3+ Regulatory T Cells by Syngeneic Bone Marrow Transplantation.
|
Ouyang, Jian
|
|
|
110 |
11 |
p. 4857
|
artikel
|
| 4140 |
Reversal of P-Glycoprotein-Dependent Resistance to Adriamycin by 5-bromotetrandrine in K562/A02 Cell Line.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 4175
|
artikel
|
| 4141 |
Reversible Bony Changes after Treatment with Bevacizumab in a Child with Cutaneovisceral Angiomatosis with Thrombocytopenia Syndrome: A Case Report and Review of the Literature.
|
Smith, Angela R.
|
|
|
110 |
11 |
p. 1323
|
artikel
|
| 4142 |
Reversible Posterior Leukoencephalopathy Syndrome (RPLS) Complicating Biologic and Small-Molecule Therapies for Cancer.
|
Kane, Robert C.
|
|
|
110 |
11 |
p. 3341
|
artikel
|
| 4143 |
Reversible Self-Assembly of Weibel-Palade Body-Like Tubules from Recombinant N-Terminal Domains of von Willebrand Factor.
|
Huang, Ren-Huai
|
|
|
110 |
11 |
p. 291
|
artikel
|
| 4144 |
Reversible Transplantable Chronic Phase CML-Like Disease in SCLtTA/BCR-ABL Transgenic Mice.
|
Schemionek, Mirle
|
|
|
110 |
11 |
p. 1002
|
artikel
|
| 4145 |
RGD-Substituted High Molecular Weight Hyper-Branched Polyglycerols (HPG) Are Effective Platelet Inhibitors.
|
Zhang, Jerry G.
|
|
|
110 |
11 |
p. 925
|
artikel
|
| 4146 |
RGT, a Sythetic Peptide, Selectively Inhibits Integrin αIIbβ3 Outside-In Signaling in Human Platelets through Disassociating SRC Kinase from β3 Subunit.
|
Su, Xiaoyu
|
|
|
110 |
11 |
p. 3633
|
artikel
|
| 4147 |
R-HCVAD/R-MTX-ARAC Is an Effective Regimen for Untreated Diffuse Large B-Cell Lymphoma (DLBCL) with Aggressive Features in Patients Younger Than 60 Years
|
Fayad, Luis
|
|
|
110 |
11 |
p. 1285
|
artikel
|
| 4148 |
RH Gene Polymorphisms Are Risk Factor for Alloimmunization in Patients with Sickle Cell Disease.
|
Westhoff, Connie M.
|
|
|
110 |
11 |
p. 455
|
artikel
|
| 4149 |
Rho GTPase Cdc42 Maintains Neutrophil Polarity during Directed Migration by Regulating CD11b Integrin Signals.
|
Szczur, Kathleen
|
|
|
110 |
11 |
p. 238
|
artikel
|
| 4150 |
RhoH-Deficient Mice Show Altered B Cell Populations In Vivo.
|
Sanchez-Aguilera, Abel
|
|
|
110 |
11 |
p. 2307
|
artikel
|
| 4151 |
RhoH Functions as an Adaptor Molecule for ZAP-70 in TCR Signaling Pathway.
|
Chae, Hee-Don
|
|
|
110 |
11 |
p. 795
|
artikel
|
| 4152 |
Ribosomal Proteins Are Overexpressed in Hyperdiploid Multiple Myeloma.
|
Weinhold, Niels
|
|
|
110 |
11 |
p. 2495
|
artikel
|
| 4153 |
R-ICE Versus R-DHAP in Relapsed Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Followed by Stem Cell Transplantation and Maintenance Treatment with Rituximab or Not: First Interim Analysis on 200 Patients. CORAL Study.
|
Gisselbrecht, Christian
|
|
|
110 |
11 |
p. 517
|
artikel
|
| 4154 |
Risk-Adapted Therapy of Aggressive Lymphoma Based on FDG-PET Performed after 2 or 3 Cycles of Initial Chemotherapy.
|
Kasamon, Yvette L.
|
|
|
110 |
11 |
p. 1894
|
artikel
|
| 4155 |
Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Updated Results of the Spanish PETHEMA LPA99 Trial Using ATRA and Anthracycline Monochemotherapy.
|
Sanz, Miguel A.
|
|
|
110 |
11 |
p. 590
|
artikel
|
| 4156 |
Risk-Adjusted Therapy of Acute Lymphoblastic Leukemia Can Decrease Treatment Burden and Improve Survival: Treatment Results of 2169 Unselected Pediatric and Adolescent Patients Enrolled in the Trial ALL-BFM 95.
|
Möricke, Anja
|
|
|
110 |
11 |
p. 584
|
artikel
|
| 4157 |
Risk Factor Analysis of Outcomes after Unrelated Cord Blood Transplantation for Children with Hurler's Syndrome. An Eurocord-Duke University Collaborative Study.
|
Boelens, Jaap Jan
|
|
|
110 |
11 |
p. 5076
|
artikel
|
| 4158 |
Risk Factors Analyses for Outcomes after Unrelated Cord Blood Transplantation for Children with Myelodysplastic Syndromes. An Analysis on Behalf of EWOG-MDS and Eurocord Groups.
|
Moreno-Madureira, Adrienne B.
|
|
|
110 |
11 |
p. 2022
|
artikel
|
| 4159 |
Risk Factors and Outcome after Second HLA-Matched Sibling Donor Transplantation for Graft Failure after a First HLA-Matched Sibling Transplant in Severe Aplastic Anemia.
|
Horan, John
|
|
|
110 |
11 |
p. 1110
|
artikel
|
| 4160 |
Risk Factors and Outcomes for Relapse after Autologous Stem Cell Transplantation for Hodgkin Lymphoma.
|
Dean, Robert M.
|
|
|
110 |
11 |
p. 1903
|
artikel
|
| 4161 |
Risk Factors Associated with Occurrence of Febrile Neutropenia in NHL Patients in the First Cycle of Chemotherapy - A Prospective Multivariate Model.
|
Pettengell, Ruth
|
|
|
110 |
11 |
p. 1372
|
artikel
|
| 4162 |
Risk Factors for Acute Graft-Versus-Host Disease (GvHD) after Related Donor HLA-Matched Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Adult Leukemia: Identification of Modifiable and Non-Modifiable Factors. A CIBMTR Study.
|
Hahn, Theresa
|
|
|
110 |
11 |
p. 1069
|
artikel
|
| 4163 |
Risk Factors for BK Viruria and Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplant (HSCT) Recipients.
|
McHayleh, Wassim
|
|
|
110 |
11 |
p. 1072
|
artikel
|
| 4164 |
Risk Factors for Blood Product Usage Following Sibling Allogeneic Haemopoietic Stem Cell Transplantation (allo-HCT).
|
Hurst, Nicola
|
|
|
110 |
11 |
p. 2909
|
artikel
|
| 4165 |
Risk Factors for Disease Progression in del(5q) MDS Patients Treated with Lenalidomide.
|
Giagounidis, Aristoteles A.
|
|
|
110 |
11 |
p. 1460
|
artikel
|
| 4166 |
Risk Factors for Graft Failure and Mortality after HLA-Matched Sibling Donor Transplant for Severe Aplastic Anemia in Brazil.
|
Pasquini, Ricardo
|
|
|
110 |
11 |
p. 622
|
artikel
|
| 4167 |
Risk Factors for Isolated Pulmonary Embolism Are Opposite to Those for DVT-Associated PE: Results of the 7532-Patients Prospective OPTIMEV Cohort Study.
|
Bosson, Jean Luc
|
|
|
110 |
11 |
p. 3977
|
artikel
|
| 4168 |
Risk Factors for Primary Hemorrhagic Stroke in Adults with Sickle Cell Disease.
|
Strouse, John J.
|
|
|
110 |
11 |
p. 3809
|
artikel
|
| 4169 |
Risk Factors for Response after Initial Therapy for Acute Graft-Versus-Host-Disease (aGVHD).
|
Westin, Jason R.
|
|
|
110 |
11 |
p. 5015
|
artikel
|
| 4170 |
Risk Factors for Venous Thromboembolism (VTE) among Patients with Active Hematological Cancer: A Population-Based Case-Control Study.
|
Ashrani, Aneel A.
|
|
|
110 |
11 |
p. 1642
|
artikel
|
| 4171 |
Risk Factors Predisposing to Thromboembolism in Children with Cancer.
|
Athale, Uma
|
|
|
110 |
11 |
p. 1633
|
artikel
|
| 4172 |
Risk of Acute Leukemia Post-Autologous Stem Cell Tranplant (ASCT) for Hodgkin's Lymphoma (HL) Depends on Choice of Salvage Chemotherapy and Use of Radiation.
|
Dhani, N.C.
|
|
|
110 |
11 |
p. 1674
|
artikel
|
| 4173 |
Risk of Adverse Events Is Similar in Patients (Pts) Who Did or Did Not Achieve Hemoglobin (Hb) Above 12g/dL in a Phase 3 Clinical Trial of Darbepoetin alfa (DA) Administered Weekly (QW) or Every 3 Weeks (Q3W) in Anemic Cancer Pts Receiving Chemotherapy.
|
Ludwig, Heinz
|
|
|
110 |
11 |
p. 4086
|
artikel
|
| 4174 |
Risk of Cataracts among Idiopathic Thrombocytopenic Purpura (ITP) Patients in the UK General Practice Research Database (GPRD).
|
Feudjo-Tepie, Maurille A.
|
|
|
110 |
11 |
p. 3922
|
artikel
|
| 4175 |
Risk of Hepatitis B and Efficacy of Treatment with Lamivudine in Patients Undergoing Allogeneic Stem Cell Transplant.
|
Giaccone, Luisa
|
|
|
110 |
11 |
p. 1970
|
artikel
|
| 4176 |
Risk Prediction of Heparin Induced Thrombocytopenia and Thrombosis in the Tertiary Care Setting.
|
Jooma, Nuruddin
|
|
|
110 |
11 |
p. 3225
|
artikel
|
| 4177 |
Rituximab + ABVD Improves Event-Free Survival (EFS) in Patients with Classical Hodgkin Lymphoma in All International Prognostic Score (IPS) Groups and in Patients Who Have PET Positive Disease after 2–3 Cycles of Therapy.
|
Wedgwood, Amanda R.
|
|
|
110 |
11 |
p. 215
|
artikel
|
| 4178 |
Rituximab and Alemtuzumab in Combination, but Not Alone, Induce Complete Remissions in a Preclinical Animal Model of Primary Human ALL: Rationale for Combination Treatment.
|
Nijmeijer, Bart
|
|
|
110 |
11 |
p. 2833
|
artikel
|
| 4179 |
Rituximab and 2-Chlorodeoxyadenosine in Hairy Cell Leukemia as First Line Treatment: A Faster Way to Remission. Report of Five Cases.
|
Farina, Giuliana
|
|
|
110 |
11 |
p. 4721
|
artikel
|
| 4180 |
Rituximab Blocks Binding of Radiolabeled Anti-CD20 Antibodies (Ab) but Not Radiolabeled Anti-CD45-Ab.
|
Gopal, Ajay K.
|
|
|
110 |
11 |
p. 525
|
artikel
|
| 4181 |
Rituximab Combined to ACVBP (R-ACVBP) Supported by Pegfilgrastim as a New Inductive Treatment Followed by High-Dose Consolidative Autotransplantation (HDC) for Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) in First-Line. Results of LNH 03–39B. A GELA Study.
|
Belhadj, Karim
|
|
|
110 |
11 |
p. 3437
|
artikel
|
| 4182 |
Rituximab Combined with Chemotherapy and Interferon in Follicular Lymphoma Patients: Final Analysis of the GELA-GOELAMS FL2000 Study with a 5-Year Follow-Up.
|
Salles, Gilles Andre
|
|
|
110 |
11 |
p. 792
|
artikel
|
| 4183 |
Rituximab Combined with Intravenous or Oral Fludarabine for Previously Untreated Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients.
|
Salar, Antonio
|
|
|
110 |
11 |
p. 4450
|
artikel
|
| 4184 |
Rituximab Consolidation and Maintenance Immunotherapy Improve Outcome in B-Cell Chronic Lymphocytic Leukemia.
|
Del Poeta, Giovanni
|
|
|
110 |
11 |
p. 2035
|
artikel
|
| 4185 |
Rituximab-EPOCH, an Efective Front-Line Therapy for Mantle Cell Lymphoma.
|
Palacios, Andres
|
|
|
110 |
11 |
p. 4490
|
artikel
|
| 4186 |
Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin's Lymphoma (NHL) Patients.
|
Li, Jing
|
|
|
110 |
11 |
p. 2371
|
artikel
|
| 4187 |
Rituximab Improves the Outcome of Upfront Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: A Comparison of Different Strategies.
|
Rieger, Michael
|
|
|
110 |
11 |
p. 5106
|
artikel
|
| 4188 |
Rituximab in Combination with High-Dose Steroids in Advanced, Refractory Chronic Lymphocytic Leukaemia.
|
Quinn, John
|
|
|
110 |
11 |
p. 4719
|
artikel
|
| 4189 |
Rituximab Infusion after Allogeneic HCT Delays B Cell Reconstitution and Alloimmunity.
|
Sahaf, Bita
|
|
|
110 |
11 |
p. 2982
|
artikel
|
| 4190 |
Rituximab in Warfarin Resistance Treatment in Patients with Thrombophilia Due to Primary Antiphospholipid Syndrome: A Pilot Study.
|
Chavez, Jaime Garcia
|
|
|
110 |
11 |
p. 4001
|
artikel
|
| 4191 |
Rituximab Maintenance Following High Dose Therapy and Autologous Stem Cell Rescue after RICE Cytoreduction Improves Event Free and Overall Survival
|
Rice, Robert D.
|
|
|
110 |
11 |
p. 1280
|
artikel
|
| 4192 |
Rituximab Maintenenance Therapy Prolongs Event Free Survival in Patients with CD20+ B-Cell Non-Hodgkin-Lymphoma.
|
Witzens-Harig, Mathias
|
|
|
110 |
11 |
p. 4472
|
artikel
|
| 4193 |
Rituximab Reduces the Incidence of Acute Graft Versus Host Disease and Delays CD3+CD4+ Lymphocyte Recovery.
|
Christopeit, Maximilian
|
|
|
110 |
11 |
p. 5005
|
artikel
|
| 4194 |
Rituximab (R) in Addition to Dose-Dense Chemotherapy MegaCEOP and Intensification with R-MAD Followed by High Dose Chemotherapy BEAM with Autologous Stem Cell Transplantation (ASCT) Is Safe and Effective in Untreated High Risk Diffuse Large B-Cell Lymphoma (DLBCL).
|
Chiappella, Annalisa
|
|
|
110 |
11 |
p. 1899
|
artikel
|
| 4195 |
Rituximab (RTX) as Salvage Therapy for Refractory Chronic Graft-Versus-Host Disease (cGVHD).
|
Mohty, Mohamad
|
|
|
110 |
11 |
p. 2972
|
artikel
|
| 4196 |
Rituximab Sensitizes TRAIL-Resistant B-NHL Lines to Apoptosis by Both TRAIL and Fully Humanized Antibodies Targeting TRAIL-R1 (Mapatumumab) and TRAIL-R2 (Lexatumumab).
|
Vega, Mario I.
|
|
|
110 |
11 |
p. 2350
|
artikel
|
| 4197 |
Rituximab Therapy after Response to R-CHOP Induction Therapy for Patients with Previously Untreated Indolent Non-Hodgkin's Lymphoma (NHL): Clinical Outcomes and Pharmacokinetics (PK)
|
Fehrenbacher, Louis
|
|
|
110 |
11 |
p. 1295
|
artikel
|
| 4198 |
Rituximab Therapy for Autoimmune Hemolytic Anemia and Immune Thrombocytopenia: A Belgian Registry.
|
Dierickx, Daan
|
|
|
110 |
11 |
p. 1737
|
artikel
|
| 4199 |
Rivaroxaban - An Oral, Direct Factor Xa Inhibitor - for Thromboprophylaxis after Total Knee Arthoplasty: The RECORD3 Trial.
|
Lassen, Michael R.
|
|
|
110 |
11 |
p. 308
|
artikel
|
| 4200 |
Rivaroxaban — An Oral, Direct Factor Xa Inhibitor — Prevents Arterial Thrombotic Occlusion in Electrolytically Injured Rat Carotid Arteries.
|
Haertlein, Barbara
|
|
|
110 |
11 |
p. 4003
|
artikel
|
| 4201 |
Rivaroxaban for Prevention of Venous Thromboembolism after Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study.
|
Kwong, Louis
|
|
|
110 |
11 |
p. 1874
|
artikel
|
| 4202 |
Rivaroxaban Has Predictable Pharmacokinetics (PK) and Pharmacodynamics (PD) When Given Once or Twice Daily for the Treatment of Acute, Proximal Deep Vein Thrombosis (DVT).
|
Mueck, Wolfgang
|
|
|
110 |
11 |
p. 1880
|
artikel
|
| 4203 |
Rivaroxaban Has Protective Effects in a Model of Disseminated Intravascular Coagulation (DIC) in Rats.
|
Perzborn, Elisabeth
|
|
|
110 |
11 |
p. 935
|
artikel
|
| 4204 |
R* Magnetic Resonance Imaging (MRI) of the Liver for Patients with Iron Overload.
|
Hankins, Jane S.
|
|
|
110 |
11 |
p. 2670
|
artikel
|
| 4205 |
RNA Based Cancer Vaccines - Clinical Trials in Patients with Prostate Cancer and Malignant Melanoma.
|
Kvalheim, Gunnar
|
|
|
110 |
11 |
p. 1805
|
artikel
|
| 4206 |
RNA-Binding Protein Pum2 Promotes Self-Renewal and Suppresses Differentiation of Multipotent Hematopoietic Cells by Maintaining Them in Inactive CD34− State.
|
Zayas, Jennifer
|
|
|
110 |
11 |
p. 2231
|
artikel
|
| 4207 |
RNAi Functional Screening of the Tyrosine Kinome Identifies Therapeutic Targets in Acute Myeloid Leukemia Patients.
|
Tyner, Jeffrey W.
|
|
|
110 |
11 |
p. 208
|
artikel
|
| 4208 |
RNAi-Mediated Silencing of p190Bcr-Abl Inactivates Stat5 and Cooperates with Imatinib Mesylate and 17-Allylamino-17-Demetoxygeldanamycin in Selective Killing of p190Bcr-Abl-Expressing Leukemia Cells.
|
Futami, Muneyoshi
|
|
|
110 |
11 |
p. 2783
|
artikel
|
| 4209 |
RNAi Screen of the Druggable Genome To Identify Modulators of Bortezomib in Myeloma.
|
Zhu, Yuan Xiao
|
|
|
110 |
11 |
p. 2478
|
artikel
|
| 4210 |
RNAi Targeting MBD2 Increases γ-Globin Expression in a CID-Dependent Human β-YAC Murine Fetal Bone Marrow Cell Line.
|
Banzon, Virryan
|
|
|
110 |
11 |
p. 1769
|
artikel
|
| 4211 |
rNAPc2, a Novel Inhibitor of Tissue Factor/Factor VIIa Complex, Inhibits Tumor Growth and Metastasis in Mouse Models of Colorectal Cancer.
|
Zhao, Jingsong
|
|
|
110 |
11 |
p. 923
|
artikel
|
| 4212 |
ROCKI Regulates Critical Functions in Macrophages and Neutrophils.
|
Vemula, Sasidhar
|
|
|
110 |
11 |
p. 2406
|
artikel
|
| 4213 |
ROCKI Regulates Growth, Maturation and Migration of Mast Cells.
|
Munugalavadla, Veerendra
|
|
|
110 |
11 |
p. 2191
|
artikel
|
| 4214 |
Role of CCL5 and Interleukin-6 in the Biology of Waldenström Macroglobulinemia.
|
Elsawa, Sherine F.
|
|
|
110 |
11 |
p. 688
|
artikel
|
| 4215 |
Role of CD137/4-1BB and Its Ligand in the NK Cell Mediated Immune Surveillance of Acute Myeloid Leukemia.
|
Baessler, Tina
|
|
|
110 |
11 |
p. 880
|
artikel
|
| 4216 |
Role of CD37SMIP a Novel Engineered Small Modular Immunopharmaceutical in the Treatment of CLL.
|
Lapalombella, Rosa
|
|
|
110 |
11 |
p. 801
|
artikel
|
| 4217 |
Role of C-MYC Rearrangement in Survival Status of HIV Positive and HIV Negative Patients with Diffuse Large B-Cells Lymphoma.
|
Zhang, Ling
|
|
|
110 |
11 |
p. 1577
|
artikel
|
| 4218 |
Role of Downstream Effectors in Kras-Driven Myeloproliferative Disease.
|
Shieh, Angell C.
|
|
|
110 |
11 |
p. 1617
|
artikel
|
| 4219 |
Role of Erythropoietin Receptor in t(12;21) Positive Acute Lymphoblastic Leukemia.
|
Panzer-Gruemayer, Renate
|
|
|
110 |
11 |
p. 2792
|
artikel
|
| 4220 |
Role of Fas/FasL Pathway in Pediatric Idiopathic Neutropenia.
|
Joh, Jae Won
|
|
|
110 |
11 |
p. 3291
|
artikel
|
| 4221 |
Role of Gamma-Carboxyglutamic Acid (GLA) Domain in Phosphatidylserine (PS)-Regulated Activity of Factor IXa.
|
Majumder, Rinku
|
|
|
110 |
11 |
p. 2696
|
artikel
|
| 4222 |
Role of Glucocorticoid-Induced TNF-Related Protein (GITR) Ligand in the Interaction of Acute Myeloid Leukemia with NK Cells.
|
Krusch, Matthias
|
|
|
110 |
11 |
p. 18
|
artikel
|
| 4223 |
Role of GSK3 in Multiple Myeloma Cell Growth and Survival.
|
Piazza, Francesco A.
|
|
|
110 |
11 |
p. 2509
|
artikel
|
| 4224 |
Role of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Primary Systemic Amyloidosis: A Systematic Review and Meta-Analysis.
|
Behera, Madhusmita
|
|
|
110 |
11 |
p. 2872
|
artikel
|
| 4225 |
Role of Imatinib Mesylate in Osteoblastogenesis.
|
Tibullo, Daniele
|
|
|
110 |
11 |
p. 1928
|
artikel
|
| 4226 |
Role of Jagged/Notch Signaling in the Cell Fate Determination of Bone Marrow Human Mesenchymal Stem Cells.
|
Ugarte, Fernando
|
|
|
110 |
11 |
p. 1923
|
artikel
|
| 4227 |
Role of JAK2
V617F during In Vitro PV Erythroid Progenitor Differentiation.
|
Nussenzveig, Roberto
|
|
|
110 |
11 |
p. 2540
|
artikel
|
| 4228 |
Role of Microparticles in Thrombin Generation in Patients at Risk for Atherothrombosis.
|
Kaufmann, Viktoria
|
|
|
110 |
11 |
p. 1624
|
artikel
|
| 4229 |
Role of NOTCH1 in Aggressive NK-Cell Leukemia.
|
Makishima, Hideki
|
|
|
110 |
11 |
p. 4231
|
artikel
|
| 4230 |
Role of Novel C-Type Lectin Receptor DCL-1 in Phagocytes and Dendritic Cells.
|
Hart, Derek N.J.
|
|
|
110 |
11 |
p. 2419
|
artikel
|
| 4231 |
Role of Protein Kinase CK2 in the Retinoic Acid-Induced Differentiation of Acute Promyelocytic Leukemia Cells.
|
Gurrieri, Carmela
|
|
|
110 |
11 |
p. 879
|
artikel
|
| 4232 |
Role of the Direct Interaction between Factor VIII C2 and Factor IXa Gla Domain in the Factor Xase Complex.
|
Soeda, Tetsuhiro
|
|
|
110 |
11 |
p. 2687
|
artikel
|
| 4233 |
Role of the IL-6 Pathway in Multiple Myeloma Cell Growth and Its Implications in Target Gene Hypermethylation.
|
Ingersoll, Susan B.
|
|
|
110 |
11 |
p. 4769
|
artikel
|
| 4234 |
Role of the T-Cell Acute Lymphoblastic Leukemia Oncoprotein TLX1/HOX11 in Chromatin Dynamics and Gene Regulatory Networks.
|
Riz, Irene
|
|
|
110 |
11 |
p. 56
|
artikel
|
| 4235 |
Role of Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) in Inducing and Maintaining Complete Molecular Response in B Non Hodgkin's Lymphoma Patients in Clinical Complete Remission after Chemotherapy Regimen.
|
Orciuolo, Enrico
|
|
|
110 |
11 |
p. 4498
|
artikel
|
| 4236 |
Roles of Flow Cytometry in Bone Marrow Staging of B-Cell Non-Hodgkin Lymphoma.
|
Nakorn, Thanyaphong Na
|
|
|
110 |
11 |
p. 4408
|
artikel
|
| 4237 |
Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal While Th2 Cells Promote Tumor Growth.
|
Hong, Sungyoul
|
|
|
110 |
11 |
p. 549
|
artikel
|
| 4238 |
Roles of Raf/MEK/ERK and PI3K/Akt/mTOR Pathways in Prevention of Apoptosis and Induction of Drug Resistance in Myeloid Hematopoietic Cells.
|
Abrams, Steve L.
|
|
|
110 |
11 |
p. 641
|
artikel
|
| 4239 |
Romidepsin (depsipeptide) Induces Clinically Significant Responses in Treatment-Refractory CTCL: An International, Multicenter Study.
|
Kim, Youn H.
|
|
|
110 |
11 |
p. 123
|
artikel
|
| 4240 |
Roscovitine Prevents TCR-Mediated T Cell Clonal Expansion In-Vitro and Protects Against GvHD In-Vivo.
|
Li, Lequn
|
|
|
110 |
11 |
p. 318
|
artikel
|
| 4241 |
R-Ras Regulates Hematopoietic Stem/Progenitor Cell Adhesion, Migration, and Mobilization through Rac GTPase-Mediated Signals.
|
Shang, Xun
|
|
|
110 |
11 |
p. 221
|
artikel
|
| 4242 |
RT-PCR-Based MRD Detection in NPM1 Mutated AML: A Prospective Follow-Up Study in 130 Patients.
|
Schnittger, Susanne
|
|
|
110 |
11 |
p. 545
|
artikel
|
| 4243 |
RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.
|
Roche-Lestienne, Catherine
|
|
|
110 |
11 |
p. 2786
|
artikel
|
| 4244 |
RUNX1/EVI1 That Blocks Myeloid Differentiation Inhibits C/EBPα Function.
|
Tokita, Katsuya
|
|
|
110 |
11 |
p. 4161
|
artikel
|
| 4245 |
Safety and Antitumor Efficacy of the Proteasome Inhibitor Carfilzomib (PR-171) Dosed for Five Consecutive Days in Hematologic Malignancies: Phase 1 Results.
|
Orlowski, Robert Z.
|
|
|
110 |
11 |
p. 409
|
artikel
|
| 4246 |
Safety and Effectiveness of Prophylactic Intravenous Itraconazole in Pediatric Stem Cell Transplantation Recipients.
|
Lyu, Chuhl Joo
|
|
|
110 |
11 |
p. 4996
|
artikel
|
| 4247 |
Safety and Efficacy of a Combination of Imatinib and Pegylated Interferon α2a (Pegasys®) in Newly Diagnosed Patients with Chronic Myelogenous Leukemia - A Phase II Cohort Study.
|
Hochhaus, Andreas
|
|
|
110 |
11 |
p. 1027
|
artikel
|
| 4248 |
Safety and Efficacy of Alfimeprase in Subjects with Occluded Central Venous Access Devices: The SONOMA-2 Study.
|
Moll, Stephan
|
|
|
110 |
11 |
p. 1866
|
artikel
|
| 4249 |
Safety and Efficacy of Bortezomib and Dexamethasone (BD) in Multiple Myeloma as First-Line, Second-Line or Third-Line Treatment.
|
Li, Juan
|
|
|
110 |
11 |
p. 4817
|
artikel
|
| 4250 |
Safety and Efficacy of Bortezomib Plus ICE (BICE) for the Treatment of Relapsed/Refractory Classical Hodgkin's Lymphoma.
|
Fanale, Michelle A.
|
|
|
110 |
11 |
p. 4506
|
artikel
|
| 4251 |
Safety and Efficacy of Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) in for the Treatment of Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL).
|
Thomas, Deborah A.
|
|
|
110 |
11 |
p. 858
|
artikel
|
| 4252 |
Safety and Efficacy of Nilotinib Dose Escalation 600mg BID in Patients (pts) with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP).
|
Hochhaus, Andreas
|
|
|
110 |
11 |
p. 1038
|
artikel
|
| 4253 |
Safety and Efficacy of Primary Prophylaxis with Voriconazole in Adult Patients with Acute Leukemia.
|
Tomas, Jose F.
|
|
|
110 |
11 |
p. 4373
|
artikel
|
| 4254 |
Safety and Efficacy of the Combination of Bortezomib with the Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Trial.
|
Prince, Miles
|
|
|
110 |
11 |
p. 1167
|
artikel
|
| 4255 |
Safety and Efficacy Study of Subcutaneous Homoharringtonine (SC HHT) in Imatinib (IM)-Resistant Chronic Myeloid Leukemia (CML) with the T315I Mutation - Initial Report of a Phase II Trial.
|
Khoury, H. Jean
|
|
|
110 |
11 |
p. 1050
|
artikel
|
| 4256 |
Safety and Tolerability of Intrathecal Liposomal Cytarabine during CNS Prophylaxis in Patients with Non Hodgkin Lymphoma and Acute Lymphoblastic Leukemia.
|
Annino, Luciana
|
|
|
110 |
11 |
p. 4460
|
artikel
|
| 4257 |
Safety of Eltrombopag, an Oral Non-Peptide Platelet Growth Factor, in the Treatment of Thrombocytopenia: Results of Four Randomized, Placebo-Controlled Studies
|
Bussel, James B.
|
|
|
110 |
11 |
p. 1299
|
artikel
|
| 4258 |
Safety of Intrathecal Liposomal Cytarabine (Depocyte®) Injection Given Prophylactically in Patients with High-Risk Diffuse Large B-Cell Lymphoma: A Report of 22 Patients in Spain.
|
Canales, Miguel A.
|
|
|
110 |
11 |
p. 4459
|
artikel
|
| 4259 |
Safety of Lumbar Puncture (LP) and Instillation of Intrathecal (IT) Chemotherapy during Thrombocytopenia in Adults with Acute Lymphocytic Leukemia (ALL).
|
Atallah, Ehab
|
|
|
110 |
11 |
p. 4347
|
artikel
|
| 4260 |
Safety of MGMT Gene Transfer into Hematopoietic Progenitors: A Phase I Clinical Trial Using Retroviral Gene Transfer of G156A MGMT To Protect Hematopoiesis during BG Plus Alkylating Agent Treatment of Advanced Malignancies.
|
Reese, Jane S.
|
|
|
110 |
11 |
p. 500
|
artikel
|
| 4261 |
Safety of Recombinant Adeno-Associated Viral Vectors in a Large Animal Model.
|
Favaro, Patricia
|
|
|
110 |
11 |
p. 2586
|
artikel
|
| 4262 |
Safety Profile of Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) from Post-Authorization Safety Surveillance (PASS) Program.
|
Luu, Huong
|
|
|
110 |
11 |
p. 3972
|
artikel
|
| 4263 |
Safety, Tolerability, and Pharmacology of Bortezomib in Cancer Patients with Renal Failure Requiring Dialysis: Results from a Prospective Phase 1 Study.
|
Mulkerin, Daniel
|
|
|
110 |
11 |
p. 3477
|
artikel
|
| 4264 |
SAGE Analysis Demonstrates Increased Expression of TOSO Contributing to Fas Mediated Resistance in CLL.
|
Proto-Siqueira, Rodrigo
|
|
|
110 |
11 |
p. 1121
|
artikel
|
| 4265 |
SALL4-Dependent Signaling Networks Are Required for Survival of Leukemia Cells.
|
Yang, Jianchang
|
|
|
110 |
11 |
p. 2635
|
artikel
|
| 4266 |
Salmonella Arizonae Bacteremia Associated with Septic Arthritis Following Consumption of Rattlesnake Capsules in a Patient with Idiopathic Thrombocytopenic Purpura (ITP) on Chronic Steroid Therapy.
|
Herrada, Juan
|
|
|
110 |
11 |
p. 3919
|
artikel
|
| 4267 |
Salvage Therapy with Intravenous Bortezomib, Melphalan and Dexamathasone in Previously Treated Myeloma Patients.
|
Di Raimondo, Francesco
|
|
|
110 |
11 |
p. 2728
|
artikel
|
| 4268 |
Salvage Therapy with Standard Dose Cytarabine Is Appropriate for Patients with Acute Myelogenous Leukemia Refractory to Front-Line Therapy with Hypomethylating Agents.
|
Borthakur, Gautam
|
|
|
110 |
11 |
p. 4382
|
artikel
|
| 4269 |
S-2209, a Novel, Non-Boronic Proteasome Inhibitor, Induces Apoptosis and Cell Growth Arrest in Multiple Myeloma Cells.
|
Baumann, Philipp
|
|
|
110 |
11 |
p. 1513
|
artikel
|
| 4270 |
SB1317, a Potent and Orally Active FLT3-CDK Inhibitor with High Anti-Tumor Efficacy in Models of Hematological Malignancies.
|
Goh, Kee C.
|
|
|
110 |
11 |
p. 1593
|
artikel
|
| 4271 |
SB939: A Potent and Orally Active HDAC Inhibitor for the Treatment of Hematological Malignancies.
|
Sangthongpitag, Kanda
|
|
|
110 |
11 |
p. 1603
|
artikel
|
| 4272 |
SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders.
|
Goh, Kee C.
|
|
|
110 |
11 |
p. 538
|
artikel
|
| 4273 |
Screening for Copy Number Alterations and Loss of Heterozygosity in Chronic Lymphocytic Leukemia - A Comparative Study of Four Differently Designed, High Resolution Microarray Platforms.
|
Gunnarsson, Rebeqa
|
|
|
110 |
11 |
p. 2084
|
artikel
|
| 4274 |
Screening for Hemochromatosis by Measuring Ferritin Levels: A More Effective Approach.
|
Waalen, Jill
|
|
|
110 |
11 |
p. 2673
|
artikel
|
| 4275 |
Screening for Leptomeningeal Disease by High-Sensitivity Flow Cytometry in High Risk Patients with Aggressive Non-Hodgkin's Lymphoma.
|
Mangel, Joy
|
|
|
110 |
11 |
p. 4397
|
artikel
|
| 4276 |
Screening for TP53 Mutations Identifies Chronic Lymphocytic Leukemia Patients with Rapid Disease Progression.
|
Dicker, Frank
|
|
|
110 |
11 |
p. 490
|
artikel
|
| 4277 |
Screening of Homozygous Deletions Identifies Key Deregulated Genes and Pathways in Multiple Myeloma.
|
Leone, Paola E.
|
|
|
110 |
11 |
p. 2474
|
artikel
|
| 4278 |
Screening of Mutations in BCR-ABL Kinase Domain in Chronic Myeloid Leukemia (CML) Patients Treated with Kinase Inhibitors by Denaturing High-Performance Liquid Chromatography (D-HPLC).
|
Mascarenhas, Cintia C.
|
|
|
110 |
11 |
p. 4580
|
artikel
|
| 4279 |
Screening of Pathogenicity-Related Genes in Bone Marrow CD4+ T Cells of Aplastic Anemia Patients.
|
Zheng, Miao
|
|
|
110 |
11 |
p. 3760
|
artikel
|
| 4280 |
SDF-1 Is Responsible for the Constitutively High NF-kB Activity in Human Myeloma Cells.
|
Islam, Abul
|
|
|
110 |
11 |
p. 4737
|
artikel
|
| 4281 |
Secondary Acute Myeloid Leukemia and Myelodysplastic Syndromes Following ATRA and Anthracycline Monochemotherapy Treatment for Acute Promyelocytic Leukemia.
|
Montesinos, Pau
|
|
|
110 |
11 |
p. 1838
|
artikel
|
| 4282 |
Secondary Antifungal Prophylaxis with Liposomal Amphotericin B (AmB-L) in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
|
Busca, Alessandro
|
|
|
110 |
11 |
p. 4972
|
artikel
|
| 4283 |
Secondary Malignancies after Treatment of Aggressive Non-Hodgkin Lymphoma: A GISL Cohort Study on 1259 Patients.
|
Sacchi, Stefano
|
|
|
110 |
11 |
p. 522
|
artikel
|
| 4284 |
Secondary Prophylaxis in a Cohort of Adolescent and Adult Italian Hemophiliacs.
|
Tagliaferri, Annarita
|
|
|
110 |
11 |
p. 1148
|
artikel
|
| 4285 |
Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer Disease Free Interval after First ASCT.
|
Mikhael, Joseph R.
|
|
|
110 |
11 |
p. 946
|
artikel
|
| 4286 |
Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma (NHL).
|
Seshadri, Tara
|
|
|
110 |
11 |
p. 1673
|
artikel
|
| 4287 |
Second Report of Clinical Significance of sFas for DLBCL Treated with CHOP and New Analysis of sFas for DLBCL Treated with R-CHOP.
|
Tsurumi, Hisashi
|
|
|
110 |
11 |
p. 1570
|
artikel
|
| 4288 |
Second Transplant with HLA Haplo-Identical Hematopoietic Stem Cells for Graft Failure after Double Units Cord Blood Transplantation.
|
Yao, Wen
|
|
|
110 |
11 |
p. 5058
|
artikel
|
| 4289 |
Secretion of Angiogenic Proteins by Human Multipotent Mesenchymal Stromal Cells (MSC) under Hypoxic Culture Conditions and Clinical Application of MSC in Steroid Induced Osteonecrosis in Children.
|
Müller, Ingo
|
|
|
110 |
11 |
p. 3689
|
artikel
|
| 4290 |
Selected Members of the Angiopoietin-Like Family of Human Proteins Enhance Survival and Replating Capacity of Immature Human Hematopoietic Progenitor Cells.
|
Broxmeyer, Hal E.
|
|
|
110 |
11 |
p. 3367
|
artikel
|
| 4291 |
Selective Depletion of Alloreactive T Cells and Study of Anti-Tumor Activity of Specific T Cell Clones in Patients with Leukemia and Renal Carcinoma.
|
Matejkova, Eva
|
|
|
110 |
11 |
p. 3250
|
artikel
|
| 4292 |
Selective Inhibition of Glycogen Synthase Kinase-3 by Facilitators of Insulin Response Promotes Proliferation and Survival in Multiple Myeloma Cells.
|
Jernberg-Wiklund, Helena
|
|
|
110 |
11 |
p. 4789
|
artikel
|
| 4293 |
Selective Inhibition of JAK2 Driven Erythroid Differentiation of Polycythemia Vera Progenitors
|
Geron, Ifat
|
|
|
110 |
11 |
p. 1526
|
artikel
|
| 4294 |
Selective Silencing of the NPM1 Mutant Protein and Apoptosis Induction upon ATRA In Vitro Treatment of AML Cells Carrying NPM1 Mutations.
|
Martelli, M.P.
|
|
|
110 |
11 |
p. 868
|
artikel
|
| 4295 |
Selective Targeting of the JAK2V617F Mutation in Polycythemia Vera and Essential Thrombocythemia by ITF2357, a Novel Histone Deacetylase Inhibitor.
|
Guerini, Vittoria
|
|
|
110 |
11 |
p. 555
|
artikel
|
| 4296 |
Selective Uptake and Intracellular Distribution of Covalently Multimerized Human Stem Cell Factor (SCF)-Fusion Proteins into Human c-kit+ Acute Myeloid Leukemia (AML) Cells.
|
Sadowski, Julia
|
|
|
110 |
11 |
p. 1594
|
artikel
|
| 4297 |
Selenium Enhances the Anti-Angiogenic Effects of Bevacuzimab (Anti-VEGF Antibody) in Human Acute Myeloid Leukemia Xenograft Models.
|
Doro, Nathaniel C.
|
|
|
110 |
11 |
p. 4216
|
artikel
|
| 4298 |
Self Renewal and Proliferative Signals in the Bone Marrow Microenvironment Promote Homeostatic Peripheral Expansion of Donor-Derived T Cell Subsets Following Stem Cell Transplantation.
|
Chua, Hui Lin
|
|
|
110 |
11 |
p. 3260
|
artikel
|
| 4299 |
Sensitive NOD-scid-IL2γnull (NOG-scid) Assay for Human Precursor B Acute Lymphoblastic Leukemias (ALL).
|
Morisot, Sebastien
|
|
|
110 |
11 |
p. 4286
|
artikel
|
| 4300 |
Sequencing an Acute Myeloid Leukemia (AML) Genome with “Next Generation” Technologies.
|
Ley, Timothy James
|
|
|
110 |
11 |
p. 205
|
artikel
|
| 4301 |
Sequencing of Subcloned PCR Products Facilitates Earlier Detection of BCR-ABL1
T315I
Mutants Compared to Direct Sequencing of the ABL1 Kinase Domain.
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 1952
|
artikel
|
| 4302 |
Sequential Serum Cytokine Levels after Autologous, Related and Unrelated Allogeneic Stem Cell Transplantation: Reflection of Immune Reactivity and Reconstitution.
|
Fagoaga, Omar R.
|
|
|
110 |
11 |
p. 3885
|
artikel
|
| 4303 |
Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - A New Standard in Therapy?.
|
Trappe, Ralf
|
|
|
110 |
11 |
p. 390
|
artikel
|
| 4304 |
Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with VELCADE for Newly Diagnosed Multiple Myeloma: Interim Results of Phase II Trial.
|
Yoon, Sung-Soo
|
|
|
110 |
11 |
p. 952
|
artikel
|
| 4305 |
Serial Analysis of Hematopoietic Progenitors in Mpl−/− Mice.
|
Kaffanke, Janet
|
|
|
110 |
11 |
p. 2100
|
artikel
|
| 4306 |
Serial Serum Cytokine Measurement in a Patient with Systemic Scleromyxedema.
|
Devos, Timothy
|
|
|
110 |
11 |
p. 5100
|
artikel
|
| 4307 |
Serum Amyloid A Induces G-CSF Expression and Granulocytosis Via Toll-Like Receptor 2.
|
He, Rong L.
|
|
|
110 |
11 |
p. 3305
|
artikel
|
| 4308 |
Serum BAFF (B-Cell Activating Factor of the TNF Family) Compared with Immunoglobulin Heavy-Chain Mutation Status, ZAP-70 and CD38 as a Predictor of Time to First Treatment in Early B-Cell Chronic Lymphocytic Leukemia.
|
Molica, Stefano
|
|
|
110 |
11 |
p. 3093
|
artikel
|
| 4309 |
Serum B-Cell Activating Factor (BAFF) in Diffuse Large B-Cell Lymphoma: Its Prognostic Significance in the Rituximab Era.
|
Kim, Seok Jin
|
|
|
110 |
11 |
p. 1575
|
artikel
|
| 4310 |
Serum Concentrations of DKK-1 Correlate with the Extent of Bone Disease in Multiple Myeloma.
|
Kaiser, Martin
|
|
|
110 |
11 |
p. 3518
|
artikel
|
| 4311 |
Serum Cytokine Levels Predict Time to Progression after Rituximab as Initial Therapy in Patients with Follicular Grade 1 Non-Hodgkin Lymphoma.
|
Ansell, Stephen M.
|
|
|
110 |
11 |
p. 3410
|
artikel
|
| 4312 |
Serum Evaluation of a Panel of 10 Cytokines in Patients with Follicular Lymphoma: High Serum Level of TGF-β Correlates with Good Prognosis, Independently of the FLIPI Score.
|
Ghesquieres, Herve
|
|
|
110 |
11 |
p. 2604
|
artikel
|
| 4313 |
Serum Free Light Chain Analysis Improves Monitoring of Multiple Myeloma Patients Receiving First-Line Therapy with the Combination of Velcade, Doxil, and Dexamethasone (VDD).
|
Lebovic, Daniel
|
|
|
110 |
11 |
p. 2736
|
artikel
|
| 4314 |
Serum Free Light Chain Assessment in 311 Patients with Gammopathy.
|
Trigo, Fernanda
|
|
|
110 |
11 |
p. 4750
|
artikel
|
| 4315 |
Serum Immunoglobulin Free Light Chain (sFLC) Is a Sensitive Marker of Response in Waldenstrom Macroglobulinemia (WM).
|
Leleu, Xavier
|
|
|
110 |
11 |
p. 1486
|
artikel
|
| 4316 |
Serum Level of Hepcidin and Erythropoietic Activity after Hematopoietic Stem Cell Transplantation.
|
Kanda, Junya
|
|
|
110 |
11 |
p. 3000
|
artikel
|
| 4317 |
Serum-Soluble Interleukin-2 Receptor (sIL-2R) Is an Extremely Strong Prognostic Factor for Patients with Peripheral T-Cell Lymphoma, Unspecified (PTCL-U).
|
Hara, Takeshi
|
|
|
110 |
11 |
p. 3455
|
artikel
|
| 4318 |
Serum Uric Acid Is a Novel Prognostic Factor in Patients with Primary Systemic Amyloidosis.
|
Kumar, Shaji K.
|
|
|
110 |
11 |
p. 658
|
artikel
|
| 4319 |
Several Somatic Mutations of JAK2 Exon 12 Are Found in Patients with a JAK2 (V617F)-Negative Myeloproliferative Disorder That Is Mainly Characterized by Erythrocytosis.
|
Pietra, Daniela
|
|
|
110 |
11 |
p. 263
|
artikel
|
| 4320 |
Severe Donor Events after Allogeneic Hematopoietic Stem Cell Donation.
|
Halter, Jörg
|
|
|
110 |
11 |
p. 3276
|
artikel
|
| 4321 |
Severe Hemolysis Due to Passenger Lymphocyte Syndrome in Three Recipients of Organs from a Donor with Multiple Red Cell Alloantibodies.
|
Shortt, Jake
|
|
|
110 |
11 |
p. 4023
|
artikel
|
| 4322 |
Severe Refractory Autoimmune Hemolytic Anemia with Both Warm and Cold Autoantibodies: Complete Response with Rituximab.
|
Gupta, Shilpi
|
|
|
110 |
11 |
p. 4030
|
artikel
|
| 4323 |
SFRP1 Is Estrogen Inducible in Bone Marrow Stromal Cells and Suppresses the Earliest Events in Lymphopoiesis.
|
Yokota, Takafumi
|
|
|
110 |
11 |
p. 611
|
artikel
|
| 4324 |
SGN-33, Lintuzumab, Demonstrates Anti-Leukemic Activity in Preclinical Models of AML.
|
Sutherland, May S.K.
|
|
|
110 |
11 |
p. 919
|
artikel
|
| 4325 |
SGX70393 Inhibits Bcr-AblT315I In Vitro and In Vivo and Completely Suppresses Resistance When Combined with Nilotinib or Dasatinib.
|
O'Hare, Thomas
|
|
|
110 |
11 |
p. 535
|
artikel
|
| 4326 |
SHIP-1 Differentially Regulates Dense Granule Secretion in Platelets through Its Association with Protein Kinase C δ.
|
Chari, Ramya
|
|
|
110 |
11 |
p. 3630
|
artikel
|
| 4327 |
Short and Long Term Efficacy of Autologous Bone Marrow Cells To Support Intensive Chemotherapy in Patients Failing Peripheral Blood Stem Cell Mobilization.
|
Seshadri, Tara
|
|
|
110 |
11 |
p. 2999
|
artikel
|
| 4328 |
Short Hairpin RNA-Mediated Inhibition of Bcl-2 Gene Increases Susceptibility to Methotrexate and Suppresses Lymphoma Growth In Vitro and In Vivo.
|
Fang, Baoying
|
|
|
110 |
11 |
p. 4513
|
artikel
|
| 4329 |
Short Telomeres Combined with Low Telomerase Activity Are Associated with a Longer Survival in Patients with Acute Myeloid Leukemia.
|
Saada, Veronique
|
|
|
110 |
11 |
p. 4262
|
artikel
|
| 4330 |
Short-Term Cost Per Responder among New Tyrosine Kinase Inhibitors for Imatinib-Resistant CML in Chronic Phase (CML-CP) — Canada and Germany Perspectives.
|
Carpiuc, Kim
|
|
|
110 |
11 |
p. 4587
|
artikel
|
| 4331 |
Short-Term Ionomycin Exposure Activates Naive Murine T-Cells and Induces a Rapid Phenotypic Shift to Memory T-Cell Status: Potential for Use as a Method To Reduce GvHD Activity of Allogeneic T-Cells.
|
Hossain, Mohammad
|
|
|
110 |
11 |
p. 2182
|
artikel
|
| 4332 |
Short Term Outcome after Allogeneic Stem Cell Transplantation in 70 Cases of Severe Aplastic Anaemia.
|
Ahmed, Parvez
|
|
|
110 |
11 |
p. 5046
|
artikel
|
| 4333 |
Should Hematopoietic Stem Cell Transplantation in First Complete Remission Be Restricted to High-Risk Patients in Childhood Acute Myeloid Leukemia?.
|
Muramatsu, Hideki
|
|
|
110 |
11 |
p. 1094
|
artikel
|
| 4334 |
Should Patients with Myelodysplasia and/or Acute Myeloid Leukemia (MDS/AML) Be Screened for Inherited RUNX1 Mutations Prior to Sibling Donor Allografting?.
|
Owen, Carolyn J.
|
|
|
110 |
11 |
p. 5027
|
artikel
|
| 4335 |
Should the Initial Starting Dose of Imatinib for Treatment of Some Patients with Chronic Myelocytic Leukemia (CML) Be Lower Than 400 mg Daily?.
|
Shojania, A. Majid
|
|
|
110 |
11 |
p. 4550
|
artikel
|
| 4336 |
Should Troponin Level Be an Exclusion Criterion for Stem Cell Transplantation in Primary Amyloidosis?.
|
Gertz, Morie Abraham
|
|
|
110 |
11 |
p. 3003
|
artikel
|
| 4337 |
Sickle Cell Disease Mortality in the United States: Age at Death and Contributing Causes.
|
Haywood Jr., Carlton
|
|
|
110 |
11 |
p. 81
|
artikel
|
| 4338 |
Sickle Cell Trait, Oral Contraceptives, and the Risk of Venous Thromboembolism.
|
Austin, Harland
|
|
|
110 |
11 |
p. 1627
|
artikel
|
| 4339 |
Sickle Cell Vaso-Occlusion Is Triggered by E-Selectin Ligand Signaling and Propagated by the Leukocyte Integrin Mac-1.
|
Hidalgo, Andres
|
|
|
110 |
11 |
p. 145
|
artikel
|
| 4340 |
Sickle RBCs Stimulate Human Monocyte Cytokine Expression.
|
Xu, Ke
|
|
|
110 |
11 |
p. 2255
|
artikel
|
| 4341 |
Signaling Pathways of All-Trans Retinoic Acid (ATRA)-Induced Apoptosis in Mantle Cell Lymphoma (MCL).
|
Singh, Amareshwar T.K.
|
|
|
110 |
11 |
p. 1583
|
artikel
|
| 4342 |
Signaling Profile and Anti-Tumor Activity of the Novel HSP90 Inhibitor NVP-AUY922 in Multiple Myeloma.
|
Stühmer, Thorsten
|
|
|
110 |
11 |
p. 4788
|
artikel
|
| 4343 |
Significance of Copy Number Alterations for Molecular Treatment Response in Childhood Acute Lymphoblastic Leukemia.
|
Steinemann, Doris
|
|
|
110 |
11 |
p. 1434
|
artikel
|
| 4344 |
Significance of Suboptimal Response to Imatinib, as Defined by the European LeukemiaNet, in Long-Term Outcome for Patients (Pts) with Chronic Phase (CP) Chronic Myeloid Leukemia (CML).
|
Alvarado, Yesid
|
|
|
110 |
11 |
p. 1932
|
artikel
|
| 4345 |
Significance of Telomere Length Measurement in the Diagnosis of Dyskeratosis Congenita.
|
Du, Hong-Yan
|
|
|
110 |
11 |
p. 836
|
artikel
|
| 4346 |
Significant Activity of Dasatinib in CLL Demonstrated by Ex-Vivo Assay.
|
Sigal, Darren S.
|
|
|
110 |
11 |
p. 4197
|
artikel
|
| 4347 |
Significant Alterations in T-Cell TH1 and TH2 Cytokine Gene Profiles Associated with G-CSF Mobilization Do Not Occur in T-Cells Mobilized with AMD3100.
|
Smith, Aleah L.
|
|
|
110 |
11 |
p. 3277
|
artikel
|
| 4348 |
Significant Disease Burden in Paroxysmal Nocturnal Hemoglobinuria Patients with Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion: Clinical Improvement with Eculizumab Therapy.
|
Bessler, Monica
|
|
|
110 |
11 |
p. 840
|
artikel
|
| 4349 |
Significantly Shorter Telomeres in T-Cells of ZAP-70+/CD38+ Patients with Chronic Lymphocytic Leukemia (CLL): An Important Role of T-Cells in This Subgroup of CLL?.
|
Roeth, Alexander
|
|
|
110 |
11 |
p. 1120
|
artikel
|
| 4350 |
Significant Role of Peptidyl-Prolyl cis/trans Isomerase, Pin1 in Acute Myeloid Leukemia with C/EBPα Mutations.
|
Pulikkan, John Anto
|
|
|
110 |
11 |
p. 55
|
artikel
|
| 4351 |
Silencing of γ-Globin Gene Expression during Adult Definitive Erythropoiesis Is Mediated by a GATA-1 Repressor Complex.
|
Peterson, Kenneth R.
|
|
|
110 |
11 |
p. 271
|
artikel
|
| 4352 |
Similar Background of Graft-Versus-Host Disease (GVHD) Following Allogeneic Blood and Marrow Transplantation (Tx) in Korean and Japanese Populations Allows a Uniform Foundation To Perform Large-Scale Clinical Studies in the Region.
|
Kim, Sung-Won
|
|
|
110 |
11 |
p. 5007
|
artikel
|
| 4353 |
Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.
|
Firoozeh, Sahebi
|
|
|
110 |
11 |
p. 3030
|
artikel
|
| 4354 |
Similar Risks for Late-Onset Chronic Kidney Disease in Myeloablative and Reduced-Intensity Allogeneic Hematopoietic Cell Transplant Survivors.
|
Al-Hazzouri, Ahmed
|
|
|
110 |
11 |
p. 3008
|
artikel
|
| 4355 |
Simple, Gel-Based Determination of Nucleophosmin Mutations in Acute Myeloid Leukemias.
|
Ahrens, Kim P.
|
|
|
110 |
11 |
p. 4268
|
artikel
|
| 4356 |
Simultaneous Haploidentically Mismatched Stem Cell Transplantation from Multi-Donors (MDT) in Humans Offers Better Engraftment as Compared to Single Haploidentical Donor.
|
Shapira, Michael Y.
|
|
|
110 |
11 |
p. 4854
|
artikel
|
| 4357 |
Simultaneous Targeting of Aurora Kinases and Bcr-Abl by the Small Molecule Inhibitor PHA-739358 Is Effective in Imatinib-Resistant Mutations Including T315I.
|
Gontarewicz, Artur
|
|
|
110 |
11 |
p. 1042
|
artikel
|
| 4358 |
Single Amino Acid Substitution (Asp111Ala) in Coagulation Factor Va Causes Subunit Dissociation and Disrupted Calcium and Copper Binding.
|
Song, Jina
|
|
|
110 |
11 |
p. 2699
|
artikel
|
| 4359 |
Single and Multiple Oral Doses of LGD-4665, a Small Molecule Thrombopoietin Receptor Agonist, Increase Platelet Counts in Healthy Male Subjects
|
Dziewanowska, Zofia E.
|
|
|
110 |
11 |
p. 1298
|
artikel
|
| 4360 |
Single and Tandem Autologous Peripheral Blood Stem Cell Transplantation for Patients with Multiple Myeloma: A Korean Multicenter Retrospective Study.
|
Sym, Sun Jin
|
|
|
110 |
11 |
p. 5132
|
artikel
|
| 4361 |
Single-Cell Analysis of FVIII-Specific Memory B Cells in Murine Hemophilia A.
|
Hausl, Christina
|
|
|
110 |
11 |
p. 1157
|
artikel
|
| 4362 |
Single Center Experience with Philadelphia Chromosome-Positive Acute Myeloid Leukemia.
|
Delmonte Jr., John
|
|
|
110 |
11 |
p. 3505
|
artikel
|
| 4363 |
Single Dose Administration of rFVIIa and NN1731 in Two Hemophilia A Dogs.
|
Ezban, Mirella
|
|
|
110 |
11 |
p. 3144
|
artikel
|
| 4364 |
Single-Institute Comparable Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated and Related Donor in Patients with Myeloid Malignancies.
|
Yano, Shingo
|
|
|
110 |
11 |
p. 4946
|
artikel
|
| 4365 |
Single Institution Outcomes for Early Stage Follicular Lymphomas Treated with Radiation Therapy Alone as Initial Therapy.
|
Owen, Tymothy E.
|
|
|
110 |
11 |
p. 4457
|
artikel
|
| 4366 |
Single Mismatched Expanded Cord Blood Transplantation for the Treatment of Hematological Diseases.
|
Sun, Zimin
|
|
|
110 |
11 |
p. 4056
|
artikel
|
| 4367 |
Single-Stranded DNA-Binding Proteins (SSBPs) Regulate the Abundance of the LIM-Homeodomain Protein LHX2 and Augment Its Transcriptional Activity.
|
Cai, Ying
|
|
|
110 |
11 |
p. 1239
|
artikel
|
| 4368 |
siRNA Knockdown of MMSET Disrupts Cell Cycle and Induces Apoptosis in t(4;14) Myeloma.
|
Brito, Jose
|
|
|
110 |
11 |
p. 245
|
artikel
|
| 4369 |
siRNA Mediated Knockdown of the Chimeric Transcription Factor E2A-PBX1 Identifies Potential Target Genes.
|
Chen, Chun-Liang
|
|
|
110 |
11 |
p. 3179
|
artikel
|
| 4370 |
Sirolimus as Primary Immunoprophyllaxis for Alternative Donor Allotranspplant after Non-Myeloablative Conditioning.
|
Karch, Jon M.
|
|
|
110 |
11 |
p. 3069
|
artikel
|
| 4371 |
Sistematic Analysis of ABO Gene in A3 and A3B Individuals Reveals New ABO Variants.
|
Domingues, Alexandre E.
|
|
|
110 |
11 |
p. 2898
|
artikel
|
| 4372 |
Skeletal Involvement in Advanced Stage Lymphomas: Role of Total Body Magnetic Resonance.
|
Rusconi, Chiara
|
|
|
110 |
11 |
p. 4405
|
artikel
|
| 4373 |
Skin Changes on Continued Imatinib Therapy in Patients with Ph+ CML.
|
Saikia, Tapan
|
|
|
110 |
11 |
p. 2963
|
artikel
|
| 4374 |
Sliding-Rebinding Mechanism Governs Glycoprotein Ib/von Willebrand Factor Catch Bonds.
|
Lou, Jizhong
|
|
|
110 |
11 |
p. 3723
|
artikel
|
| 4375 |
Small Leucine-Rich Proteoglycans (SLRPs) Are Involved in the Anti-Myeloma Response of Osteoblasts.
|
Li, Xin
|
|
|
110 |
11 |
p. 815
|
artikel
|
| 4376 |
Small Molecule Inhibitor of Neutrophil Elastase Restores Impaired Production of Human Myeloid Cells Observed in Severe Congenital Neutropenia.
|
Aprikyan, Andrew A.
|
|
|
110 |
11 |
p. 664
|
artikel
|
| 4377 |
Small Molecules Targeting Rad51 Recombinase Synergize with Imatinib and Overcome Imatinib-Resistance in CML.
|
Zhou, Longen
|
|
|
110 |
11 |
p. 466
|
artikel
|
| 4378 |
Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.
|
Cillessen, Saskia A.G.M.
|
|
|
110 |
11 |
p. 803
|
artikel
|
| 4379 |
SMRT; Not So Smart in Multiple Myeloma.
|
Ghoshal, Pushpankur
|
|
|
110 |
11 |
p. 4137
|
artikel
|
| 4380 |
SNP-A Based Karyotyping Facilitates Improved Mapping of Deletions and Uniparental Disomy within the Long Arm of Chromosome 5 in Myeloid Disorders.
|
Gondek, Lukasz P.
|
|
|
110 |
11 |
p. 2435
|
artikel
|
| 4381 |
SNP-A Karyotyping Demonstrates a High Incidence of Segmental Uniparental Disomy in Patients with CMML and Shows Impact of Newly Identified Chromosomal Aberrations on Clinical Course.
|
Dunbar, Andrew J.
|
|
|
110 |
11 |
p. 2428
|
artikel
|
| 4382 |
SNP Array Analysis Reveals Copy Number Alterations and Uniparental Disomy in Mantle Cell Lymphomas at High Resolution.
|
Hartmann, Elena M.
|
|
|
110 |
11 |
p. 1585
|
artikel
|
| 4383 |
SNP-Array-Based Karyotyping Has Impact on Cytogenetic Diagnosis and Prognosis of Non-Core Binding Factor Primary and Secondary AML.
|
Tiu, Ramon V.
|
|
|
110 |
11 |
p. 597
|
artikel
|
| 4384 |
SNP Array Karyotyping Improves Detection Rate of Clonal Chromosomal Abnormalities in Refractory Anemia with Ringed Sideroblasts.
|
Ghazal, Theodore
|
|
|
110 |
11 |
p. 4132
|
artikel
|
| 4385 |
SNP-Array Karyotyping Reveals the Presence of Previously Cryptic Clonal Chromosomal Aberrations Including Segmental UPD in Patients with Fanconi Anemia.
|
Wlodarski, Marcin
|
|
|
110 |
11 |
p. 1678
|
artikel
|
| 4386 |
SNP Arrays Facilitate Genotyping of Non-Synonymous SNP in MDS To Identify Disease Susceptibility Loci.
|
Jankowska, Anna M.
|
|
|
110 |
11 |
p. 2421
|
artikel
|
| 4387 |
SNP Chip Analysis of Myelodysplastic Syndromes Disclosed High Frequency of Uniparental Disomy and a Novel Dominant Mutation as the Target of 11q UPD.
|
Sanada, Masashi
|
|
|
110 |
11 |
p. 119
|
artikel
|
| 4388 |
SNS-595 Demonstrates Clinical Responses in a Phase 1 Study in Acute Leukemia.
|
Lancet, Jeffrey
|
|
|
110 |
11 |
p. 442
|
artikel
|
| 4389 |
Socio-Economic and Clinical Factors Are Associated with In-Hospital Mortality in Patients Admitted for Diffuse Large B-Cell Lymphoma.
|
Morgan, James S.
|
|
|
110 |
11 |
p. 3316
|
artikel
|
| 4390 |
SOCS2 Expression in AML: A Context Dependent Effect?.
|
McIntosh, Courtney A.L.
|
|
|
110 |
11 |
p. 4152
|
artikel
|
| 4391 |
Sodium Gluconate Containing Parenteral Nutrition Solution as a Cause of False Positive Aspergillus Galactomannan Assay in Paediatric Patients with Hematological Malignancies.
|
Ribaud, Patricia
|
|
|
110 |
11 |
p. 4958
|
artikel
|
| 4392 |
Soluble BAFF Is Elevated Following Allogeneic SCT but Is Not an Early Predictor for the Development of cGVHD.
|
Dickinson, John D.
|
|
|
110 |
11 |
p. 167
|
artikel
|
| 4393 |
Soluble CD44 Is Increased in Haematopoietic Stem Cell Grafts of Patients with Acute Myeloid Leukemia, Multiple Myeloma and Non-Hodgkin's Lymphoma.
|
Krause, Daniela S.
|
|
|
110 |
11 |
p. 3286
|
artikel
|
| 4394 |
Soluble IL-6 Receptor Synergistically Stimulates the Growth of Multiple Myeloma with IL-6 and Confers Resistance to Bortezomib.
|
Lee, Young Y.
|
|
|
110 |
11 |
p. 4741
|
artikel
|
| 4395 |
Somatic Mutations in Factor VIII Inhibitors Determine Their Factor VIII Binding and Inhibitory Properties.
|
Mertens, Koen
|
|
|
110 |
11 |
p. 1762
|
artikel
|
| 4396 |
Species-Dependent Variability of ADAMTS-13 Mediated Proteolysis of Human Recombinant von Willebrand Factor.
|
Varadi, Katalin
|
|
|
110 |
11 |
p. 2139
|
artikel
|
| 4397 |
Specific Intensive Chemotherapy Plus Rituximab for Advanced Burkitt's Lymphoma or Leukemia in HIV-Positive and Negative Adult Patients.
|
Ribera, Josep-Maria
|
|
|
110 |
11 |
p. 3448
|
artikel
|
| 4398 |
Specific Micro-RNA Expression Profile in Hodgkin Lymphoma.
|
Ping Tan, Lu
|
|
|
110 |
11 |
p. 381
|
artikel
|
| 4399 |
Specific MiRNA Silencing by Lentivirus Mediated Antagomir Expression in Chronic Myeloid Leukemia (CML) Cells.
|
Scherr, Michaela
|
|
|
110 |
11 |
p. 1017
|
artikel
|
| 4400 |
Spectratype Analysis of In Vitro Donor Anti-Host T Cell Repertoire Responses Predict Those of In Vivo Post-BMT.
|
Friedman, Thea M.
|
|
|
110 |
11 |
p. 2163
|
artikel
|
| 4401 |
Spectrum of Thromboses in Patients with Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms: Continuing Controversy.
|
Sullivan, Kevin
|
|
|
110 |
11 |
p. 3979
|
artikel
|
| 4402 |
Sphingosine Kinase 1 as a Potential Target To Inhibit Proliferation of Myeloid Leukemia Cells.
|
Ricci, Clara
|
|
|
110 |
11 |
p. 4196
|
artikel
|
| 4403 |
Sphingosine-1 Phosphate (S1P) Is a Myeloma Survival Factor and Protects Myeloma Cells from Thalidomide-Induced Growth Inhibition by Counteracting Ceramide Activity.
|
Li, Xin
|
|
|
110 |
11 |
p. 3509
|
artikel
|
| 4404 |
Spindle Checkpoint Insufficiency in Acute Myeloid Leukemia.
|
Schnerch, Dominik
|
|
|
110 |
11 |
p. 873
|
artikel
|
| 4405 |
Spinning Disk Confocal Fluorescent Microscopy (SDCFM) Analyses of Complement Activation Promoted by Anti-CD20 Monoclonal Antibodies (mAbs) Rituximab and Ofatumumab.
|
Taylor, Ronald P.
|
|
|
110 |
11 |
p. 2345
|
artikel
|
| 4406 |
Spleen Related Complications and Implications of Splenectomy in Patients with Hemoglobin SC Disease.
|
Subbannan, Karthi
|
|
|
110 |
11 |
p. 3798
|
artikel
|
| 4407 |
Splenectomy in Patients with Chronic Myeloid Leukemia or Myeloproliferative Diseases: Outcomes, Complications and Prognostic Implications.
|
Tam, Constantine S.
|
|
|
110 |
11 |
p. 2553
|
artikel
|
| 4408 |
Spontaneous CD4 and CD8 Memory T Cell Responses Against MUC1 and Carcinoembryonic Antigen in Bone Marrow of Multiple Myeloma Patients.
|
Witzens-Harig, Mathias
|
|
|
110 |
11 |
p. 3533
|
artikel
|
| 4409 |
Spontaneous Tumoural Regression in a Patient with t(4;14) Translocation Multiple Myeloma. A Case Report.
|
Puig, Noemi
|
|
|
110 |
11 |
p. 4777
|
artikel
|
| 4410 |
Sporadic Bloody Diarrhea-Associated Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) in Adults in Oklahoma: Comparison to Adults with Severe Adamts13 Deficiency and to Children with Typical HUS.
|
Nguyen, Loan
|
|
|
110 |
11 |
p. 1317
|
artikel
|
| 4411 |
Stable Thrombus Formation in the Inferior Vena Cava in Response to FeCl3-Induced Injury Is GPIb-Dependent.
|
Joglekar, Manali
|
|
|
110 |
11 |
p. 3890
|
artikel
|
| 4412 |
Stage I/II Hodgkin's Disease: Comparison of Outcomes of Patients with Bulky Mediastinal Disease Versus Other Risk Factors; the Stanford V Experience.
|
Advani, Ranjana H.
|
|
|
110 |
11 |
p. 2316
|
artikel
|
| 4413 |
Stat5a Is Epigenetically Silenced by Oncogenic Tyrosine Kinase NPM/ALK and Acts as Tumor Suppressor by Reciprocally Inhibiting Expression of NPM/ALK.
|
Zhang, Qian
|
|
|
110 |
11 |
p. 4170
|
artikel
|
| 4414 |
STAT5A Overexpression Enhances Killer Immunoglobulin Receptor (KIR) Expression in Developing NK Cells and Is Associated with a Loss of Reverse Transcription from the Proximal KIR Promoter.
|
Cichocki, Frank M.
|
|
|
110 |
11 |
p. 798
|
artikel
|
| 4415 |
Statins Impair Antitumor Effects of CD20 mAb by Inducing Conformational Changes of CD20.
|
Golab, Jakub
|
|
|
110 |
11 |
p. 2341
|
artikel
|
| 4416 |
Statin Use and Risk of Non-Hodgkin Lymphoma (NHL): Preliminary Results from the Mayo Clinic Case-Control Study.
|
Cerhan, James R.
|
|
|
110 |
11 |
p. 2615
|
artikel
|
| 4417 |
Statistical Evidence for the Existence of a Regulatory Mechanism That Balances α-Globin and AHSP Expression in Erythroid Cells.
|
Fabucci, Maria Elena
|
|
|
110 |
11 |
p. 1775
|
artikel
|
| 4418 |
STAT3 Signaling in Donor-Derived CD4+ T-Cells Plays a Critical Role in the Induction of Acute and Chronic GVHD in Murine Models of alloBMT.
|
Radojcic, Vedran
|
|
|
110 |
11 |
p. 2179
|
artikel
|
| 4419 |
STAT5 Signaling Is Associated with the Outcome of Follicular and Mantle Cell Lymphoma Patients Treated with Immunochemotherapy.
|
Leppä, Sirpa
|
|
|
110 |
11 |
p. 2626
|
artikel
|
| 4420 |
Stem Cell Recovery Following Implementation of an Automated Cord Blood Processing System in a High Volume Laboratory.
|
Harris, David T.
|
|
|
110 |
11 |
p. 4919
|
artikel
|
| 4421 |
Stem Cell Transplantation (SCT) Improves Survival in Acute Biphenotypic (ABL) and Acute Undifferentiated Leukemia (AUL): A Single Centre Experience.
|
Narayanan, Sujaatha
|
|
|
110 |
11 |
p. 1093
|
artikel
|
| 4422 |
Stereotyped Patterns of Somatic Hypermutation (SHM) in Subsets of Patients with Chronic Lymphocytic Leukemia (CLL): Implications for the Role of Antigen Selection in Leukemogenesis.
|
Murray, Fiona
|
|
|
110 |
11 |
p. 744
|
artikel
|
| 4423 |
Stereotypic IGHV3-21/IGLV3-21 Antibodies Expressed in High-Risk Chronic Lymphocytic Leukemia Bind Peptostreptococcus Magnus Protein L.
|
Ghia, Emanuela M.
|
|
|
110 |
11 |
p. 740
|
artikel
|
| 4424 |
“Sticky Platelet Syndrome”: In Vitro Response to Small Dose Aspirin Is Reflected in Clinical Benefit.
|
Sahay, Tannu
|
|
|
110 |
11 |
p. 3212
|
artikel
|
| 4425 |
Streptamer Technology for the Assessment of CMVpp65 Specific CD8+ T Cell Frequencies and for the Adoptive T Cell Transfer to Post-Transplant Patients.
|
Schmitt, Anita
|
|
|
110 |
11 |
p. 1964
|
artikel
|
| 4426 |
Stroke in a Multiple Myeloma Cohort.
|
Keyrouz, Salah G.
|
|
|
110 |
11 |
p. 4772
|
artikel
|
| 4427 |
Stromal Cells Support a Myeloid Pathway of Human NK Cell Differentiation.
|
Grzywacz, Bartosz J.
|
|
|
110 |
11 |
p. 1336
|
artikel
|
| 4428 |
Structural Determinants for Heparin Binding in Human Coagulation Factor XI.
|
Shikov, Sergei
|
|
|
110 |
11 |
p. 2705
|
artikel
|
| 4429 |
Studies of the Affinity and Stoichiometry of Convulxin Binding to Glycoprotein VI: Clues into Its Potent Agonism.
|
Herr, Andrew B.
|
|
|
110 |
11 |
p. 3657
|
artikel
|
| 4430 |
Study of Expression of FLVCR in Childhood Thalassemic Patients Demonstrate the Importance of FLVCR in Effective Erythropoiesis.
|
Zhu, Yiping
|
|
|
110 |
11 |
p. 1687
|
artikel
|
| 4431 |
Study of In Vitro Proliferation Potential of CD133 Positive Cells Derived from Umbilical Cord Blood.
|
Zhang, Ri
|
|
|
110 |
11 |
p. 4039
|
artikel
|
| 4432 |
Study of NHEJ Function and Expression of Protein Ku70 in CML Patients.
|
Chen, Pei-shuai
|
|
|
110 |
11 |
p. 2934
|
artikel
|
| 4433 |
Study of Patients Having Splenectomy Due to Trauma for Long Term Infectious and Vascular Complications.
|
Purcell, Patricia L.
|
|
|
110 |
11 |
p. 974
|
artikel
|
| 4434 |
Study of the Correlation between Phenotype - Including Acute Leukemia/MDS- and Genotype in Shwachman Diamond Syndrome in 60 Patients from the French SCN Registry.
|
Donadieu, Jean
|
|
|
110 |
11 |
p. 3301
|
artikel
|
| 4435 |
Study on Clinical and Laboratory Characteristics of Chronic Eosinophilic Leukemia CEL/Hypereosinophilic Syndrome (CEL/HES).
|
Xiao, Zhijian
|
|
|
110 |
11 |
p. 4637
|
artikel
|
| 4436 |
Study on Dendritic Cells in Peripheral Blood of the Patients with Autoimmune Hemolytic Anemia/Evans Syndromes.
|
Shao, Zonghong
|
|
|
110 |
11 |
p. 3874
|
artikel
|
| 4437 |
Study on Early Diagnosis of Invasive Aspergillosis in Patients with Hematological Diseases.
|
Sun, Ai-ning
|
|
|
110 |
11 |
p. 4982
|
artikel
|
| 4438 |
Study on Effect Hemopoiesis Reconstituted of Auto-Mesenchymal Stromal Cells or Allo-Mesenchymal Stromal Cells Transplantion.
|
Wang, Chun Yan
|
|
|
110 |
11 |
p. 5056
|
artikel
|
| 4439 |
Study on Mechanism of Human Marrow Mesenchymal Stem Cell in Treating Patients with Aplastic Anemia.
|
Qiao, Zhenhua
|
|
|
110 |
11 |
p. 4099
|
artikel
|
| 4440 |
Study on Receptor-Regulated Smad Protein of Acute Promyelocytic Leukemia Cell Differentiation Process in TGF-β1 Signaling Pathway.
|
Lin, Jiayao
|
|
|
110 |
11 |
p. 4078
|
artikel
|
| 4441 |
Study on the Preparation of the Immunotoxin 2E8-NCTD and Its Targeting Killing Effect In Vitro.
|
Tang, Yongmin
|
|
|
110 |
11 |
p. 4186
|
artikel
|
| 4442 |
Study on the Role of Recombinant Factor VIIa in the Management of Intractable Blood Loss in Patients without Inherited Bleeding Disorder in a UK District General Hospital.
|
Choudhuri, Satarupa
|
|
|
110 |
11 |
p. 3145
|
artikel
|
| 4443 |
Subcutaneous Alemtuzumab Is Safe and Effective for Treatment of Global or Single-Lineage Immune-Mediated Marrow Failure: A Pilot Study.
|
Risitano, Antonio M.
|
|
|
110 |
11 |
p. 1692
|
artikel
|
| 4444 |
Subcutaneous Alemtuzumab (MabCampath) in Fludarabine-Refractory CLL (CLL2H Trial of the GCLLSG).
|
Stilgenbauer, Stephan
|
|
|
110 |
11 |
p. 3120
|
artikel
|
| 4445 |
Subcutaneous Alemtuzumab May Be Useful in the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.
|
Gomez-Almaguer, David
|
|
|
110 |
11 |
p. 2983
|
artikel
|
| 4446 |
Subcutaneous (sc) Anti-D Treatment of Childhood Idiopathic Thrombocytopenic Purpura (ITP).
|
Kjaersgaard, Mimi
|
|
|
110 |
11 |
p. 1312
|
artikel
|
| 4447 |
Subpopulations with Iron Deficiency, Liver Disease, or HFE Mutations Revealed by Statistical Mixture Modeling of Transferrin Saturation and Serum Ferritin Concentration in Asians, African Americans, Hispanics, and Whites.
|
McLaren, Christine E.
|
|
|
110 |
11 |
p. 2672
|
artikel
|
| 4448 |
Succesful Treatment with Sirolimus in a Refractory Case of Pure Red Cell Aplasia (PRCA).
|
Ovilla, Roberto
|
|
|
110 |
11 |
p. 3778
|
artikel
|
| 4449 |
Successful Administration of Rituximab To Prevent Recurrence of Delayed Haemolytic Transfusion Reaction Developed in a Sickle Cell Disease Patient.
|
Noizat-Pirenne, France
|
|
|
110 |
11 |
p. 2904
|
artikel
|
| 4450 |
Successful Engraftment of Cord Blood Transplantation Following Reduced-Intensity Conditioning Regimen Using Fludarabine and Busulfan for Advanced Hematologic Malignancies.
|
Satou, Yuji
|
|
|
110 |
11 |
p. 5066
|
artikel
|
| 4451 |
Successful Engraftment Using Varied Stem Cell Sources, Low Toxicity, and Long-Term Survival Using a Bu/Flu/ATG Reduced Intensity Allogeneic Transplantation in High Risk Pediatric Patients Ineligible for Myelablative Therapy: Results of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study ONC0313.
|
Pulsipher, Michael A.
|
|
|
110 |
11 |
p. 623
|
artikel
|
| 4452 |
Successful Full-Term Live Birth in an Allogeneic Stem Cell Transplant Patient with Active Extensive Chronic Graft-Versus-Host Disease.
|
Shah, Heather
|
|
|
110 |
11 |
p. 5016
|
artikel
|
| 4453 |
Successful Hematopoietic Stem Cell Transplantation in a Patient with a Novel DNA Ligase IV Mutation.
|
Unal, Sule
|
|
|
110 |
11 |
p. 5043
|
artikel
|
| 4454 |
Successful Isolation of Novel Cancer-Testis Antigens Suitable for Immunotherapy of Hematologic Malignancies Using a Yeast Two-Hybrid System in a Testicular cDNA Library.
|
Meklat, Farouk
|
|
|
110 |
11 |
p. 1215
|
artikel
|
| 4455 |
Successful Orthotopic Liver Transplantation in Severe Hemophilia A with High Responding Inhibitor.
|
Chen, Robert
|
|
|
110 |
11 |
p. 3968
|
artikel
|
| 4456 |
Successful Overcoming of Imatinib Resistance by Synergistic Effect of Imatinib and Simvastatin in Imatinib Resistant Chronic Myelogenous Leukemia Cell Line.
|
Oh, Bora
|
|
|
110 |
11 |
p. 4548
|
artikel
|
| 4457 |
Successful Peripheral Stem Cell Autologous Engraftment in Skin of a Patient with Severe Dermal Atrophy and Senile Purpura. First Venezuelan Report.
|
Herrera-Cepeda, Jorge I.
|
|
|
110 |
11 |
p. 4908
|
artikel
|
| 4458 |
Successful Preemptive Treatment of Molecular Relapse after Autologous Stem Cell Transplantation in Mantle Cell Lymphoma
|
Andersen, Niels S.
|
|
|
110 |
11 |
p. 1281
|
artikel
|
| 4459 |
Successful Production of Canine FVIII: Biochemical and Functional Characterization in Hemophilia A Dogs.
|
Freguia, Christian Furlan
|
|
|
110 |
11 |
p. 495
|
artikel
|
| 4460 |
Successful Reduced-Intensity Conditioning (RIC) Allogeneic Transplantation of Peripheral Blood Stem Cells and Bone Marrow Cells in an Advanced Idiopathic Myelofibrosis with Myeloid Myeloaplasia (MMM).
|
Jiang, Zhisheng
|
|
|
110 |
11 |
p. 5057
|
artikel
|
| 4461 |
Successful Stem Cell Mobilization Rescue by AMD3100 (Plerixafor)+G-CSF for Patients Who Failed Primary Mobilization: Results from the Phase III (3101-NHL) Study.
|
Micallef, Ivana
|
|
|
110 |
11 |
p. 602
|
artikel
|
| 4462 |
Successful Translation of a GMP-Based, Clinical Scale Selective Allodepletion Approach for Matched Donor-Recipient Pairs from Bench-to-Bedside.
|
Mielke, Stephan
|
|
|
110 |
11 |
p. 3279
|
artikel
|
| 4463 |
Successful Treatment of Factor IX Inhibitor Complicated by Nephrotic Syndrome with Rituxan.
|
Bernstein, Jonathan
|
|
|
110 |
11 |
p. 3971
|
artikel
|
| 4464 |
Successful Treatment of Pure Red Cell Aplasia after Major ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia with Repeated Doses of the Single-Agent Rituximab: A Case Report.
|
Mota, Karla O.
|
|
|
110 |
11 |
p. 4934
|
artikel
|
| 4465 |
Successful Use of Recombinant Factor IX Concentrate (Nonacog-alfa, Benefix®) in Two Patients with Severe Hemophilia B and Total Knee Replacement (TKR).
|
Gerhardt, Andrea
|
|
|
110 |
11 |
p. 3947
|
artikel
|
| 4466 |
Sucessful Management of Pregnancy and Remission-Induction of a Patient with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) by Means of Imatinib Mesilate and HyperCVAD.
|
Suzuki, Toshiya
|
|
|
110 |
11 |
p. 4327
|
artikel
|
| 4467 |
Sulindac Sulfide Reverts the Activation of the WNT-Signaling and Aberrant Self Renewal Induced by the AML-Associated Fusion Proteins PML/RARα and PLZF/RARα.
|
Steinert, Gunnar
|
|
|
110 |
11 |
p. 878
|
artikel
|
| 4468 |
Sumoylation of TRF1 Is Essential for Its Recruitment to ALT-Associated PML Bodies.
|
Yu, Jian
|
|
|
110 |
11 |
p. 4169
|
artikel
|
| 4469 |
Superdonors Have Decreased Iron Stores but Can Repeatedly Donate Whole Blood through Use of Iron Supplements and Decreased Serum Hepcidin Concentration.
|
Mast, Alan E.
|
|
|
110 |
11 |
p. 2887
|
artikel
|
| 4470 |
Superior Anti-Tumor Activity of the CD19-Directed Immunotoxin, SAR3419 to Rituximab in Non-Hodgkin's Xenograft Animal Models: Preclinical Evaluation.
|
Aboukameel, Amro
|
|
|
110 |
11 |
p. 2339
|
artikel
|
| 4471 |
Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.
|
Cavo, Michele
|
|
|
110 |
11 |
p. 730
|
artikel
|
| 4472 |
Superiority of Lenalidomide (Len) Plus High-Dose Dexamethasone (HD) Compared to HD Alone as Treatment of Newly-Diagnosed Multiple Myeloma (NDMM): Results of the Randomized, Double-Blinded, Placebo-Controlled SWOG Trial S0232.
|
Zonder, Jeffrey A.
|
|
|
110 |
11 |
p. 77
|
artikel
|
| 4473 |
Superior Long Term Progression Free Survival of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Compared to Autologous Hematopoietic Stem Cell Transplantation after Identical Conditioning Regimen.
|
Khaled, Yasser
|
|
|
110 |
11 |
p. 3031
|
artikel
|
| 4474 |
Superior Warfarin Dosing Using Pharmacogenomics in a Multi-Ethnic Patient Population.
|
Riley, Christian J.
|
|
|
110 |
11 |
p. 3151
|
artikel
|
| 4475 |
Support for a Possible "Vaccinal" Effect of Rituximab; Lymphoma Idiotype Specific T-Cell Responses in Follicular Lymphoma Patients Treated with Rituximab.
|
Hilchey, Shannon P.
|
|
|
110 |
11 |
p. 3424
|
artikel
|
| 4476 |
Supportive Role of TNF-Family Death Receptors in Hematopoietic Cell Engraftment.
|
Pearl-Yafe, Michal
|
|
|
110 |
11 |
p. 4048
|
artikel
|
| 4477 |
Suppression of Angiogenesis and Resistance to Doxorubicin by the Thyroid Hormone Tetraiodothyroacetic Acid.
|
Mousa, Shaker A.
|
|
|
110 |
11 |
p. 4209
|
artikel
|
| 4478 |
Suppression of CXCL12 Production by Bone Marrow Osteoblasts Is a Common and Critical Pathway for Cytokine-Induced Mobilization.
|
Christopher, Matthew J.
|
|
|
110 |
11 |
p. 220
|
artikel
|
| 4479 |
Suppression of Cyclin D1 by on 01910.Na Is Associated with Decreased Survival of Trisomy 8 Myelodyplastic Bone Marrow Progenitors: A Potential Targetted Therapy.
|
Sloand, Elaine M.
|
|
|
110 |
11 |
p. 822
|
artikel
|
| 4480 |
Suppression of Markers of Thrombin Generation and Inflammation in Patients Receiving Low Molecular Weight Heparin Compared to Unfractionated Heparin for TEE-Guided Cardioversion of Atrial Fibrillation.
|
Hoppensteadt, Debra
|
|
|
110 |
11 |
p. 3621
|
artikel
|
| 4481 |
Surface Adhesion and Growth of Microaggregates under Flow Condition (II): Clinical Findings in Patients with Thrombosis and Thrombocytopenia.
|
Bidot, Loreta
|
|
|
110 |
11 |
p. 3628
|
artikel
|
| 4482 |
Surface Adhesion and Growth of Microaggregates under Flow Conditions (I): Role of Cell-Derived Microparticles and Leukocytes.
|
Jy, Wenche
|
|
|
110 |
11 |
p. 3725
|
artikel
|
| 4483 |
Surface Plasmon Resonance Study of Apoptotic Regulators Bcl-2, Bcl-w, Bcl-XL, and Mcl-1 Indicate That the Preclinical Small Molecule Inhibitor (SMI) TW-37 Binds to the Hydrophobic Groove Competitively with tBid To Form a Heterodimer Which Cannot Be Disrupted by 200-Fold Molar Excess of TW-37.
|
Goustin, Anton-Scott
|
|
|
110 |
11 |
p. 1606
|
artikel
|
| 4484 |
Surface Sialic Acid Prevents Loss of GPIbα during Platelet Storage and Rescues In Vivo Survival of Murine Platelets.
|
Jansen, Gerard
|
|
|
110 |
11 |
p. 138
|
artikel
|
| 4485 |
Surprising Lack of Correlation between CD38 and Time to First Treatment in Chronic Lympocytic Leukemia.
|
Kaufman, Matthew S.
|
|
|
110 |
11 |
p. 2058
|
artikel
|
| 4486 |
Survival and Efficacy of Decitabine in Myelodysplastic Syndromes (MDS), Analysis of the 5-Day IV Dosing Regimen.
|
Kantarjian, Hagop
|
|
|
110 |
11 |
p. 115
|
artikel
|
| 4487 |
Survival in Follicular Lymphoma: The Stanford Experience, 1960–2003.
|
Tan, Daryl
|
|
|
110 |
11 |
p. 3428
|
artikel
|
| 4488 |
Survival Is Poorer in Patients with Secondary Core Binding Factor Acute Myelogenous Leukemia Compared with De Novo Core Binding Factor Leukemia.
|
Borthakur, Gautam
|
|
|
110 |
11 |
p. 2856
|
artikel
|
| 4489 |
Survival Outcomes for Patients (Pts) with Chronic Myeloid Leukemia (CML) with Clonal Evolution (CE) Treated with 2nd Generation Tyrosine Kinase Inhibitors (TKI) after Imatinib Failure.
|
Verma, Dushyant
|
|
|
110 |
11 |
p. 2949
|
artikel
|
| 4490 |
Survival Patterns among Chronic Lymphocytic Leukemia and Other Lymphoma Patients with Family History of Lymphoma.
|
Anderson, Lesley A.
|
|
|
110 |
11 |
p. 4683
|
artikel
|
| 4491 |
Surviving Host CD4+CD25+Foxp3+ Cells Following Ablative Conditioning Expand and Comprise the Major Component of the Treg Compartment during the Lymphoid Reconstitution Period Following HCT.
|
Bayer, Allison L.
|
|
|
110 |
11 |
p. 65
|
artikel
|
| 4492 |
Survivin Inhibition of p34Cdc2 Via Protection of Wee1 Correlates with Survival.
|
Guzman, Javier Rivera
|
|
|
110 |
11 |
p. 3352
|
artikel
|
| 4493 |
Survivin Regulates Aberrant Proliferation of Hematopoietic Progenitor Cells with Self Renewal Capability and Development of Acute Leukemia Induced by Internal-Tandem-Duplication of Flt3.
|
Fukuda, Seiji
|
|
|
110 |
11 |
p. 599
|
artikel
|
| 4494 |
Susceptibility of Endocrine, Cardiac, and Macrophage Cell Lines to Iron-Mediated Oxidative Damage and the Cytoprotective Effect of the Orally Active Chelator Deferasirox (Exjade®, ICL670).
|
Glickstein, Hava
|
|
|
110 |
11 |
p. 3825
|
artikel
|
| 4495 |
Sustained Engraftment Using Fludarabine, Melphalan and Thiotepa Conditioning for Haploidentical Stem Cell Transplantation.
|
Ciurea, Stefan O.
|
|
|
110 |
11 |
p. 5081
|
artikel
|
| 4496 |
Sustained Improvements in Transfusion Requirements, Fatigue and Thrombosis with Eculizumab Treatment in Paroxysmal Nocturnal Hemoglobinuria.
|
Socié, Gerard
|
|
|
110 |
11 |
p. 3672
|
artikel
|
| 4497 |
Sustained Molecular Responses with Interferon α2a Maintenance Therapy after Imatinib Plus IFN Induction Treatment for Chronic Phase Chronic Myelogenous Leukemia.
|
Hochhaus, Andreas
|
|
|
110 |
11 |
p. 28
|
artikel
|
| 4498 |
Switch to Full-Length of XAF1 mRNA Expression in Myeloma RPMI8226 Cells by DNA Methylation Inhibitor 5-Azacytidine.
|
Chen, Guanghua
|
|
|
110 |
11 |
p. 4093
|
artikel
|
| 4499 |
Syk Is a New Target for AML Differentiation.
|
Hahn, Cynthia K.
|
|
|
110 |
11 |
p. 209
|
artikel
|
| 4500 |
Syk Kinase Inhibition by R406 Inhibits BCR Mediated B Cell Proliferation and Interferes with BCR Signal Transduction in Primary Tumor Samples.
|
Sharman, Jeff P.
|
|
|
110 |
11 |
p. 802
|
artikel
|
| 4501 |
Syk Tyrosine Kinase Is Overexpressed in the Majority of Peripheral T- and NK-Cell Lymphomas, and Represents a Potential Therapeutic Target.
|
Feldman, Andrew L.
|
|
|
110 |
11 |
p. 690
|
artikel
|
| 4502 |
Symptomatic Improvement Following Intravesicular Cidofovir for the Management of BK Virus Associated Cystitis.
|
Buie, Larry W.
|
|
|
110 |
11 |
p. 3007
|
artikel
|
| 4503 |
Symptomatic Waldenstrom's Macroglobulinemia (WM) in Young Patients: Disease Characteristics and Outcome.
|
Kastritis, Efstathios
|
|
|
110 |
11 |
p. 4730
|
artikel
|
| 4504 |
Synergistic Activity of the Novel Src/Abl Inhibitor Bosutinib in Combination with Imatinib.
|
Redaelli, Sara
|
|
|
110 |
11 |
p. 2930
|
artikel
|
| 4505 |
Synergistic Anti-Leukemic Effect of Protein Kinase A Activator and PPARγ Agonist Is Independent of Bcl-2 Status.
|
Erikstein, Bjarte S.
|
|
|
110 |
11 |
p. 4200
|
artikel
|
| 4506 |
Synergistic Effect of Magnetic Nanopartical Fe304, Au and Daunomycin on K562/A02.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 4171
|
artikel
|
| 4507 |
Synergistic Induction of Apoptosis by Simultaneous Disruption of the Bcl-2 and mTOR/Akt Pathways in Acute Myeloid Leukemia.
|
Zeng, Zhihong
|
|
|
110 |
11 |
p. 1588
|
artikel
|
| 4508 |
Synergistic Tumor Immunity Induced by Chemotherapy and Agonist Anti-GITR Antibody.
|
Cohen, Adam D.
|
|
|
110 |
11 |
p. 1788
|
artikel
|
| 4509 |
Synergy of the Purine-Scaffold HSP90 Inhibitor, PU-H71, with Doxorubicin in Non-Hodgkin's Lymphoma Cell Lines.
|
Varticovski, Lyuba
|
|
|
110 |
11 |
p. 1399
|
artikel
|
| 4510 |
Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein with In Vitro and In Vivo Activity Against Non-Hodgkin's Lymphoma and Other Hematologic Malignancies.
|
Guerin, Mireille
|
|
|
110 |
11 |
p. 1388
|
artikel
|
| 4511 |
Systematic Definition and Evolutionary Analsis of Macrophage Genes: Evidence for Novel Host Defense Genes.
|
MacDonald, Jennifer J.
|
|
|
110 |
11 |
p. 3856
|
artikel
|
| 4512 |
Systematic Evaluation of Hypereosinophilic Syndrome-Related Organ Damage According to FIP1L1-PDGFRA Status and Response to the Therapy: Analysis from Prospective Clinical Trial with Imatinib Mesylate.
|
Rondoni, Michela
|
|
|
110 |
11 |
p. 3557
|
artikel
|
| 4513 |
Systematic Genomic Screen for Tyrosine Kinase Mutations in CLL.
|
Brown, Jennifer R.
|
|
|
110 |
11 |
p. 2069
|
artikel
|
| 4514 |
Systematic Profiling and Novel Targets of the Bcr-Abl Kinase Inhibitors Imatinib, Nilotinib and Dasatinib.
|
Hantschel, Oliver
|
|
|
110 |
11 |
p. 4542
|
artikel
|
| 4515 |
Systemic Inflammatory Response Syndrome (SIRS) as Predictor of Severe Sepsis (SS) in Hospitalized Patients (pts) with Hematologic Malignancies.
|
Mato, Anthony
|
|
|
110 |
11 |
p. 633
|
artikel
|
| 4516 |
Systemic Mastocytosis with c-KITD816V Mutation Treated with Dasatinib.
|
Benz, Rudolf
|
|
|
110 |
11 |
p. 4656
|
artikel
|
| 4517 |
Systems Biology Analysis of Human Primary T Cells Identifies SAP145 as Rate Limiting for the G1→S Phase Transition.
|
Orr, Stephen J.
|
|
|
110 |
11 |
p. 3350
|
artikel
|
| 4518 |
Tacrolimus and Short-Term Methotrexate (mini-MTX) for Graft Versus Host Disease (GVHD) Prophylaxis after Unrelated Single Unit Cord Blood Transplant (CBT) in Pediatric Patients.
|
Petropoulos, Demetrios
|
|
|
110 |
11 |
p. 5018
|
artikel
|
| 4519 |
Tacrolimus and Sirolimus without Methotrexate as Acute GVHD Prophylaxis after Matched Related Donor Reduced Intensity Conditioning (RIC) Stem Cell Transplantation (SCT).
|
Ho, Vincent T.
|
|
|
110 |
11 |
p. 3046
|
artikel
|
| 4520 |
Tacrolimus Dosing in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients Receiving Concomitant Voriconazole.
|
Trifilio, Steven
|
|
|
110 |
11 |
p. 4956
|
artikel
|
| 4521 |
Tandem Autologous Transplant Versus Reduced Intensity Conditioned Allogeneic Transplant (Allo-RIC) as Second Intensification in Chemosensitive Patients with Multiple Myeloma (MM) Not Achieving Complete Remission (CR) or Near-CR with a First Autologous Transplant. Results from a Spanish PETHEMA/GEM Study.
|
Blade, Joan
|
|
|
110 |
11 |
p. 729
|
artikel
|
| 4522 |
Tandem Versus Single Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma: A Meta-Analysis of Randomized Controlled Trials (RCT).
|
Kumar, Ambuj
|
|
|
110 |
11 |
p. 936
|
artikel
|
| 4523 |
Tanespimycin (T) + Bortezomib (BZ) in Multiple Myeloma (MM): Confirmation of the Recommended Dose Using a Novel Formulation.
|
Richardson, Paul G.
|
|
|
110 |
11 |
p. 1165
|
artikel
|
| 4524 |
TARC and RANTES Enhance Immunological Antitumor Effect Induced by GM-CSF Transduced Leukemia Vaccine in Mouse Model.
|
Inoue, Hiroyuki
|
|
|
110 |
11 |
p. 1787
|
artikel
|
| 4525 |
Targeted Deletion of γ-Adducin in Mice.
|
Sahr, Kenneth E.
|
|
|
110 |
11 |
p. 1723
|
artikel
|
| 4526 |
Targeted Deletion of α-Adducin Results in Absent β-Adducin, Compensated Hemolytic Anemia, and Hydrocephalus in Mice.
|
Robledo, Raymond F.
|
|
|
110 |
11 |
p. 141
|
artikel
|
| 4527 |
Targeted Disruption of GAS6-Mertk Pathway Leads to Defects in Physiological Clearance of Expelled Nuclei from Erythroblasts by Bone Marrow Macrophages.
|
Kadi, Linda
|
|
|
110 |
11 |
p. 1708
|
artikel
|
| 4528 |
Targeted Killing of Glioblastoma Multiforme In Vivo by IL-13 Zetakine Redirected CTLs Made Glucocorticoid Resistant with Zinc Finger Nucleases.
|
Reik, Andreas
|
|
|
110 |
11 |
p. 2597
|
artikel
|
| 4529 |
Targeted ‘Off-the-Shelf' Tumor Immunotherapy Using Allogeneic T-Cell Precursors.
|
Zakrzewski, Johannes L.
|
|
|
110 |
11 |
p. 579
|
artikel
|
| 4530 |
Targeted Therapy Against Clonogenic Myeloma Cells with Iodine I-131 Tositumomab (Bexxar™).
|
Jakubowiak, Andrzej
|
|
|
110 |
11 |
p. 4796
|
artikel
|
| 4531 |
Targeted Therapy with Arsenic Trioxide and Interferon alpha Eradicates Leukemic Cells in SCID Mice Model of Adult T-Cell Leukemia/Lymphoma.
|
Hajj, Hiba El
|
|
|
110 |
11 |
p. 1379
|
artikel
|
| 4532 |
Targeting BH3-Domain Anti-Apoptotic Proteins with ABT-737 Decreases DNA Synthesis, Induces Cell Death and Sensitizes Rituximab-Sensitive and Rituximab-Resistant Non-Hodgkin's Lymphoma Cell Lines to the Anti-Tumor Activity of Chemotherapy Agents.
|
Vinjamaram, Sanjay
|
|
|
110 |
11 |
p. 1393
|
artikel
|
| 4533 |
Targeting Btk in Lymphoma: PCI-32765 Inhibits Tumor Growth in Mouse Lymphoma Models and a Fluorescent Analog of PCI-32765 Is an Active-Site Probe That Enables Assessment of Btk Inhibition In Vivo.
|
Honigberg, Lee A.
|
|
|
110 |
11 |
p. 1592
|
artikel
|
| 4534 |
Targeting CCR1 for the Treatment of Osteolytic Bone Disease in Multiple Myeloma.
|
Vallet, Sonia
|
|
|
110 |
11 |
p. 2503
|
artikel
|
| 4535 |
Targeting CD22 in Childhood B-Precursor Acute Lymphoblastic Leukemia (Pre-B ALL): Pre-Clinical Studies and Phase I Trial of the Anti-CD22 Immunotoxin CAT-3888 (BL22).
|
Wayne, Alan S.
|
|
|
110 |
11 |
p. 855
|
artikel
|
| 4536 |
Targeting CDK4/6 and the Cell Cycle in Combination with Bortezomib in the 5T33MM Myeloma Model.
|
Menu, Eline
|
|
|
110 |
11 |
p. 254
|
artikel
|
| 4537 |
Targeting Cdk4/6 in Combination Therapy Overcomes Proteasome Inhibitor Resistance in Multiple Myeloma through Synergistic Mitochondria Depolarization.
|
Huang, Xiangao
|
|
|
110 |
11 |
p. 667
|
artikel
|
| 4538 |
Targeting CD134 Results in Selective Depletion of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors.
|
Ge, Xupeng
|
|
|
110 |
11 |
p. 2174
|
artikel
|
| 4539 |
Targeting Drug-Resistant CML and Ph+-ALL with the Spectrum Selective Protein Kinase Inhibitor XL228.
|
Shah, Neil P.
|
|
|
110 |
11 |
p. 474
|
artikel
|
| 4540 |
Targeting FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia.
|
Ikeda, Alan K.
|
|
|
110 |
11 |
p. 912
|
artikel
|
| 4541 |
Targeting Histone Deacetylase 6 and the Aggresome Pathway in Acute Lymphoblastic Leukemia Cells.
|
Rodriguez-Gonzalez, Augustin
|
|
|
110 |
11 |
p. 1602
|
artikel
|
| 4542 |
Targeting Histone Deacetylases and Unfolded Protein Mediated Endoplasmic Reticulum (ER) Stress as a Strategy Against Human Mantle Cell Lymphoma.
|
Rao, Rekha
|
|
|
110 |
11 |
p. 1378
|
artikel
|
| 4543 |
Targeting Late Relapsed Acute Myeloid Leukemia Cells by Cytotoxic T Cells Generated from Late but Not Early Leukemic Antigen-Presenting Dendritic Cells.
|
Liang, Yin
|
|
|
110 |
11 |
p. 4902
|
artikel
|
| 4544 |
Targeting MEK/MAPK Signal Transduction Module Potentiates Arsenic Trioxide (ATO)-Induced Apoptosis in Multiple Myeloma Cells through Multiple Signaling Pathways.
|
Lunghi, Paolo
|
|
|
110 |
11 |
p. 1517
|
artikel
|
| 4545 |
Targeting MUC1 as a Marker for Myeloid Leukemia Stem Cells by DC/AML Fusions.
|
Rosenblatt, Jacalyn
|
|
|
110 |
11 |
p. 1794
|
artikel
|
| 4546 |
Targeting Myeloproliferative Diseases with JAK2 Inhibitors.
|
Markovtsov, Vadim
|
|
|
110 |
11 |
p. 3550
|
artikel
|
| 4547 |
Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).
|
Leleu, Xavier
|
|
|
110 |
11 |
p. 2512
|
artikel
|
| 4548 |
Targeting Pim Kinases in Hematological Malignancies.
|
Gourley, Eric S.
|
|
|
110 |
11 |
p. 2655
|
artikel
|
| 4549 |
Targeting Proteinkinase C Alters ER-Stress and b-Catenin Signaling in Multiple Myeloma: Therapeutic Implications.
|
Raab, Marc S.
|
|
|
110 |
11 |
p. 258
|
artikel
|
| 4550 |
Targeting 14-3-3 Sensitizes Native and Mutant BCR-ABL to Inhibition with U0126, Rapamycin and Bcl-2 Inhibitor GX15-070.
|
Dong, Shaozhong
|
|
|
110 |
11 |
p. 2920
|
artikel
|
| 4551 |
Targeting the Human Double Minute (HDM)-2 p53 Ubiquitin Ligase as a Strategy Against Non-Hodgkin Lymphoma.
|
Jones, Richard J.
|
|
|
110 |
11 |
p. 1374
|
artikel
|
| 4552 |
Targeting the JAK2 Kinase in Hematological Malignancies.
|
Olsen, Colin E.
|
|
|
110 |
11 |
p. 3560
|
artikel
|
| 4553 |
Targeting UPR Sensors: A Novel Approach To Promote Death of Multiple Myeloma Cells.
|
Michallet, Anne-Sophie A.S.
|
|
|
110 |
11 |
p. 113
|
artikel
|
| 4554 |
Targeting Wnt Signaling in Myeloma In Vivo; Differential Effects on Tumor Burden and Myeloma Bone Disease.
|
Edwards, Claire M.
|
|
|
110 |
11 |
p. 812
|
artikel
|
| 4555 |
T-Cell Autoimmunity May Contribute to Neutropenia in a Patient with Cyclic Neutropenia (CN) and Double De-Novo Mutations in Gfi-1.
|
Armistead, Paul M.
|
|
|
110 |
11 |
p. 3298
|
artikel
|
| 4556 |
T Cell Blast Phase (T-BP) of Chronic Myelogenous Leuikemia (CML).
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 4560
|
artikel
|
| 4557 |
T-Cell-Independent Re-Stimulation of FVIII-Specific Memory B Cells Requires Help from Activated Plasmacytoid Dendritic Cells.
|
Pordes, Aniko Ginta
|
|
|
110 |
11 |
p. 1155
|
artikel
|
| 4558 |
T-Cell Large Granular Lymphocyte Leukemia of Donor Origin Following Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.
|
Rabinowits, Guilherme
|
|
|
110 |
11 |
p. 5021
|
artikel
|
| 4559 |
T Cell Mediated Autologous Cytotoxicity Against Hematopoietic Precursor Cells in Low and Intermediate-1 Risk Myelodysplastic Syndrome.
|
Chamuleau, Martine E.D.
|
|
|
110 |
11 |
p. 4603
|
artikel
|
| 4560 |
T Cell Pathway Deficiencies in Chronic Lymphocityc Leukemia: Partial Restoration with OKT3/IL-2 Activation.
|
Di Ianni, Mauro
|
|
|
110 |
11 |
p. 4692
|
artikel
|
| 4561 |
T Cell Receptor Gene Transfer to Virus-Specific T Cells for Cellular Anti-Tumor Immunotherapy.
|
Griffioen, Marieke
|
|
|
110 |
11 |
p. 2594
|
artikel
|
| 4562 |
T-Cell Receptor Vß CDR3 Oligoclonality Frequently Occurs in Childhood Refractory Cytopenia and Severe Aplastic Anemia.
|
de Vries, Andrica C.H.
|
|
|
110 |
11 |
p. 2449
|
artikel
|
| 4563 |
T-Cell Receptor Vβ Repertoire Analysis in Patients with Chronic Idiopathic Neutropenia: Evidence for Presence of Predominant T-Cell Clones with Possible Pathogenetic Significance.
|
Papadaki, Helen A.
|
|
|
110 |
11 |
p. 3302
|
artikel
|
| 4564 |
T-Cells Redirected Against CD70 for the Immunotherapy of Hematological Malignancies.
|
Shaffer, Donald
|
|
|
110 |
11 |
p. 2757
|
artikel
|
| 4565 |
TCL1 Expression in Chronic Lymphocytic Leukemia Correlates with the Intensity of 11q Deletions and ZAP-70.
|
Rassenti, Laura
|
|
|
110 |
11 |
p. 2068
|
artikel
|
| 4566 |
TCR Gene Rearrangement in B-Cell Chronic Lymphocytic Leukaemia.
|
Catherwood, Mark A.
|
|
|
110 |
11 |
p. 4700
|
artikel
|
| 4567 |
TCR Vbeta Repertoire Analyses in Childhood Aquired Servere Aplastic Anemia: A New Predictor for IST Response?.
|
Hubner, Bernd
|
|
|
110 |
11 |
p. 1701
|
artikel
|
| 4568 |
TEL-AML1 Dysregulates the TGFβ Pathway: A Basis for Pre-Leukaemic Stem Cell Selection.
|
Ford, Anthony
|
|
|
110 |
11 |
p. 59
|
artikel
|
| 4569 |
TEL/AML1 Rearrangement Is Rare in Children with Acute Lymphoblastic Leukemia (ALL) and Down Syndrome (DS). Presenting Features and Treatment Outcome in the Experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
|
Arico, Maurizio
|
|
|
110 |
11 |
p. 848
|
artikel
|
| 4570 |
Telomerase Activity and Telomere Length in APL: May Be Proliferative and Prognostic Markers.
|
Ghaffari, Seyed Hamidolah
|
|
|
110 |
11 |
p. 4236
|
artikel
|
| 4571 |
Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis?.
|
Rocci, Alberto
|
|
|
110 |
11 |
p. 3025
|
artikel
|
| 4572 |
Telomere Length Shortening in Langerhans Cell Histiocytosis.
|
Bechan, Gitanjali I.
|
|
|
110 |
11 |
p. 2411
|
artikel
|
| 4573 |
Telomeric Recombination in Lymphocytes Implicates ALT, an Alternative Mechanism for Telomere Length Maintenance, in Normal Human Hematopoietic Cells.
|
Calado, Rodrigo T.
|
|
|
110 |
11 |
p. 1332
|
artikel
|
| 4574 |
Temporal Proteomic Analysis of CLL B Cell Response to Antigen Receptor Stimulation.
|
Vallat, Laurent
|
|
|
110 |
11 |
p. 1134
|
artikel
|
| 4575 |
Temporal, Quantitative and Functional Characteristics of Single-KIR Positive Alloreactive NK Cell Recovery Account for Impaired Graft Versus Leukemia Activity after Haploidentical HSCT.
|
Vago, Luca
|
|
|
110 |
11 |
p. 3274
|
artikel
|
| 4576 |
Temporal Variation in Intensity of Laboratory Response to DDAVP.
|
Tran, Minh H.
|
|
|
110 |
11 |
p. 3970
|
artikel
|
| 4577 |
Tetra-Arsenic Tetra-Sulfide Containing Triple-Agent Regimen as the First Line Therapy for Acute Promyelocytic Leukemia: Expeditiously Consecutive Complete Remission and Improved Disease-Free Survival.
|
Wu, Tong
|
|
|
110 |
11 |
p. 591
|
artikel
|
| 4578 |
TG101348: A Dual-Acting JAK2/FLT3 Small Molecule Kinase Inhibitor for the Treatment of AML.
|
Tam, Betty
|
|
|
110 |
11 |
p. 898
|
artikel
|
| 4579 |
TGF-β Receptor Kinase Inhibitor LY2109761 Reverses the Anti-Apoptotic Effects of TGF-β1 in Leukemic Cells Co-Cultured with Stromal Cells.
|
Tabe, Yoko
|
|
|
110 |
11 |
p. 2846
|
artikel
|
| 4580 |
ThaDD-V Treatment for Patients with Relapsed/Refractory Multiple Myeloma: A Feasibility/Activity Study.
|
Offidani, Massimo
|
|
|
110 |
11 |
p. 2729
|
artikel
|
| 4581 |
Thalidomide Alone and in Combination with Fludarabine Exerts Distinct Molecular and Antileukemic Effects in B-Cell Chronic Lymphocytic Leukemia.
|
Giannopoulos, Krzysztof
|
|
|
110 |
11 |
p. 3124
|
artikel
|
| 4582 |
Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.
|
Simpson, Lijo
|
|
|
110 |
11 |
p. 3607
|
artikel
|
| 4583 |
Thalidomide Based Regimens (TBR) for Relapsed/Refractory Multiple Myeloma Patients: Long Term Follow Up, Unmaintained Remissions and Disease Control after Subsequent Treatments.
|
Roussou, Maria
|
|
|
110 |
11 |
p. 4812
|
artikel
|
| 4584 |
Thalidomide Combinations Improve Response Rates; Results from the MRC IX Study.
|
Morgan, Gareth J.
|
|
|
110 |
11 |
p. 3593
|
artikel
|
| 4585 |
Thalidomide–Containing Regimens Induce Recovery of Normal Immunoglobulins in Newly Diagnosed Patients with Multiple Myeloma; Recovery of Normal Immunoglobulins Improves Survival.
|
Katodritou, Eirini
|
|
|
110 |
11 |
p. 2738
|
artikel
|
| 4586 |
Thalidomide-Dexamethasone vs Interferon-α-Dexamethasone as Maintenance Treatment after ThaDD Induction for Multiple Myeloma (MM): Final Analysis of a Prospective, Randomized Study.
|
Offidani, Massimo
|
|
|
110 |
11 |
p. 532
|
artikel
|
| 4587 |
Thalidomide-Dexamethasone vs. Melphalan-Prednisone as First Line Treatment and Thalidomide-Interferon vs. Interferon Maintenance Therapy in Elderly Patients with Multiple Myeloma.
|
Ludwig, Heinz
|
|
|
110 |
11 |
p. 529
|
artikel
|
| 4588 |
Thalidomide in Combination with Idarubicin, Dexamethasone and Etoposide (TIDE) Is an Effective Oral Combination in Heavily Pre-Treated Myeloma Patients.
|
Linch, Mark D.
|
|
|
110 |
11 |
p. 4841
|
artikel
|
| 4589 |
TH17 Cells Mediate Extensive Skin Pathology in Acute GVHD.
|
Carlson, Michael J.
|
|
|
110 |
11 |
p. 2166
|
artikel
|
| 4590 |
The Absence of Vasoactive Intestinal Peptide Augments Allo-Reactivity and the Anti-Viral Response in Bone Marrow Transplantation.
|
Southerland, Lauren T.
|
|
|
110 |
11 |
p. 3267
|
artikel
|
| 4591 |
The Acidic COOH-Terminal Region of Factor Va Heavy Chain Controls the Rate of Prothrombin Activation by Prothrombinase.
|
Hirbawi, Jamila
|
|
|
110 |
11 |
p. 1745
|
artikel
|
| 4592 |
The Activating KIR2DS2 Gene Influences NK Alloreactivity and NK Repertoire.
|
Chewning, Joseph H.
|
|
|
110 |
11 |
p. 313
|
artikel
|
| 4593 |
The Activation of Fas Receptor by APO010, a Recombinant Form of Fas Ligand, Induces In Vitro and In Vivo Antimyeloma Activity.
|
Ocio, Enrique M.
|
|
|
110 |
11 |
p. 1515
|
artikel
|
| 4594 |
The Activity and Toxicity of Dasatinib in Relapsed or Plateau-Phase Multiple Myeloma.
|
Wildes, Tanya M.
|
|
|
110 |
11 |
p. 1182
|
artikel
|
| 4595 |
The ADAMTS13 Gene as the Immunological Culprit in Acute Acquired TTP - First Evidence of Genetic Out-Breeding Depression in Humans.
|
Meyer, Sara C.
|
|
|
110 |
11 |
p. 277
|
artikel
|
| 4596 |
The Addition of Rituximab to CHOP Chemotherapy Improves Response Rate, Failure-Free Survival and Overall Survival for Follicular Grade 3 Lymphoma Compared to CHOP Alone
|
Overman, Michael J.
|
|
|
110 |
11 |
p. 1289
|
artikel
|
| 4597 |
The Addition of sFLCR Improves ISS Prognostication in Multiple Myeloma (MM).
|
Kyrtsonis, Marie-Christine
|
|
|
110 |
11 |
p. 1490
|
artikel
|
| 4598 |
The Addition of Thalidomide in Any Line of Treatment of Multiple Myeloma, Improves Overall Survival: Single Center Experience in 246 Patients.
|
Katodritou, Eirini
|
|
|
110 |
11 |
p. 4813
|
artikel
|
| 4599 |
The Adhesion of Sickle Cell Disease Neutrophils to Endothelial Layers, In Vitro, Is Mediated by the Mac-1, LFA-1 and VLA-4 Integrins.
|
Canalli, Andreia A.
|
|
|
110 |
11 |
p. 2264
|
artikel
|
| 4600 |
The AKT Inhibitor, A443654, Induces Cell Cycle Arrest, Apoptosis and Synergizes with Chemotherapeutic Drugs in Multi-Drug Resistant T-Cell Acute Lymphoblastic Leukemia - A Novel Agent for Therapy of Drug Resistant ALL.
|
McCubrey, James A.
|
|
|
110 |
11 |
p. 3344
|
artikel
|
| 4601 |
The Akt/Mcl-1 Pathway Plays a Prominent Role in Mediating Pro-Survival Signals Derived from the B-Cell Receptor in Chronic Lymphocytic Leukemia B-Cells.
|
Longo, Pablo G.
|
|
|
110 |
11 |
p. 341
|
artikel
|
| 4602 |
The AML1/ETO Target LAT2 Membrane Adaptor Molecule Is Regulated during Normal Monocytic Differentiation.
|
Duque-Afonso, Jesus
|
|
|
110 |
11 |
p. 2401
|
artikel
|
| 4603 |
The Analysis of Chronic GVHD after Cord Blood Transplantation in Comparison with Bone Marrow Transplantation.
|
Seo, Sachiko
|
|
|
110 |
11 |
p. 5092
|
artikel
|
| 4604 |
The Anti-Apoptotic Role of the Unfolded Protein Response in Bcr-Abl Positive Leukemia Cells.
|
Tanimura, Atsuko
|
|
|
110 |
11 |
p. 4527
|
artikel
|
| 4605 |
The Anti-CD19 Bispecific T-Cell Engager (BiTE) MT103 (MEDI-538), Induces Dose-Dependent Complete and Partial Responses in Relapsed Non-Hodgkin Lymphoma (NHL): Phase I Study MT103-104.
|
Bargou, Ralf C.
|
|
|
110 |
11 |
p. 2557
|
artikel
|
| 4606 |
The Aptamer ARC1779 Potently and Specifically Inhibits the Excessive von Willebrand Factor (vWF) Activity and vWF-Mediated Ex Vivo Platelet Function of Patients with Thrombotic Thrombocytopenic Purpura (TTP).
|
Jilma, Bernd
|
|
|
110 |
11 |
p. 279
|
artikel
|
| 4607 |
The Architecural Pattern of FOXP3+ T Cells Predicts Risk of Transformation in Patients with Follicular Lymphoma (FL).
|
Farinha, Pedro
|
|
|
110 |
11 |
p. 358
|
artikel
|
| 4608 |
The Assessment of IL-6R Gene Using FISH in MM.
|
Min, Hyun Jung
|
|
|
110 |
11 |
p. 4849
|
artikel
|
| 4609 |
The Association between Hematological and Inflammatory Factors and Stress Fractures among Female Military Recruits.
|
Merkel, Drorit
|
|
|
110 |
11 |
p. 5160
|
artikel
|
| 4610 |
The Association between Hepatitis C Infection and Lymphoma in AIDS.
|
Ghanem, Zuhair
|
|
|
110 |
11 |
p. 2284
|
artikel
|
| 4611 |
The Axl/Gas6 Pathway Is Required for Human Natural Killer Cell Development.
|
Park, Il-Kyoo
|
|
|
110 |
11 |
p. 2305
|
artikel
|
| 4612 |
The Balance between Myc and Bcl6 Determines Self-Renewal or Differentiation of Pre-B Cells.
|
Duy, Cihangir
|
|
|
110 |
11 |
p. 797
|
artikel
|
| 4613 |
The Balance of Effector and Regulatory Cell Populations in Oral Chronic GVHD: Potential Role of IL-15.
|
Imanguli, Matin
|
|
|
110 |
11 |
p. 1059
|
artikel
|
| 4614 |
The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.
|
Ricciardi, Maria Rosaria
|
|
|
110 |
11 |
p. 155
|
artikel
|
| 4615 |
The BCL6 Oncogene Drives an Epigenomic Program Linking Stem Cells to the Pathogenesis of Human Diffuse Large B Cell Lymphoma in Mice.
|
Perez-Caro, Maria
|
|
|
110 |
11 |
p. 3372
|
artikel
|
| 4616 |
The Bcr-Abl Kinase Inhibitor INNO-406 Induces Autophagy and Different Modes of Cell Death Execution in Bcr-Abl-Positive Leukemias.
|
Kamitsuji, Yuri
|
|
|
110 |
11 |
p. 2951
|
artikel
|
| 4617 |
The BCR-Associated Tyrosine Kinase SYK Is Linked to the Activation of AKT in Mantle Cell Lymphoma.
|
Rudelius, Martina
|
|
|
110 |
11 |
p. 1586
|
artikel
|
| 4618 |
The BH3-Mimetic Obatoclax Restores the Response to Dexamethasone in Glucocorticoid-Resistant ALL through Induction of Autophagy.
|
Bonapace, Laura
|
|
|
110 |
11 |
p. 806
|
artikel
|
| 4619 |
The Biological Characteristics of Osteoblasts Derived from Myelodysplastic Syndrome Patients.
|
Chen, Wen-ming
|
|
|
110 |
11 |
p. 4101
|
artikel
|
| 4620 |
The Biologic Meaning of the Structural Components of Defibrotide (DF) in the Setting of HIV Disease with Refractory Herpes, Candida, Cryptosporidium Diarrhea and Multi-Organ Failure Against the Background of Down-Regulation of Cellular Immunity, Autocrine Upregulation of Inflammatory Cytokines of TNF-Alpha, IL2, IL1, IL6 and Dysregulation of cAMP/cGMP Protein Kinase A/C Signalling.
|
Burcoglu-Oral, Arsinur D.
|
|
|
110 |
11 |
p. 3865
|
artikel
|
| 4621 |
The BLyS/BAFF Receptor-Ligand System in HCV Induced B-Cell Clonal Disorders.
|
Landau, Dan Avi
|
|
|
110 |
11 |
p. 3866
|
artikel
|
| 4622 |
The Bone Resorption Marker Serum-ICTP and the Circulating Proteasome Levels Separate ISS-Stages 1–3 and Are the Most Powerful Prognostic Factors for Overall Survival in Newly Diagnosed Symptomatic Multiple Myeloma.
|
Jakob, Christian
|
|
|
110 |
11 |
p. 1475
|
artikel
|
| 4623 |
The B56α PP2A B Regulatory Subunit Promotes Mitochondrial PP2A Activity and Supports Etoposide-Induced Cell Death in Human ALL Derived REH Cells.
|
Ruvolo, Peter P.
|
|
|
110 |
11 |
p. 3358
|
artikel
|
| 4624 |
The Brain Transcription Factor OTX1 Is Activated in Specific Non-Hodgkin Lymphoma Subtypes and Normally Expressed in a Germinal Center-Restricted Small Subpopulation of CD138+ Plasmacell-Like Cells.
|
Russo, Filippo
|
|
|
110 |
11 |
p. 2618
|
artikel
|
| 4625 |
The Calcineurin/NFAT Signaling Pathway Is a Target for the Collagen Type I-Induced Calcium Response in Megakaryocytes and Mediates Expression of Megakaryocytic Genes.
|
Kyttaelae, Satu
|
|
|
110 |
11 |
p. 3647
|
artikel
|
| 4626 |
The CD22 Epitope, Dose, Dosing Interval, and Timing All Effect Efficacy of Anti-CD22 mAb-Based Therapy of NHL.
|
O'Donnell, Robert
|
|
|
110 |
11 |
p. 2355
|
artikel
|
| 4627 |
The Characterization of DYRK3 mRNA and the Utility of DYRK3 Inhibitors in a Carboplatin/Radiation Mouse Model of Anemia.
|
Erickson-Miller, Connie L.
|
|
|
110 |
11 |
p. 2202
|
artikel
|
| 4628 |
The Clinical Features and the Efficient Therapy of 66 Acute Promyelocytic Leukemia Patients with High Initial White Blood Cell Count.
|
Qiu, Hui-ying
|
|
|
110 |
11 |
p. 4363
|
artikel
|
| 4629 |
The Clinical Observation on Arsenic Trioxide with ATRA in Treating Acute Promyelocytic Leukemia for Six Years.
|
Zhong, Zhou
|
|
|
110 |
11 |
p. 2868
|
artikel
|
| 4630 |
The Clinical Outcomes of Autologous Stem Cell Transplantation in Peripheral T Cell Lymphoma: from Retrospective Multicenter Study in Korea.
|
Yang, Deok-Hwan
|
|
|
110 |
11 |
p. 1892
|
artikel
|
| 4631 |
The Clinical Phenotype of Patients with Essential Thrombocythemia Harboring MPL 515W>L/K Mutation.
|
Vannucchi, Alessandro M.
|
|
|
110 |
11 |
p. 678
|
artikel
|
| 4632 |
The Clinical Usefulness of Novel Prognostic Factors in CLL: A Study of 477 Patients with Low-Risk (Non-11q, Non-17p) FISH and Known IGVH Mutation Status.
|
Tam, Constantine S.
|
|
|
110 |
11 |
p. 3079
|
artikel
|
| 4633 |
The Clonal Inventory of Gene Corrected Hematopoiesis in Three Successful Clinical Gene Therapy Trials
|
Schwarzwaelder, Kerstin
|
|
|
110 |
11 |
p. 3733
|
artikel
|
| 4634 |
The c-myb Protooncogene and microRNA (miR)-15a Form an Autoregulatory Loop That May Play a Role in Normal Human Erythropoiesis.
|
Zhao, Huiwu
|
|
|
110 |
11 |
p. 2642
|
artikel
|
| 4635 |
The Coexpression of AML1-ETO9a Isoform and AML1-ETO in Acute Myeloid Leukemia M2 Subtype and Its Clinical Significance.
|
Zhang, Hong
|
|
|
110 |
11 |
p. 2390
|
artikel
|
| 4636 |
The Combination of Bortezomib and NPI-0052 Exerts Anti-Tumor Activity in Waldenstrom Macroglobulinemia (WM).
|
Roccaro, Aldo
|
|
|
110 |
11 |
p. 1516
|
artikel
|
| 4637 |
The Combination of Bortezomib, Doxorubicin, and Dexamethasone (PAD) Is an Effective Regimen for High Risk, Newly Diagnosed, Patients with Multiple Myeloma, Reduces Bone Resorption and Normalizes Angiopoietin-1 to Angiopoietin-2 Ratio.
|
Terpos, Evangelos
|
|
|
110 |
11 |
p. 3596
|
artikel
|
| 4638 |
The Combination of 2-CDA and Rituximab in Patients with Chronic Lymphocytic Leukemia (CLL): A Prospective Multicenter Phase II Trial (SAKK 34/02).
|
Leupin, Nicolas
|
|
|
110 |
11 |
p. 2057
|
artikel
|
| 4639 |
The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial.
|
Dearden, Claire E.
|
|
|
110 |
11 |
p. 2044
|
artikel
|
| 4640 |
The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.
|
Shalitin, Dror
|
|
|
110 |
11 |
p. 4800
|
artikel
|
| 4641 |
The Combination of Velcade, Idarubicin and Melphalan (VIM) Demonstrates Significant Clinical Activity in Relapsed/Refractory Myeloma Patients.
|
Davies, Faith E.
|
|
|
110 |
11 |
p. 2727
|
artikel
|
| 4642 |
The Comparative Analysis of Bone Marrow Transplantation and Cord Blood Transplantation from Unrelated Donors in Patients with Myelodysplastic Syndrome in Japan.
|
Takahashi, Satoshi
|
|
|
110 |
11 |
p. 2012
|
artikel
|
| 4643 |
The Comparison of the Cytobiological Role of Bone Marrow CD4+ T Cells in Aplastic Anemia Patients and Healthy Subjects.
|
Zheng, Miao
|
|
|
110 |
11 |
p. 3758
|
artikel
|
| 4644 |
The Construction and Expression of Recombination Adenovirus Vector of G156A O6-methylguanine-DNA-methyltransferase.
|
Wang, JiShi
|
|
|
110 |
11 |
p. 5134
|
artikel
|
| 4645 |
The Contact Activation Coagulation Pathway Is Involved in (Recurrent) Coronary Disease.
|
Dielis, Arne W.J.H.
|
|
|
110 |
11 |
p. 129
|
artikel
|
| 4646 |
The Correlation Analysis of Venous Thromboembolism and Acute Myocardial Infarction with the Levels and Polymorphisms of Coagulation and Anticoagulation Factors.
|
Yang, Linhua
|
|
|
110 |
11 |
p. 3929
|
artikel
|
| 4647 |
The Cost of Managing Pleural Effusion Associated with Dasatinib in CML Patients Post Imatinib Failure.
|
Stephens, Jennifer
|
|
|
110 |
11 |
p. 4586
|
artikel
|
| 4648 |
The C-Terminal Zinc Finger of GATA2 Is Necessary for Normalization of Aberrant Myelomonocytic Differentiation Induced by Activating PTPN11 Mutations.
|
Yang, Zhenyun
|
|
|
110 |
11 |
p. 3177
|
artikel
|
| 4649 |
The Cyclic GMP-Dependent Pathway Is Involved in the Mechanisms of Action of Hydroxyurea.
|
Suzuki, Yusuke
|
|
|
110 |
11 |
p. 2256
|
artikel
|
| 4650 |
The Cyclin Interactor p26INCA1 Regulates the Hematopoietic Stem Cell Pool Via CDK Inhibition.
|
Baeumer, Nicole
|
|
|
110 |
11 |
p. 637
|
artikel
|
| 4651 |
The Cytofluorimetric/FISH Diagnostic Approach Define a B-Cell Variant-CLL with Peculiar Clinico-Biological Features.
|
Cro, Lilla
|
|
|
110 |
11 |
p. 2077
|
artikel
|
| 4652 |
The Cytokine Signal Inhibitor Lnk Promotes αIIbβ3 Integrin Outside-In Signaling through β3 Tyrosine Phosphorylation in Platelets.
|
Eto, Koji
|
|
|
110 |
11 |
p. 3651
|
artikel
|
| 4653 |
The Declining Risk of ABO Incompatibilities: Twelve Years of Hemovigilance in France.
|
Renaudier, Philippe
|
|
|
110 |
11 |
p. 2891
|
artikel
|
| 4654 |
The Decrease of Regulatory T Cells through the Low Levels of FOXP3 Expression Mediated by NFAT1 in Infancy with Autoimmune Neutropenia.
|
Nakamura, Kazuhiro
|
|
|
110 |
11 |
p. 666
|
artikel
|
| 4655 |
The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation.
|
Ricca, Irene
|
|
|
110 |
11 |
p. 1672
|
artikel
|
| 4656 |
The Design and Synthesis of Small Molecule Inhibitors of Collagen Binding to Integrin α2β1 as Antithrombotic Agents.
|
Miller, Meredith W.
|
|
|
110 |
11 |
p. 306
|
artikel
|
| 4657 |
The Detection of Donor-Directed, HLA-Specific Alloantibodies in Recipients of Unrelated Hematopoietic Cell Transplantation Is Predictive of Graft Failure.
|
Bray, Robert
|
|
|
110 |
11 |
p. 475
|
artikel
|
| 4658 |
The Development of Severe Anti-HPA 1a-Related Neonatal Alloimmune Thrombocytopenia Is Influenced by the Maternal ABO Type.
|
Ahlen, Maria T.
|
|
|
110 |
11 |
p. 2093
|
artikel
|
| 4659 |
The Direct Factor Xa Inhibitor Apixaban Produces Broad Antithrombotic Activity with Limited Effects on Bleeding Time in Rats.
|
Schumacher, William A.
|
|
|
110 |
11 |
p. 4005
|
artikel
|
| 4660 |
The Direct Medical Costs Associated with Suspected and Confirmed Cases of Heparin-Induced Thrombocytopenia.
|
Nanwa, Natasha
|
|
|
110 |
11 |
p. 972
|
artikel
|
| 4661 |
The Dose-Match Interaction in Umbilical Cord Blood (UCB) Transplantation: An Analysis of the Impact of Cell Dose and HLA-Match on the Disease-Free Survival (DFS) of 989 Patients Transplanted with Single Units for Hematologic Malignancy.
|
Barker, Juliet N.
|
|
|
110 |
11 |
p. 333
|
artikel
|
| 4662 |
The Dose of CD34+ Cells Negatively Impacts the Outcome of Patients Treated with Genoidentical Allo SCT Prepared with a Reduced Intensity Conditioning (RIC).
|
Blaise, Didier
|
|
|
110 |
11 |
p. 1086
|
artikel
|
| 4663 |
The Early Treatment Response of the Clinically Challenging Group of Childhood T-ALL without NOTCH1 Mutations Is Signified by a Specific mRNA Gene Profile.
|
Kulozik, Andreas
|
|
|
110 |
11 |
p. 2789
|
artikel
|
| 4664 |
The Economic Impact of Anamnestic Response in the Management of Hemophilia Patients with Inhibitors Undergoing Immune Tolerance Induction in Germany.
|
Odeyemi, Isaac
|
|
|
110 |
11 |
p. 5161
|
artikel
|
| 4665 |
The Effectiveness of Once-Daily Intravenous Busulfan as Conditioning for Hematopoietic Stem Cell Transplantation in Children with Acute Myelogenous Leukemia.
|
Park, Seong Shik
|
|
|
110 |
11 |
p. 4948
|
artikel
|
| 4666 |
The Effectiveness of Recombinant Factor VIIa in the Treatment of Bleeding in Pediatric Patients: A Ten-Year Experience from 1997 to 2007.
|
Chuansumrit, Ampaiwan
|
|
|
110 |
11 |
p. 3949
|
artikel
|
| 4667 |
The Effect of Aquaporin 2 Gene Variations on Plasma Levels of von Willebrand Factor and Factor VIII and on the Risk of Venous Thrombosis.
|
Nossent, Anne Yael
|
|
|
110 |
11 |
p. 1749
|
artikel
|
| 4668 |
The Effect of CAHB on Myelodysplastic Syndrome In Vitro and Its Application in a Prospective Clinical Trial.
|
Cai, Zhen
|
|
|
110 |
11 |
p. 4628
|
artikel
|
| 4669 |
The Effect of Costimulatory Moleculars on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
|
Qiao, Zhenhua
|
|
|
110 |
11 |
p. 4875
|
artikel
|
| 4670 |
The Effect of Hemoglobin (Hb) Level at ESA Initiation on Outcomes in Cancer Patients (pts) with Chemotherapy-Induced Anemia (CIA): A Patient-Based Meta-Analysis from 6 Randomized, Placebo-Controlled Trials (RCTs) of Darbepoetin alfa (DA).
|
Crawford, J.
|
|
|
110 |
11 |
p. 3780
|
artikel
|
| 4671 |
The Effect of Infusion of Polyclonal Immunoglobulin or Its Fragments in the Improvement of the Immune Reconstitution after Autologous Stem Cells Transplantation (ASCT) in a Murine Model.
|
Pires, Ana E.
|
|
|
110 |
11 |
p. 3263
|
artikel
|
| 4672 |
The Effect of In Vivo T-Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia.
|
Delgado, Julio
|
|
|
110 |
11 |
p. 3014
|
artikel
|
| 4673 |
The Effect of Iodine-131-Rituximab on B Cell Lymphoma In Vitro and In Vivo.
|
Luo, Rongcheng
|
|
|
110 |
11 |
p. 4512
|
artikel
|
| 4674 |
The Effect of Levofloxacin Prophylaxis on Epidemiology and Microbial Resistance Profiles of Sterile Site Infections in Acute Leukemia Patients.
|
Barreto, Jason N.
|
|
|
110 |
11 |
p. 3337
|
artikel
|
| 4675 |
The Effect of Rituximab on Mobilization with AMD3100 Plus G-CSF in Patients with Relapsed or Refractory NHL or HD.
|
Kaufman, Jonathan L.
|
|
|
110 |
11 |
p. 1912
|
artikel
|
| 4676 |
The Effect of Statin Use at the Time of Autologous Transplant on Response and Survival in Patients with Multiple Myeloma.
|
Hamadani, Mehdi
|
|
|
110 |
11 |
p. 5129
|
artikel
|
| 4677 |
The Effect of the Interaction between Proton Pump Inhibitors (PPI) and Tyrosine Kinase Inhibitors (Imatinib, Nilotinib and Dasatinib).
|
La Cava, Piera
|
|
|
110 |
11 |
p. 2957
|
artikel
|
| 4678 |
The Effect of von Willebrand Factor Normandy Mutations on Intracellular Co-Trafficking of Factor VIII to Storage Organelles.
|
van den Biggelaar, Maartje
|
|
|
110 |
11 |
p. 765
|
artikel
|
| 4679 |
The Effect of von Willebrand Factor (VWF) on Site-Specific Factor VIII (FVIII) Expression in Hemophilia A Mice.
|
Shi, Qizhen
|
|
|
110 |
11 |
p. 764
|
artikel
|
| 4680 |
The Effects of Chronic Opiates Pain Therapy in Sickle Cell Anemia.
|
Jonassaint, Charles R.
|
|
|
110 |
11 |
p. 3404
|
artikel
|
| 4681 |
The Effects of Induction Chemotherapy and High-Dose Melphalan with Tandem Autologous Transplantation in Multiple Myeloma: The Prospective Randomized DSMM 2 Study.
|
Straka, Christian
|
|
|
110 |
11 |
p. 446
|
artikel
|
| 4682 |
The Effects of Rapamune on NK Cell Post Bone Marrow Transplantation in Mice.
|
Chen, Guanghua
|
|
|
110 |
11 |
p. 4858
|
artikel
|
| 4683 |
The Effects of Tcf-1 Gene Silence on Marrow CD4+ T Cells from Aplastic Anemia Patients.
|
Zheng, Miao
|
|
|
110 |
11 |
p. 3761
|
artikel
|
| 4684 |
The Effects of the Degree of Mobility Reduction and Prespecified Risk Factors on Venous Thromboembolism Rates in Acutely Ill Medical Patients in the EXCLAIM Study.
|
Yusen, Roger D.
|
|
|
110 |
11 |
p. 1862
|
artikel
|
| 4685 |
The Effects of Zoledronic Acid on Serum Lipids in Multiple Myeloma Patients.
|
Gozzetti, Alessandro
|
|
|
110 |
11 |
p. 4828
|
artikel
|
| 4686 |
The Efficacy and Toxicity of the RAD Regimen (Revlimid®, Adriamycin®, Dexamethasone) in Relapsed and Refractory Multiple Myeloma - A Phase I/II Trial of “Deutsche Studiengruppe Multiples Myelom”.
|
Knop, Stefan
|
|
|
110 |
11 |
p. 2716
|
artikel
|
| 4687 |
The Efficacy of R-ICE Therapy as a Salvage Treatment for Relapse and Refractory Diffuse Large B-Cell Lymphoma.
|
Kodaira, Makoto
|
|
|
110 |
11 |
p. 4441
|
artikel
|
| 4688 |
The EGFR-Inhibitor Erlotinib Induces Differentiation, Cell Cycle Arrest and Apoptosis in EGFR-Negative Cells of MDS and AML.
|
Boehrer, Simone
|
|
|
110 |
11 |
p. 399
|
artikel
|
| 4689 |
The Epigenetic Effect of Phenylhexyl Isothiocyanate on Histone Acetylation in Patients with Acute Leukemia and Non-Leukemic Disorders.
|
Xiao, Liyun
|
|
|
110 |
11 |
p. 4145
|
artikel
|
| 4690 |
The Equal Activity of Azacytidine in 4 Risk Groups of IPSS in MDS.
|
Bang, Soo-Mee
|
|
|
110 |
11 |
p. 4615
|
artikel
|
| 4691 |
The Establishment and Characterization of a Human Acute Myelocytic Leukemia Cell Line, SH-2 Carrying t(16;17))(q24;q12) Translocation.
|
Qiu, Huiying
|
|
|
110 |
11 |
p. 4128
|
artikel
|
| 4692 |
The Expression and Clinical Significance of PRAME Gene in Acute Leukemia.
|
Fu, Rong
|
|
|
110 |
11 |
p. 4225
|
artikel
|
| 4693 |
The Expression of CD56 Is Frequently Accompanied with the Expression of Neuronal Cell Markers and Its Down-Regulation Is Induced by IL-6 in Human Myeloma Cells.
|
Iqbal, Mohd S.
|
|
|
110 |
11 |
p. 3534
|
artikel
|
| 4694 |
The Expression of MT1-MMP in Human Hematopoietic Cell Lines and Its Influences on the Biological Behaviors of HL60.
|
Jiang, Juxiang
|
|
|
110 |
11 |
p. 4123
|
artikel
|
| 4695 |
The Expression of Polycomb Group Genes Products, Bmi1 and Mel-18, Regulate the Function of Murine Primitive Hematopoietic Cells.
|
Kajiume, Teruyuki
|
|
|
110 |
11 |
p. 1261
|
artikel
|
| 4696 |
The Expression of SALL4, a Newly Identified Stem Cell Factor, Is Correlated with Chronic Myeloid Leukemia (CML) Disease Progression.
|
Ma, Yupo
|
|
|
110 |
11 |
p. 2915
|
artikel
|
| 4697 |
The Expression of the GTPase-Deficient, Hematopoietic-Specific RhoH GTPase Is Implicated in Development of Chronic Lymphocytic Leukemia (CLL).
|
Rattmann, Ina
|
|
|
110 |
11 |
p. 339
|
artikel
|
| 4698 |
The Expression Signature of M3 AML Suggests Direct and Indirect Effects of PML-RARA on Target Genes.
|
Payton, Jacqueline E.
|
|
|
110 |
11 |
p. 719
|
artikel
|
| 4699 |
The Expression Signatures of Mammary Tumor Associated Macrophages.
|
Ojalvo, Laureen S.
|
|
|
110 |
11 |
p. 3850
|
artikel
|
| 4700 |
The Feasibility and Safety of Anticoagulation during Chemotherapy Associated Thrombocytopenia for Thrombotic Complications of Malignancy.
|
Polizzotto, Mark N.
|
|
|
110 |
11 |
p. 1872
|
artikel
|
| 4701 |
The Feature of CD3-zeta Chain Gene Expression in Mononuclear Cells without and with Stimulation by Different Factors from Umbilical Cord Blood.
|
Chen, Shaohua
|
|
|
110 |
11 |
p. 3870
|
artikel
|
| 4702 |
The Feature of TCR Vβ Repertoire, Thymic Recent Output Function and TCR-zeta Chain Expression in Patients with Immune Thrombocytopenic Purpura.
|
Zhang, Xueli
|
|
|
110 |
11 |
p. 2099
|
artikel
|
| 4703 |
The Feature of TCR Zeta Gene in CD4+ and CD8+ T Cells in Patients with CML.
|
Chen, Si
|
|
|
110 |
11 |
p. 4526
|
artikel
|
| 4704 |
The First Trimester Human Placenta Is a Site of Primitive Red Blood Cell Maturation.
|
Van Handel, Benjamin J.
|
|
|
110 |
11 |
p. 2224
|
artikel
|
| 4705 |
The First Zinc Finger Domain of EVI1 Enhances Self-Renewal of Hematopoietic Progenitors.
|
Laricchia-Robbio, Leopoldo
|
|
|
110 |
11 |
p. 1237
|
artikel
|
| 4706 |
The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).
|
Swisher, Karen K.
|
|
|
110 |
11 |
p. 2090
|
artikel
|
| 4707 |
The GATA-1/FOG-1/NuRD Axis Is Essential for Normal Hematopoiesis.
|
Hong, Wei
|
|
|
110 |
11 |
p. 375
|
artikel
|
| 4708 |
The Generation of Potent Dendritic Cells Can Be Modulated by Interaction between Immature Dendritic Cells and Invariant NK Cells with the Presence of Stimulatory Cytokines and TLR Agonist.
|
Yang, Deok-Hwan
|
|
|
110 |
11 |
p. 4896
|
artikel
|
| 4709 |
The Genotype NPM1mut/FLT3-ITDneg Is a Highly Significant Predictive Factor for Response to Therapy with All-Trans Retinoic Acid in Acute Myeloid Leukemia - Results from AMLSG Trial AML HD98B.
|
Schlenk, Richard F.
|
|
|
110 |
11 |
p. 297
|
artikel
|
| 4710 |
The Green Tea Polyphenol Epigallocatechin Gallate (EGCG) Antagonizes the Inhibitory Effect of Bortezomib on Myeloma Cells.
|
Burger, Renate
|
|
|
110 |
11 |
p. 4794
|
artikel
|
| 4711 |
The Hematopoietic Stem Cell Compartment Is Different in Polycythemia Vera and Idiopathic Myelofibrosis.
|
James, Chloe
|
|
|
110 |
11 |
p. 259
|
artikel
|
| 4712 |
The Hematopoietic Stem Cell Is a Source of Endothelial Cells in Cancer Vasculogenesis and Depends on SDF-1.
|
Cogle, Christopher R.
|
|
|
110 |
11 |
p. 3722
|
artikel
|
| 4713 |
The Hematopoietic Stem Cell Niche in Whole Bone Marrow Fragments Can Be Maintained In-Vitro.
|
Smith, Aaron
|
|
|
110 |
11 |
p. 1418
|
artikel
|
| 4714 |
The High Prevalence of FLT3-ITD Mutations Is Associated with the Poor Outcome in Adult Patients with t(6;9)(p23;q34) Positive AML - Results of an International Metaanalysis.
|
Thiede, Christian
|
|
|
110 |
11 |
p. 761
|
artikel
|
| 4715 |
The Histone Acetyltransferase CBP Is Essential for Conventional T Cell Development.
|
Fukuyama, Tomofusa
|
|
|
110 |
11 |
p. 2294
|
artikel
|
| 4716 |
The Histone Deacetylase Inhibitor, Sodium Butyrate, Augments Chlorambucil Cytotoxicity in the Promyelocytic Leukaemia Cell Line, HL-60.
|
Kwa, Faith
|
|
|
110 |
11 |
p. 4198
|
artikel
|
| 4717 |
The HSP 90 Inhibitor, 17-AAG, Increases Gemtuzumab Ozogamicin-Induced Cytotoxicity in Acute Myeloid Leukemia (AML) Cells.
|
Walter, Roland B.
|
|
|
110 |
11 |
p. 1607
|
artikel
|
| 4718 |
The Humanized Anti-CD40 Monoclonal Antibody, SGN-40, Potentiates Chemotherapy Regimens in NHL Xenograft Models Via Pro-Apoptotic Signaling.
|
Lewis, Timothy S.
|
|
|
110 |
11 |
p. 2342
|
artikel
|
| 4719 |
The Human Severe Congenital Neutropenia-Associated Gfi1N382S Mutant Critically Requires Deregulated Expression of CSF1 To Block Granulopoiesis.
|
Velu, Chinavenmeni S.
|
|
|
110 |
11 |
p. 1248
|
artikel
|
| 4720 |
The Hypoxic Microenvironment in Acute Myelogenous Leukemia: Critical Role of CXCR4 in the Induction of HIF-1α.
|
Andreeff, Michael
|
|
|
110 |
11 |
p. 1819
|
artikel
|
| 4721 |
The Identification and Characterization of Zebrafish Mast Cells.
|
Berman, Jason N.
|
|
|
110 |
11 |
p. 2405
|
artikel
|
| 4722 |
The Identification and Genomic Analysis of microRNAs in Human Erythrocytes in Sickle Cell Diseases.
|
Chen, Shao-Yin
|
|
|
110 |
11 |
p. 3400
|
artikel
|
| 4723 |
The Immature Platelet Fraction in HIV Patients with Thrombocytopenia.
|
Garibaldi, Brian T.
|
|
|
110 |
11 |
p. 2095
|
artikel
|
| 4724 |
The Immunosuppressor Sirolimus Reduces the Number and Maturation of Colony-Forming Units of Erythroid Progenitor Cells.
|
Diaz-Ricart, Maribel
|
|
|
110 |
11 |
p. 3765
|
artikel
|
| 4725 |
The Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents with Recurring Hodgkin's Lymphoma: An EBMT Study on 151 Patients.
|
Claviez, Alexander
|
|
|
110 |
11 |
p. 3061
|
artikel
|
| 4726 |
The Impact of Histological Subtypes on Outcome in Patients with Mantle Cell Lymphoma Treated with or without Autologous Stem Cell Transplant.
|
Zulfiqar, Muhammad I.
|
|
|
110 |
11 |
p. 1904
|
artikel
|
| 4727 |
The Impact of Incorporating Targeted Radioimmunotherapy (RIT) into Transplant Preparative Regimens on the Incidence of Therapy Related Myelodysplasia (t-MDS) or AML (t-AML) Following Autologous Stem Cell Transplant (ASCT) for Lymphoma.
|
Krishnan, Amrita Y.
|
|
|
110 |
11 |
p. 1082
|
artikel
|
| 4728 |
The Impact of NOD2/CARD15 and KIR Polymorphisms on the Incidence of Infectious Complications in allo-HSCT Recipients.
|
Holowiecka-Goral, Aleksandra
|
|
|
110 |
11 |
p. 2968
|
artikel
|
| 4729 |
The Impact of P2Y-Mediated Activation on Release of Angiogenic Proteins by Platelets from Healthy Individuals.
|
Bambace, Nadia M.
|
|
|
110 |
11 |
p. 3894
|
artikel
|
| 4730 |
The Impact of Race and Socioeconomic Status (SES) on Survival in Non-Hodgkin's Lymphoma (NHL): A Population-Based Study from the California Cancer Registry (CCR).
|
Foran, James M.
|
|
|
110 |
11 |
p. 3580
|
artikel
|
| 4731 |
The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.
|
Terada, Yoshiki
|
|
|
110 |
11 |
p. 4456
|
artikel
|
| 4732 |
The Impact of Telomere Shortening in Dyskeratosis Congenita Cells on DNA Damage Response Pathways.
|
Witt, Travis
|
|
|
110 |
11 |
p. 4052
|
artikel
|
| 4733 |
The Impact of Therapy-Related and Secondary AML in Relation to Karyotype and Molecular Markers: A Study of the AMLSG.
|
Kayser, Sabine
|
|
|
110 |
11 |
p. 881
|
artikel
|
| 4734 |
The Impact of Transfusion-Dependency on the Outcome of Patients with Myelodysplastic Syndromes (MDS) Receiving Allogeneic Peripheral Blood Stem Cell Transplantation after Myeloablative Conditioning.
|
Platzbecker, Uwe
|
|
|
110 |
11 |
p. 1467
|
artikel
|
| 4735 |
The Importance of Harmonizing Transplantation Procedures in Children with ALL: ALL-SCT-BFM 2003, a Prospective Multicenter Trial.
|
Schrauder, André
|
|
|
110 |
11 |
p. 1099
|
artikel
|
| 4736 |
The Importance of the Human β-Globin Locus Control Region HS1 and HS4 Elements for Therapeutic β-Globin Gene Expression in β-Thalassemic Mice.
|
Lisowski, Leszek
|
|
|
110 |
11 |
p. 272
|
artikel
|
| 4737 |
The Incidence of Idiopathic Thrombocytopenic Purpura (ITP) among Adults in the United Kingdom's General Practice Research Database (GPRD), 1992–2005.
|
Feudjo-Tepie, Maurille A.
|
|
|
110 |
11 |
p. 3209
|
artikel
|
| 4738 |
The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation.
|
Chen, Wei
|
|
|
110 |
11 |
p. 1344
|
artikel
|
| 4739 |
The Inflammatory Subset of Monocytes Stimulates Angiogenesis at Sites of Ischemia by Altering the Balance of Pro- and Anti-Inflammatory Cytokines.
|
Gregory, Alyssa D.
|
|
|
110 |
11 |
p. 240
|
artikel
|
| 4740 |
The Influence of CYP2C9 and VKORC1 1173C/T Genotype on Reversal of Anticoagulation (INR) Following Phytonadione Administration.
|
Limdi, Nita A.
|
|
|
110 |
11 |
p. 3135
|
artikel
|
| 4741 |
The Interaction of CXCR4/SDF-1 and VLA-4 Regulates Adhesion and Transendothelial Migration in Waldenstrom Macroglobulinemia.
|
Ngo, Hai T.
|
|
|
110 |
11 |
p. 2617
|
artikel
|
| 4742 |
The Interaction of Platelet GPIB with the VWF-A1 Domain in Solution or Immobilized Is Regulated by the D3 Domain (A.A. 1238–1260) and the A2A3 Domains
|
Cruz, Miguel A.
|
|
|
110 |
11 |
p. 3726
|
artikel
|
| 4743 |
The International Prognostic Scoring System for Waldestrom's Macroglobulinemia (ISSWM) Is Applicable in Patients Treated with Rituximab-Based Regimens.
|
Dimopoulos, Meletios Athanasios
|
|
|
110 |
11 |
p. 3615
|
artikel
|
| 4744 |
The Intracellular ABC Transporter A3 Contributes to Imatinib Resistance of CML Cells by Subcellular Sequestration.
|
Chapuy, Bjoern
|
|
|
110 |
11 |
p. 2921
|
artikel
|
| 4745 |
The Investigation of HMGA2 Dysregulation and Promoter Mutations in PIG-M in the Molecular Pathogenesis of Paroxysmal Nocturnal Haemoglobinuria (PNH).
|
Kelly, Richard J.
|
|
|
110 |
11 |
p. 3671
|
artikel
|
| 4746 |
The In Vitro and In Vivo Antioxidant Effects of Erythropoietin in Thalassemia.
|
Fibach, Eitan
|
|
|
110 |
11 |
p. 573
|
artikel
|
| 4747 |
The In Vivo Impact of Human Regulatory T Cells on the Graft Versus Tumor Effect.
|
Mutis, Tuna
|
|
|
110 |
11 |
p. 349
|
artikel
|
| 4748 |
The In Vivo Inactivation of MASTL Kinase Results in Thrombocytopenia.
|
Johnson, Helen J.
|
|
|
110 |
11 |
p. 3368
|
artikel
|
| 4749 |
The IPI Predicts Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: A Report of the University of Iowa/Mayo Clinic SPORE
|
Habermann, Thomas M.
|
|
|
110 |
11 |
p. 1279
|
artikel
|
| 4750 |
The JAK2 Kinase Inhibitor LS104 Induces Growth-Arrest and Apoptosis in JAK2V617F Positive Cells.
|
Lipka, Daniel B.
|
|
|
110 |
11 |
p. 3544
|
artikel
|
| 4751 |
The JAK2V617F Mutation in Blood Donors with High Haematocrit.
|
Tagariello, Giuseppe
|
|
|
110 |
11 |
p. 4635
|
artikel
|
| 4752 |
The JAK2-V617F Mutation Load Remains Stable over Several Years in Most Patients with Myeloproliferative Disorders Analyzed in a Retrospective Single Center Study.
|
Theocharides, Alexandre
|
|
|
110 |
11 |
p. 2526
|
artikel
|
| 4753 |
The Kinase Inhibitors Sunitinib (Sutent®) and Sorafenib (Nexavar®) Differentially Affect Reactivity of NK Cells Against Renal Cell Cancer.
|
Manuela, Schlicke
|
|
|
110 |
11 |
p. 4182
|
artikel
|
| 4754 |
The KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Exhibits a High Response Rate in Aggressive Systemic Mastocytosis (ASM): Interim Results of a Phase II Trial.
|
Gotlib, Jason
|
|
|
110 |
11 |
p. 3536
|
artikel
|
| 4755 |
The Landscape of Thrombophilia in Sickling Disorders: Unfamiliar Terrain.
|
Littsey, Lisabette
|
|
|
110 |
11 |
p. 3810
|
artikel
|
| 4756 |
The Ligand Occupancy of Endothelial Protein C Receptor Switches the PAR-1 Dependent Signaling Specificity of Thrombin from a Disruptive to a Protective Response in Endothelial Cells.
|
Rezaie, Alireza R.
|
|
|
110 |
11 |
p. 1746
|
artikel
|
| 4757 |
The Lymphoid Cell Surface Receptor NTB-A: A Novel Monoclonal Antibody Target for Leukemia and Lymphoma Therapeutics.
|
Korver, Wouter
|
|
|
110 |
11 |
p. 4511
|
artikel
|
| 4758 |
The Major Phagocyte Peroxidase-Derived Oxidant, HOSCN (Hypothiocyanous Acid), Induces Proinflammatory and Cytoprotective Gene Expression in Endothelium: A Mechanism for Microlocalized Regulation of Inflammation.
|
Mahmud, Shawn A.
|
|
|
110 |
11 |
p. 3295
|
artikel
|
| 4759 |
The Mask Mutation Identifies TMPRSS6 as an Essential Suppressor of Hepcidin Gene Expression, Required for Normal Uptake of Dietary Iron.
|
Beutler, Ernest
|
|
|
110 |
11 |
p. 3
|
artikel
|
| 4760 |
The MAXIMA Study: Safety of Rituximab (MabThera®) Maintenance Therapy in Patients with Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy.
|
Wenger, Michael K.
|
|
|
110 |
11 |
p. 4475
|
artikel
|
| 4761 |
The MDM2 Antagonist Nutlin-3 Is a Potent Inducer of Apoptosis in Pediatric Acute Lymphoblastic Leukemia Cells with Wild-Type p53 and Overexpression of MDM2.
|
Gu, Lubing
|
|
|
110 |
11 |
p. 4277
|
artikel
|
| 4762 |
The MDM2 Antagonist Nutlin-3 Is Lethal to Mantle Cell Lymphoma with Wild Type p53.
|
Tabe, Yoko
|
|
|
110 |
11 |
p. 1382
|
artikel
|
| 4763 |
The Mechanism of Constitutive NF-kB Activity in Myeloma Cell Lines.
|
Amin, Jakia
|
|
|
110 |
11 |
p. 4740
|
artikel
|
| 4764 |
The MHC I Immunopeptidome Is Moulded by the Transcriptome and Conceals a Tissue-Specific Signature.
|
Fortier, Marie-Hélène
|
|
|
110 |
11 |
p. 1327
|
artikel
|
| 4765 |
The MLL PHD Fingers of MLL Block MLL Fusion Protein Mediated Transformation.
|
Muntean, Andrew G.
|
|
|
110 |
11 |
p. 976
|
artikel
|
| 4766 |
The MLL Recombinome of Adult ALL - Results from the GMALL Study Group.
|
Burmeister, Thomas
|
|
|
110 |
11 |
p. 977
|
artikel
|
| 4767 |
The MMSET Gene Contributes to the Growth, Adhesion, and Tumorigencitiy of t(4;14) Multiple Myeloma Cells.
|
Lauring, Josh
|
|
|
110 |
11 |
p. 2636
|
artikel
|
| 4768 |
The MN1 Oncogene Blocks Differentiation of Multiple Hematopoietic Lineages.
|
Heuser, Michael
|
|
|
110 |
11 |
p. 600
|
artikel
|
| 4769 |
The Mobilization Effects of G-CSF, GM-CSF and Darbepoetin-α for Allogeneic Peripheral Blood Stem Cell Transplantation.
|
Kim, Shi Nae
|
|
|
110 |
11 |
p. 4932
|
artikel
|
| 4770 |
The Molecular Characteristics in CDR3 of TCR Vα and Vβ Genes Associated with cGVHD in Patients after Allogeneic Hematopoietic Stem Cell Transplantation.
|
Wu, Xiuli
|
|
|
110 |
11 |
p. 3247
|
artikel
|
| 4771 |
The Mouse Mutation “Thrombocytopenia and Cardiomyopathy” (trac) Is within the ABCG5 Gene: A Single Gene Model for Human Mediterranean Macrothrombocytopenia.
|
Shultz, Leonard D.
|
|
|
110 |
11 |
p. 98
|
artikel
|
| 4772 |
The mTOR Inhibitor RAD001 (Everolimus) Improves Survival in Preclinical Models of Primary Human ALL.
|
Crazzolara, Roman
|
|
|
110 |
11 |
p. 856
|
artikel
|
| 4773 |
The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.
|
Campbell, Richard A.
|
|
|
110 |
11 |
p. 4801
|
artikel
|
| 4774 |
The mTOR Inhibitor Rapamycin Demonstrates Activity Against AML in Combination with Imatinib Mesylate and with 5-Azacytidine.
|
Liesveld, Jane L.
|
|
|
110 |
11 |
p. 4318
|
artikel
|
| 4775 |
The Multiple Myeloma Research Consortium Genomics Initiative.
|
Trent, Jeffrey
|
|
|
110 |
11 |
p. 2498
|
artikel
|
| 4776 |
The Mutation Leu335Pro in Factor VIII Results in Its Rapid Inactivation by Thrombin-Catalyzed Proteolysis at Arg336.
|
Varfaj, Fatbardha
|
|
|
110 |
11 |
p. 2690
|
artikel
|
| 4777 |
The Mutation Spectrum of CML Patients Resistant to Imatinib: More Heterogeneous Than Just BCR-ABL Kinase Domain Point Mutations?.
|
Lundan, Tuija
|
|
|
110 |
11 |
p. 1948
|
artikel
|
| 4778 |
The Mutations SER2117→LEU, and TRP/TRP2063/64→MET/PHE in the Hydrophobic Spikes of the Factor V C2 Domain Lead to Tenacious Phospholipid Binding and Suggest a Mechanism through Which Phosphatidylserine Activates the Prothrombinase Complex.
|
Gilbert, Gary E.
|
|
|
110 |
11 |
p. 2703
|
artikel
|
| 4779 |
The Myocyte Enhancer Factor 2C (MEF2C) Is a Direct Transcriptional Target of HOXA9 and Mediates Leukemia Survival in Human Mixed-Lineage Leukemias.
|
Faber, Jorg
|
|
|
110 |
11 |
p. 58
|
artikel
|
| 4780 |
The Natural History and Treatment Outcome of De-Novo Chromosome 17p Deletion CLL: A Single Institution Experience with 48 Patients.
|
Tam, Constantine S.
|
|
|
110 |
11 |
p. 2041
|
artikel
|
| 4781 |
The N-Glycans Modulate the Binding of ADAMTS13 with von Willebrand Factor.
|
Zhou, Wenhua
|
|
|
110 |
11 |
p. 2710
|
artikel
|
| 4782 |
The NHR2 Oligomerization Domain of AML1/ETO as a Novel Therapeutic Target Structure in t(8;21) Positive Leukemias.
|
Wichmann, Christian
|
|
|
110 |
11 |
p. 210
|
artikel
|
| 4783 |
The ΔN Isoform of the p73 Gene Is Induced during the G0→G1 Transition in Primary Human T Cells.
|
Chronis, Constantinos
|
|
|
110 |
11 |
p. 3353
|
artikel
|
| 4784 |
The Non-Death Domain Containing TNFR Member HVEM Induces Apoptosis and Chemokine Production on B-Chronic Lymphocytic Leukemia Cells.
|
Olive, Daniel R.
|
|
|
110 |
11 |
p. 4720
|
artikel
|
| 4785 |
The Novel Akt Inhibitor Perifosine Induces Apoptosis, Cell Cycle Arrest and Synergizes with Chemotherapeutic Drugs in Acute Myelogenous Leukemia Cells by a JNK Dependent Mechanism - A Novel Therapeutic Approach for Leukemia Displaying Elevated Akt Signaling.
|
Martelli, Alberto M.
|
|
|
110 |
11 |
p. 3355
|
artikel
|
| 4786 |
The Novel Aurora Kinase Inhibitor AS703569 Shows Potent Anti-Tumor Activity in Acute Myeloid Leukemia (AML).
|
Sarno, Samantha
|
|
|
110 |
11 |
p. 915
|
artikel
|
| 4787 |
The Novel Glycolysis Inhibitor, 3-BrOP, Has Broad Activity Against Acute Lymphoblastic Leukemias and Potentiates Methotrexate and Rapamycin.
|
Akers, Lauren J.
|
|
|
110 |
11 |
p. 4203
|
artikel
|
| 4788 |
The Novel Histone Deacetylase Inhibitor, LBH589, Induces Expression of DNA Damage Response Genes and Apoptosis in Ph-Acute Lymphoblastic Leukemia Cells.
|
Anna, Scuto
|
|
|
110 |
11 |
p. 2796
|
artikel
|
| 4789 |
The Novel HSP90 Inhibitor IPI-504 Synergizes with Bortezomib in Mantle Cell Lymphoma Cells by Targeting Both NF-kappaB Signaling and Unfolded Protein Response and Leading to Increased Mitochondrial Apoptosis.
|
Roue, Gael
|
|
|
110 |
11 |
p. 1601
|
artikel
|
| 4790 |
The Novel, Orally Available Multi-Kinase Inhibitor BAY 73-4506 Targets Myeloma Cells and Their Bone Marrow Microenvironment.
|
Raab, Marc S.
|
|
|
110 |
11 |
p. 2525
|
artikel
|
| 4791 |
The Novel Potent Pan-Deacetylase (DAC) Inhibitor, Panobinostat (LBH589), Markedly Enhances the Anti-Myeloma Effects of Chemotherapy In Vitro and In Vivo.
|
Campbell, Richard A.
|
|
|
110 |
11 |
p. 2520
|
artikel
|
| 4792 |
The Obligate Role of TAK1 in the Survival of Hematopoietic Stem Cells and Progenitors in Mice.
|
Tang, Minghui
|
|
|
110 |
11 |
p. 642
|
artikel
|
| 4793 |
The Occurrence of Four Globin Abnormalities in One Individual: Hb SC Disease with Hb Chicago and Deletional Alpha Thalassemia.
|
Hughes, Heather
|
|
|
110 |
11 |
p. 3802
|
artikel
|
| 4794 |
The Occurrence of Mutations in PTPN11 and KRAS Is Not Dissimilar in Patients with Indolent Juvenile Myelomonocytic Leukemia (JMML) from Those with Clinically More Aggressive Disease.
|
Rao, Anupama G.
|
|
|
110 |
11 |
p. 2424
|
artikel
|
| 4795 |
The Ontogeny of Definitive Hematopoiesis in the Zebrafish.
|
Traver, David
|
|
|
110 |
11 |
p. 438
|
artikel
|
| 4796 |
The Optimal Processing Time of Adipose-Derived Mesenchymal Stem Cell after Lipoaspiration.
|
Jang, Jun Ho
|
|
|
110 |
11 |
p. 4107
|
artikel
|
| 4797 |
The Oral Off-Patent Antimicrobial Clioquinol Inhibits the Proteasome and Induces Cell Death in AML and Myeloma Cells through a Copper-Dependent Mechanism.
|
Mao, Xinliang
|
|
|
110 |
11 |
p. 1595
|
artikel
|
| 4798 |
The Outcome in AML Is Predicted by Cytogenetics, NPM1/FLT3 Mutation, Age and Sex, but Not by Treatment Variables.
|
Buchner, Thomas
|
|
|
110 |
11 |
p. 593
|
artikel
|
| 4799 |
The Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hemophagocytic Lymphohistiocytosis in Korea.
|
Lee, Jae Hee
|
|
|
110 |
11 |
p. 5073
|
artikel
|
| 4800 |
The Overexpression of Spliced Oncogenic Ikaros Isoforms in Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients Is a New Mechanism of Resistance to Tyrosine Kinase Inhibitors.
|
Iacobucci, I.
|
|
|
110 |
11 |
p. 722
|
artikel
|
| 4801 |
The P47 GTPase Lrg-47 Links Host Defense and HSC Proliferation.
|
Weksberg, David C.
|
|
|
110 |
11 |
p. 640
|
artikel
|
| 4802 |
The Physician-Patient Relationship Impacts Patient Quality of Life in Chronic Lymphocytic Leukemia: Results of an International Survey of 1482 Patients.
|
Shanafelt, Tait D.
|
|
|
110 |
11 |
p. 2060
|
artikel
|
| 4803 |
The Plant-Derived Agent Silvestrol Has B-Cell Selective Activity In Vitro in Chronic Lymphocytic Leukemia Patient Cells and In Vivo in the Tcl-1 Mouse Model of CLL.
|
Lucas, David M.
|
|
|
110 |
11 |
p. 3123
|
artikel
|
| 4804 |
The Plk-1 Inhibitor BI 2536 Counteracts Proliferation and Viability of CML Cells and Synergizes with Imatinib and Nilotinib (AMN107) in Producing Growth Inhibition.
|
Gleixner, Karoline V.
|
|
|
110 |
11 |
p. 1046
|
artikel
|
| 4805 |
The Plk-1 Inhibitor BI 2536 Counteracts the Growth of Neoplastic Mast Cells and Synergizes with the KIT D816V-Targeting Drug Midostaurin (PKC412) in Producing Growth-Inhibition.
|
Ferenc, Veronika
|
|
|
110 |
11 |
p. 3554
|
artikel
|
| 4806 |
The PPARß Activation Mechanism Which Suppresses the Constitutive NF-kB Activity in Human Myeloma Cell Lines.
|
Otsuyama, Ken-ichiro
|
|
|
110 |
11 |
p. 4739
|
artikel
|
| 4807 |
The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy.
|
Masmas, Tania N.
|
|
|
110 |
11 |
p. 1079
|
artikel
|
| 4808 |
The Predictive Value of the Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index (CI) in Recipients of Umbilical Cord Blood (UCB) Transplantation.
|
Brunstein, Claudio G.
|
|
|
110 |
11 |
p. 5065
|
artikel
|
| 4809 |
The Presence of Central Nervous System Disease at Diagnosis in Pediatric Acute Myeloid Leukemia Does Not Affect Outcome.
|
Johnston, Donna L.
|
|
|
110 |
11 |
p. 1827
|
artikel
|
| 4810 |
The Presence of the JAK2V617F Mutation in Primary Myelofibrosis and Its Allele Burden in Polycythemia Vera Predict Chemosensitivity to Hydroxyurea.
|
Sirhan, Shireen
|
|
|
110 |
11 |
p. 3539
|
artikel
|
| 4811 |
The Prevalence of Reduced VWF Survival Phenotype (Type 1C VWD) in Type 1 Index Cases Recruited into the TS Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB - VWD).
|
Haberichter, Sandra L.
|
|
|
110 |
11 |
p. 2133
|
artikel
|
| 4812 |
The Prevalence of Renal Dysfunction in Young Adults with Sickle Cell Disease.
|
Osarogiagbon, Raymond U.
|
|
|
110 |
11 |
p. 3804
|
artikel
|
| 4813 |
The Production of Vascular Endothelial Growth Factor Is Decreased in Acute Myelogenous Leukemia Cases That Are Treated with Chemotherapeutic Agents and Show the Prolonged Bone Marrow Suppression.
|
Tashiro, Haruko
|
|
|
110 |
11 |
p. 4313
|
artikel
|
| 4814 |
The Prognostic Importance of T and NK-Cells in a Consecutive Series of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia.
|
Palmer, Shanique
|
|
|
110 |
11 |
p. 3080
|
artikel
|
| 4815 |
The Prognostic Role of Clinical and Microbiological Factors on Mortality Related to Candida Bloodstream Infections in Hospitalized Patients with Hematologic Malignancies.
|
Bigni, Ricardo S.
|
|
|
110 |
11 |
p. 3861
|
artikel
|
| 4816 |
The Prognostic Significance of Complex Karyotype in Philadelphia Chromosome-Negative (Ph−) Acute Lymphoblastic Leukemia (ALL) in Adults Is Related with Risk Group.
|
Granada, Isabel
|
|
|
110 |
11 |
p. 3501
|
artikel
|
| 4817 |
The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL).
|
Zent, Clive S.
|
|
|
110 |
11 |
p. 746
|
artikel
|
| 4818 |
The Prognostic Significance of 11q Deletion Detected by Fluorescence In Situ Hybridization (FISH) in Untreated Chronic Lymphocytic Leukemia (CLL): The MDACC Experience.
|
Tsimberidou, Apostolia-Maria
|
|
|
110 |
11 |
p. 2078
|
artikel
|
| 4819 |
The Proliferative Response to CpG ODN Stimulation Predicts Disease Progression in B-Cell Chronic Lymphocytic Leukemia.
|
Laurenti, Luca
|
|
|
110 |
11 |
p. 3098
|
artikel
|
| 4820 |
The Prolonged Time to Progression with Pegylated Liposomal Doxorubicin + Bortezomib Versus Bortezomib Alone in Relapsed or Refractory Multiple Myeloma Is Unaffected by Extent of Prior Therapy or Previous Anthracycline Exposure.
|
Blade, Joan
|
|
|
110 |
11 |
p. 410
|
artikel
|
| 4821 |
The Proportion of Natural Regulatory T-Cells CD4+CD25+Foxp3+ in Chronic Phase Chronic Myelogenous Leukemia Patients Correlates with Sokal Score at Diagnosis and Is Increased during Imatinib Mesylate Treatment.
|
Bachy, Emmanuel
|
|
|
110 |
11 |
p. 2933
|
artikel
|
| 4822 |
The Proteasome Inhibitor Bortezomib Simultaneously Enhances NK Cell Tumor Cytotoxicity While Paradoxically Reducing Antigen Specific T-Cell Tumor Cytotoxicity.
|
Lundqvist, Andreas
|
|
|
110 |
11 |
p. 1789
|
artikel
|
| 4823 |
The Proteasome Inhibitor BSc2118 Causes Growth Inhibition, Cell Cycle Arrest and Cyclin D1 Degradation in Mantle Cell Lymphoma Cell Lines.
|
Jakob, Christian
|
|
|
110 |
11 |
p. 1401
|
artikel
|
| 4824 |
The Protective Role of Protein C in Endotoxin-Induced Shock.
|
Lay, Angelina J.
|
|
|
110 |
11 |
p. 1748
|
artikel
|
| 4825 |
The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning.
|
Kornblit, Brian
|
|
|
110 |
11 |
p. 1969
|
artikel
|
| 4826 |
The Purine Nucleoside Phosphorylase Inhibitor Forodesine (BCX-1777) Is a Potent Cytotoxic Agent and Has Synergistic Activity with Bendamustine in Chronic Lymphocytic Leukemia (CLL) Irrespective of ZAP-70 Levels and p53 Status.
|
Alonso, Roberto
|
|
|
110 |
11 |
p. 3122
|
artikel
|
| 4827 |
Therapeutic Application of Small Interfering RNA Directed Against bcr-abl Transcripts to a Patient with Imatinib-Resistant Chronic Myeloid Leukemia.
|
Koldehoff, Michael
|
|
|
110 |
11 |
p. 4581
|
artikel
|
| 4828 |
Therapeutic Drug Monitoring (TDM) of IV Busulfan in Patients with Severe Obesity.
|
Hutcherson, Donald A.
|
|
|
110 |
11 |
p. 1990
|
artikel
|
| 4829 |
Therapeutic Effectiveness of Adaptive T-Cell Transfer for Minimal Residual Mantle Cell Lymphoma Following High Dose Therapy.
|
Joshi, Shantaram S.
|
|
|
110 |
11 |
p. 2760
|
artikel
|
| 4830 |
Therapeutic Effect of CXCR3-Expressing Regulatory T Cells on Liver and Intestinal Damages in a Murine Acute GVHD Model.
|
Yamanouchi, Jun
|
|
|
110 |
11 |
p. 2161
|
artikel
|
| 4831 |
Therapeutic Lymphoma Idiotype Vaccine Generated in Insect Cells Results in Mannose Receptor Targeting and Enhanced Immune Activation.
|
Betting, David J.
|
|
|
110 |
11 |
p. 2343
|
artikel
|
| 4832 |
Therapy of Early Stage Myelodysplastic Syndrome (MDS) with Anti-Thymocyte Globulin (ATG) and Etanercept.
|
Scott, Bart L.
|
|
|
110 |
11 |
p. 1462
|
artikel
|
| 4833 |
Therapy of Myelodysplastic Syndrome (MDS) with Azacitidine Given in Combination with Etanercept: A Phase II Study.
|
Holsinger, Aaron L.
|
|
|
110 |
11 |
p. 1452
|
artikel
|
| 4834 |
Therapy Related Acute Myelogenous Leukemia and Myelodysplastic Syndrome in Patients with Acute Lymphoblastic Leukemia Treated with the Hyper-CVAD Regimen.
|
Verma, Dushyant
|
|
|
110 |
11 |
p. 2832
|
artikel
|
| 4835 |
Therapy Response by Decrease of Free Light Chain Concentration in Multiple Myeloma Patients Treated with Bortezomib/Doxorubicin/Dexamethasone as First-Line Therapy.
|
Zinke-Cerwenka, Wilma
|
|
|
110 |
11 |
p. 4818
|
artikel
|
| 4836 |
The RARa-PLZF Oncogenic Protein Inhibits C/EBPa Function in Myeloid Cells.
|
Tremblay, Mathieu
|
|
|
110 |
11 |
p. 1825
|
artikel
|
| 4837 |
The Ratio of Angiopoietin-1 to Angiopoietin-2 Is Reduced and Predicts Independently for Survival in Newly Diagnosed Patients with Multiple Myeloma.
|
Dimopoulos, Meletios A.
|
|
|
110 |
11 |
p. 1478
|
artikel
|
| 4838 |
The Ratio of Serum Transferrin Receptor and Serum Ferritin in the Diagnosis of Iron Deficiency Anaemia in Young Children
|
Park, EunSil
|
|
|
110 |
11 |
p. 3746
|
artikel
|
| 4839 |
The Receptor for Hyaluronic Acid Mediated Motility (RHAMM): Characterization as an Immunotherapeutical Target in Chronic Lymphocytic Leukemia (CLL) and First Results of RHAMM-Derived Peptide Vaccination Trial.
|
Giannopoulos, Krzysztof
|
|
|
110 |
11 |
p. 2051
|
artikel
|
| 4840 |
The Recurrent SET-NUP214 Fusion as a New HOXA Activation Mechanism in Pediatric T-Cell Acute Lymphoblastic Leukemia.
|
Van Vlierberghe, Pieter
|
|
|
110 |
11 |
p. 233
|
artikel
|
| 4841 |
The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.
|
Holowiecki, Jerzy
|
|
|
110 |
11 |
p. 4375
|
artikel
|
| 4842 |
The Relationship between ABO Groups, Factor VIII, von Willebrand Factor Levels and Platelet Function Analysis Using Cone and Plate(let) Analyzer.
|
Castro, Maria Lourdes Barjas
|
|
|
110 |
11 |
p. 4024
|
artikel
|
| 4843 |
The Relationship of Opiate Analgesia to Quality of Life in an Adult Sickle Cell Population.
|
Adam, Soheir S.
|
|
|
110 |
11 |
p. 2261
|
artikel
|
| 4844 |
The Relevance of the Inhibitory Receptor FcγIIB for the Regulation of Anti-Factor VIII Antibody Responses in Murine Models.
|
Hausl, Christina
|
|
|
110 |
11 |
p. 785
|
artikel
|
| 4845 |
The Reliability of Point-of-Care (POC) Prothrombin Time Testing - A Comparison of CoaguChek XS® INR Measurements with Hospital Laboratory Monitoring.
|
Ryan, Fiona
|
|
|
110 |
11 |
p. 973
|
artikel
|
| 4846 |
The Renin-Angiotensin Axis Regulates the Development of a Yolk Sac-Like Hemangioblastic Progenitor of Primitive and Definitive Hematopoiesis from Human Pluripotent Stem Cells.
|
Zambidis, Elias T.
|
|
|
110 |
11 |
p. 433
|
artikel
|
| 4847 |
The Risk of Intrauterine Growth Restriction (IGR) Is Increased by Risk Determinants of Arterial Thrombosis.
|
Gerhardt, Andrea
|
|
|
110 |
11 |
p. 2145
|
artikel
|
| 4848 |
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following Intensive Therapy and Autograft Correlates with the Type of Cells Grafted: A Survey on 1,347 Lymphoma Patients Receiving the High-Dose Sequential (HDS) Program.
|
Zanni, Manuela
|
|
|
110 |
11 |
p. 1083
|
artikel
|
| 4849 |
The Risk of Thrombotic Events in Neonates Treated with Recombinant Factor VIIa.
|
Puetz, John
|
|
|
110 |
11 |
p. 3193
|
artikel
|
| 4850 |
The Risk of Transfusion-Transmitted Babesiosis Due to Babesia microti in Connecticut.
|
Cable, Ritchard G.
|
|
|
110 |
11 |
p. 2900
|
artikel
|
| 4851 |
The Role of AKT and ERK in Regulating D-Cyclin Translation Inhibition and G1 Arrest in Multiple Myeloma Cells Treated with mTOR Inhibitors: Rationale for Combination Thereapy.
|
Frost, Patrick J.
|
|
|
110 |
11 |
p. 4795
|
artikel
|
| 4852 |
The Role of Apoptosis and DNA Repair in Normal and Abnormal Hematopoiesis.
|
Mohrin, Mary E.
|
|
|
110 |
11 |
p. 3362
|
artikel
|
| 4853 |
The Role of Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Waldenström's Macroglobulinemia.
|
Kyriakou, Charalampia
|
|
|
110 |
11 |
p. 941
|
artikel
|
| 4854 |
The Role of Bone Marrow Examination in the Initial Evaluation of Pediatric Hodgkin' Disease: The Canadian Perspective.
|
Simpson, David C.
|
|
|
110 |
11 |
p. 2326
|
artikel
|
| 4855 |
The Role of Cytomegalovirus in Immune Thrombocytopenia Purpura.
|
Di Maggio, Dina M.
|
|
|
110 |
11 |
p. 2101
|
artikel
|
| 4856 |
The Role of ERK and XIAP in Tolerance Induction by Veto CTLs.
|
Reich-zeliger, Shlomit
|
|
|
110 |
11 |
p. 3256
|
artikel
|
| 4857 |
The Role of Gemtuzumab Ozogamicin in Elderly AML Patients in Complete Remission.
|
Quintini, Gerlando
|
|
|
110 |
11 |
p. 4354
|
artikel
|
| 4858 |
The Role of Iron Chelation Activity of Wheat Grass Juice in Blood Transfusion Requirement of Intermediate Thalassaemia.
|
Mukhopadhyay, Soma
|
|
|
110 |
11 |
p. 3829
|
artikel
|
| 4859 |
The Role of Iron in the Cytotoxicity Induced in Hematopoietic Malignant Cell Lines by an Anti-Transferrin Receptor IgG3-Avidin Fusion Protein and Gambogic Acid.
|
Ortiz-Sanchez, Elizabeth
|
|
|
110 |
11 |
p. 4204
|
artikel
|
| 4860 |
The Role of Nramp1 in Erythrophagocytosis.
|
Soe-Lin, Shan
|
|
|
110 |
11 |
p. 3851
|
artikel
|
| 4861 |
The Role of PNAS-2 in Apoptotic Pathway.
|
Wang, Hai-Rong
|
|
|
110 |
11 |
p. 4092
|
artikel
|
| 4862 |
The Role of Race and Ethnicity in the Clinical Outcomes of Severe Hemophilia A Patients with Inhibitors.
|
Kruse-Jarres, Rebecca
|
|
|
110 |
11 |
p. 1163
|
artikel
|
| 4863 |
The Role of Serial Testing for Heparin/PF4 Antibodies in Evolving HITT: A Unique Phenomenon of Delayed Seroconversion with Thrombosis.
|
Sabnani, Indu
|
|
|
110 |
11 |
p. 1309
|
artikel
|
| 4864 |
The Roles of Akt1 and Akt2 in GPIb-IX-Mediated Platelet Activation Signaling.
|
Yin, Hong
|
|
|
110 |
11 |
p. 3635
|
artikel
|
| 4865 |
The Roles of Wilms' Tumor Gene Peptide-Specific Cytotoxic T Lymphocytes in Immunologic Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria.
|
Ikeda, Kazuhiko
|
|
|
110 |
11 |
p. 3676
|
artikel
|
| 4866 |
The Safety and the Risk of Allogeneic Bone Marrow and Peripheral Blood Stem Cell Donation; Results of Nation-Wide Consecutive Pre-Transplant Registration of Related Donors in Japan.
|
Kato, Shunichi
|
|
|
110 |
11 |
p. 3275
|
artikel
|
| 4867 |
The Serine/Threonine Kinase Pim-2 Is a Novel Anti-Apoptotic Mediator in Myeloma Cells.
|
Asano, Jin
|
|
|
110 |
11 |
p. 243
|
artikel
|
| 4868 |
The Severity of Bleeding Tendency in 5 Patients with Factor V Deficiency Due to Distinct Kinds of Factor V Mutations.
|
Shinozawa, Keiko
|
|
|
110 |
11 |
p. 1764
|
artikel
|
| 4869 |
The Significance of MicroRNA-155 in Lymphocytic Malignancy.
|
Banerjee, Arnob
|
|
|
110 |
11 |
p. 4166
|
artikel
|
| 4870 |
The Sooner the Better: Rapid Transduction Enhances the Engraftment/Selection of Gene Corrected Fanconi Anemia HSC.
|
Muller, Lars U.W.
|
|
|
110 |
11 |
p. 194
|
artikel
|
| 4871 |
The Src-Abl Kinase Inhibitor Dasatinib (BMS-354825) Shows Anti-Proliferative and Anti-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL) Cells In Vitro.
|
Veldurthy, Aditya
|
|
|
110 |
11 |
p. 3101
|
artikel
|
| 4872 |
The Stanford V Regimen Is an Effective Treatment for Good Prognosis Patients with Hodgkin's Disease.
|
Abuzetun, Jamil Y.
|
|
|
110 |
11 |
p. 2323
|
artikel
|
| 4873 |
The Structure of the GM-CSF Receptor Ternary Complex Reveals a New Mode of Cytokine Receptor Activation.
|
Lopez, Angel
|
|
|
110 |
11 |
p. 88
|
artikel
|
| 4874 |
The Studies in Various Murine Strains with Defects in Activation of Complement Cascade (CC) Reveal Both Pivotal and Pleiotropic Role of CC in Mobilization of Hematopoietic Stem/Progenitor Cells.
|
Wysoczynski, Marcin
|
|
|
110 |
11 |
p. 774
|
artikel
|
| 4875 |
The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.
|
Du, Xin
|
|
|
110 |
11 |
p. 4970
|
artikel
|
| 4876 |
The Study of Bortezomib Alone or in Combination with Harringtonine or Arsenic Trioxide on Proliferation and Apoptosis of Multidrug Resistant Leukemic Cells.
|
Meng, Fan Yi
|
|
|
110 |
11 |
p. 4193
|
artikel
|
| 4877 |
The Synthetic Hest Shock Protein (Hsp) 90 Inhibitor EC141 Induces Degradation of the Bcr-Abl p190 Protein and Apoptosis of Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Cells.
|
Ferrajoli, Alessandra
|
|
|
110 |
11 |
p. 2784
|
artikel
|
| 4878 |
The t(6;9) Associated DEK/CAN Fusion Protein Does Not Block Differentiation of Early Hematopoietic Stem Cells but Increases Their Stem Cell Capacity.
|
Oancea, Claudia
|
|
|
110 |
11 |
p. 882
|
artikel
|
| 4879 |
The % Tetrahydrobiopterin (BH4) and Serine 1177 Phosphorylation Is Reduced in Sickle Transgenic Mice.
|
Chen, Qiuying
|
|
|
110 |
11 |
p. 3398
|
artikel
|
| 4880 |
The Time to Cytogenetic Response Determines Survival in CML Patients (Pts) Receiving Second-Line Tyrosine Kinase Inhibitors, and Allows Early Identification of Pts Destined To Fail Therapy.
|
Tam, Constantine S.
|
|
|
110 |
11 |
p. 1931
|
artikel
|
| 4881 |
The t(14;18) Is Associated with Germinal Center Phenotype Subset of the Diffuse Large B-Cell Lymphoma Patients in Egypt.
|
Abdel-Ghaffar, Hasan A.
|
|
|
110 |
11 |
p. 4124
|
artikel
|
| 4882 |
The Transfusion Iron Overload Score Is a Potential Predictor of Survival in Stem Cell Transplant Patients.
|
Storey, Jonathan A.
|
|
|
110 |
11 |
p. 1108
|
artikel
|
| 4883 |
The Treatment Cost To Achieve a Complete Cytogenetic Response in Imatinib Resistant Chronic Phase (CP) Chronic Myelogenous Leukemia (CML) Patients: Nilotinib vs. Dasatinib.
|
Mataveli, Fabio D.
|
|
|
110 |
11 |
p. 3327
|
artikel
|
| 4884 |
The Type of Upfront Induction Therapy for Newly Diagnosed Multiple Myeloma Patients Has No Significant Impact on Clinical Outcomes after Autologous Hematopoietic Stem Cell Transplantation.
|
Chung, Stephen S.
|
|
|
110 |
11 |
p. 5128
|
artikel
|
| 4885 |
The Tyrophostin Adaphostin (NSC680410) Inhibits Multiple Myeloma Bone Marrow Angiogenesis In Vitro and In Vivo.
|
Podar, Klaus
|
|
|
110 |
11 |
p. 2507
|
artikel
|
| 4886 |
The Tyrosine Kinase Inhibitor TK258 Differentially Targets Proliferating Human Hematopoietic Progenitor Cells but Does Not Eliminate the Quiescent Fraction.
|
Alvares, Caroline
|
|
|
110 |
11 |
p. 3356
|
artikel
|
| 4887 |
The Use of alpha Interferon To Augment the Graft-Versus-Leukaemia Effect of 2nd Stem Cell Transplants and Donor Lymphocyte Infusions in High Risk Paediatric Leukaemias.
|
Cooper, Nichola
|
|
|
110 |
11 |
p. 3241
|
artikel
|
| 4888 |
The Use of Ideal Amphipathic Helical Peptides To Reduce Hemorrhage In Vivo.
|
Charbonneau, Sophie
|
|
|
110 |
11 |
p. 3152
|
artikel
|
| 4889 |
The Use of the Point of Care in Evaluating the Anticoagulation Effect of Low Molecular Weight Heparin Nadroparin during Hemodialysis.
|
Berruyer, Micheline
|
|
|
110 |
11 |
p. 4008
|
artikel
|
| 4890 |
The Utility of 18F-FDG PET for Malignant Lymphoma; Single Cancer Center Survey.
|
Tamai, Yotaro
|
|
|
110 |
11 |
p. 4418
|
artikel
|
| 4891 |
The Utility of Radionuclide Ventriculography (RNV) Prior to Anthracycline Chemotherapy in Patients with Acute Myeloid Leukemia: A Retrospective, Single Institution Study.
|
McQuilten, Zoe
|
|
|
110 |
11 |
p. 4369
|
artikel
|
| 4892 |
The Value of Bone Marrow Biopsy in the Mobilization of Hematopoietic Stem Cells into the Peripheral Blood in Hematologic Malignancies.
|
De Padua Silva, Leandro
|
|
|
110 |
11 |
p. 4113
|
artikel
|
| 4893 |
The Value of CT-Guided Percutaneous Lung Biopsy in the Diagnosis of Pulmonary Fungal Infections in Patients with Hematologic Diseases.
|
Cai, Zhen
|
|
|
110 |
11 |
p. 3860
|
artikel
|
| 4894 |
The Various Procoagulant Effects of PolyP Require Different Minimal Polymer Lengths.
|
Smith, Stephanie A.
|
|
|
110 |
11 |
p. 1761
|
artikel
|
| 4895 |
The Vent-Like Homeobox Gene VENTX2 Is Expressed in Human Hematopoietic Progenitor Cells and Promotes Human Myeloid Development In Vitro and In Vivo.
|
Arseni, Natalia
|
|
|
110 |
11 |
p. 1275
|
artikel
|
| 4896 |
Th-17 Lymphocytes, Not Regulatory T Cells, Mediate Immune Regulation of Bone Marrow Infiltrating Lymphocytes and Induce Osteoclast Activation in Multiple Myeloma.
|
Noonan, Kimberly A.
|
|
|
110 |
11 |
p. 811
|
artikel
|
| 4897 |
TH17 Pathway and Associated Pro-Inflammatory Cytokines Promote Immune Dysfunction in Myeloma.
|
Prabhala, Rao
|
|
|
110 |
11 |
p. 3517
|
artikel
|
| 4898 |
Th2 Polarization Induced by the Farnesyltransferase Inhibitor Tipifarnib (Zarnestra®, R115777) through Suppression of T-bet.
|
Bai, Fanqi
|
|
|
110 |
11 |
p. 1331
|
artikel
|
| 4899 |
Th2.rapa Cell Treatment of Established Murine Acute GVHD Is Abrogated by IL-2 Therapy and T Regulatory Cells.
|
Foley, Jason E.
|
|
|
110 |
11 |
p. 2169
|
artikel
|
| 4900 |
Three Restricted Forms of Epstein-Barr Virus Latency Counteracting Apoptosis in c-Myc Expressing Burkitt Lymphoma Cells.
|
Kelly, Gemma L.
|
|
|
110 |
11 |
p. 1572
|
artikel
|
| 4901 |
Three-Way Translocations and Insertions Are the Molecular Basis for Complex MLL Rearrangements.
|
Meyer, Claus
|
|
|
110 |
11 |
p. 979
|
artikel
|
| 4902 |
Thrombelastographic Whole Blood Coagulation Parameters Demonstrate Improved Clot Strength Induced by Tranexamic Acid during Cardiopulmonary Bypass.
|
Sørensen, Benny
|
|
|
110 |
11 |
p. 3195
|
artikel
|
| 4903 |
Thrombin-Catalyzed Cleavages of Factor VIII at Arg372 and Arg1689 Are Facilitated by the Acidic Residues Glu720-Asp725.
|
Newell, Jennifer
|
|
|
110 |
11 |
p. 2686
|
artikel
|
| 4904 |
Thrombin-Cleaved Osteopontin Is Regulated by Thrombin-Activatable Carboxypeptidase B in Rheumatoid Arthritis.
|
Myles, Timothy
|
|
|
110 |
11 |
p. 1744
|
artikel
|
| 4905 |
Thrombin Contributes to the Tumor Promalignant Phenotype by Upregulation of Cathepsin D Which Stimulates Angiogenesis.
|
Hu, Liang
|
|
|
110 |
11 |
p. 498
|
artikel
|
| 4906 |
Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype.
|
Santagostino, Elena
|
|
|
110 |
11 |
p. 1154
|
artikel
|
| 4907 |
Thrombin-Releasable Protein Z-Dependent Protease Inhibitor Identified in Platelets and Is Likely Due to Uptake from Plasma.
|
Han, Xin
|
|
|
110 |
11 |
p. 1751
|
artikel
|
| 4908 |
Thromboplastin Composition Affects the Sensitivity of Prothrombin Time (PT) Clotting Tests To Direct Factor Xa Inhibitors.
|
Smith, Stephanie A.
|
|
|
110 |
11 |
p. 928
|
artikel
|
| 4909 |
Thrombopoietin Stimulates the Formation of Endothelial Cell-Cell Contacts and Activates the Small GTPase Rap1.
|
Tijssen, Marloes R.
|
|
|
110 |
11 |
p. 3713
|
artikel
|
| 4910 |
Thromboprophylaxis for Catheter-Related Thrombosis in Patients with Cancer: A Systematic Review.
|
Carrier, Marc
|
|
|
110 |
11 |
p. 1875
|
artikel
|
| 4911 |
Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria.
|
de Latour, Regis Peffault
|
|
|
110 |
11 |
p. 3670
|
artikel
|
| 4912 |
Thrombospondin-1 as a Modulator of ADAMTS13 Activity.
|
Palla, Roberta
|
|
|
110 |
11 |
p. 3711
|
artikel
|
| 4913 |
Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Single Centre Experience.
|
Ngirabacu, Marie Christine
|
|
|
110 |
11 |
p. 1669
|
artikel
|
| 4914 |
Thrombotic Thrombocytopenic Purpura with Normal Initial Hemoglobin.
|
Yarlagadda, Madhavi
|
|
|
110 |
11 |
p. 3924
|
artikel
|
| 4915 |
Thymoglobulin ® Rabbit Anti-Thymocyte Globulins (r-ATG) Induces Faster Platelet Recovery and Does Not Suppress Granulocyte Engraftment in a Non-Myeloablative Stem Cell Transplantation Setting.
|
Shapira, Michael Y.
|
|
|
110 |
11 |
p. 4942
|
artikel
|
| 4916 |
Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.
|
Richey, Elizabeth A.
|
|
|
110 |
11 |
p. 2089
|
artikel
|
| 4917 |
Tie-2-Expression Controls the Radio-Sensitivity of Hematopoietic Stem/Progenitor Cells.
|
Takahashi, Kenji
|
|
|
110 |
11 |
p. 4034
|
artikel
|
| 4918 |
Time from Diagnosis to Treatment Initiation Predicts Survival in Acute Myeloid Leukemia (AML).
|
Sekeres, Mikkael A.
|
|
|
110 |
11 |
p. 598
|
artikel
|
| 4919 |
Time of Relapse after Initial Therapy Significantly Adds to the Prognostic Value of the IPI-R in Patients with Relapsed DLBCL Undergoing Autologous HSC Transplantation.
|
Costa, Luciano J.
|
|
|
110 |
11 |
p. 1897
|
artikel
|
| 4920 |
Time to Complete Cytogenetic Response (CCyR) Does Not Affect Long-Term Outcomes for Patients on Imatinib Therapy.
|
Guilhot, Francois
|
|
|
110 |
11 |
p. 27
|
artikel
|
| 4921 |
Time to Leukaemia (TTL) Assessed in NOD/SCID Mice Transplanted with Primary ALL Leukaemia Cells Determines Early Relapse in Patients and Is Identified by a Specific Gene Signature.
|
Meyer, Lüder H.
|
|
|
110 |
11 |
p. 726
|
artikel
|
| 4922 |
TIMP-3 Inhibition of Angiopoietin-1 Signaling Recruits Hematopoietic Stem Cells from the Bone Marrow Niche.
|
Nakajima, Hideaki
|
|
|
110 |
11 |
p. 1255
|
artikel
|
| 4923 |
TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita.
|
Savage, Sharon A.
|
|
|
110 |
11 |
p. 835
|
artikel
|
| 4924 |
Tipifarnib Is Cytotoxic and a Drug Transporter Inhibiting Chemosensitizer in Hodgkin Lymphoma Tumor Cells.
|
Boll, Boris
|
|
|
110 |
11 |
p. 1386
|
artikel
|
| 4925 |
Tissue Factor and Cancer Procoagulant as Predictors of Thrombosis or Progression in Cancer Patients.
|
Molnar, Soledad
|
|
|
110 |
11 |
p. 3136
|
artikel
|
| 4926 |
Tissue Factor Pathway Inhibitor Anticoagulant and Anti-PAR Signaling Activity Requires GPI-Anchor Attachment to the Cell Surface in Chinese Hamster Ovary (CHO) Cells.
|
Maroney, Susan A.
|
|
|
110 |
11 |
p. 1755
|
artikel
|
| 4927 |
Tissue-Specific Molecular Signature May Explain Differentiative Bias of Human MSC from Different Tissues.
|
Garol, Nicholas J.
|
|
|
110 |
11 |
p. 1918
|
artikel
|
| 4928 |
TLR Agonist Induced Cytokine Production in Human Multipotent Mesenchymal Stromal Cells: A Potential Mechanism How Hematopoiesis Is Enhanced during Generalized Inflammatory Conditions.
|
Boettcher, Steffen
|
|
|
110 |
11 |
p. 1411
|
artikel
|
| 4929 |
TNF-alpha Plays a Crucial Role in the JAK2-V617F Induced Myeloproliferative Disorder.
|
Bumm, Thomas G.P.
|
|
|
110 |
11 |
p. 675
|
artikel
|
| 4930 |
TNF-α-Mediated Tumor Promotion Is Characterized by Enhanced Vasculogenesis and Generation of Myeloid/Endothelial Vascular Leukoctyes.
|
Li, Bin
|
|
|
110 |
11 |
p. 3905
|
artikel
|
| 4931 |
Tolerability of PTK787/ZK 222584 in a Phase II Study of Post-Transplant Maintenance Therapy in Patients with Multiple Myeloma Following High-Dose Chemotherapy and Autologous Stem Cell Transplant.
|
Mosley III, James C.
|
|
|
110 |
11 |
p. 5109
|
artikel
|
| 4932 |
Toll-Like Receptor Agonists Induce Immunogeneicity and Apoptosis of Acute Myeloid Leukemia Cells.
|
Shindo, Maki
|
|
|
110 |
11 |
p. 160
|
artikel
|
| 4933 |
Toll-Like Receptor 2 and 4 Are Expressed on Transplanted T-Cell Subsets and Influence Outcome after Allogeneic Unrelated Peripheral Blood Stem Cell Transplantation.
|
Platzbecker, Uwe
|
|
|
110 |
11 |
p. 1066
|
artikel
|
| 4934 |
Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA on Monocytes Modulates Their Interaction with NK Cells.
|
Kloss, Mercedes
|
|
|
110 |
11 |
p. 2415
|
artikel
|
| 4935 |
Tonsillar CD38+ Activated B Cell Fraction Harbours the Highest EBV Load in Patients with Infectious Mononucleosis.
|
Chaganti, Sridhar
|
|
|
110 |
11 |
p. 2277
|
artikel
|
| 4936 |
Total Body Irradiation (TBI) Based Versus Chemotherapy-Based Preparative Regimens Before Autologous Stem Cell Transplant for Non-Hodgkin's Lymphoma.
|
Liu, Hongwei
|
|
|
110 |
11 |
p. 5105
|
artikel
|
| 4937 |
Towards Regenerative Therapy for Thymic Insufficiency after Hematopoietic Stem Cell Transplantation: Generation of MTS24 Positive Definitive Endoderm from Murine Embryonic Stem Cells.
|
Vroegindeweij, Erik
|
|
|
110 |
11 |
p. 2241
|
artikel
|
| 4938 |
Toxicities of Intravenous (IV) Pegasparaginase (ONCASPAR®) in Adults with Acute Lymphoblastic Leukemia (ALL).
|
Advani, Anjali
|
|
|
110 |
11 |
p. 2811
|
artikel
|
| 4939 |
Toxicity and Early Response after Single Daily Dose of Intravenous Busulfan and Melphalan as Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.
|
Blanes, Margarita
|
|
|
110 |
11 |
p. 4928
|
artikel
|
| 4940 |
TPLL-1 Protocol of the German CLL Study Group (GCLLSG) - A Prospective Phase II Trial of Fludarabine Phosphate, Mitoxantrone and Cyclophosphamide (FMC) Followed by Alemtuzumab Consolidation in T-PLL.
|
Hopfinger, Georg
|
|
|
110 |
11 |
p. 2039
|
artikel
|
| 4941 |
TPO-Induced miR-150 Down-Regulates c-Myb in Primary Megakaryocytes and a Megakaryocytic Cell Line.
|
Barroga, Charlene F.
|
|
|
110 |
11 |
p. 1238
|
artikel
|
| 4942 |
Trace Capsid DNA Impurities in AAV2 Vectors Are Not Transcribed and Are Unlikely To Contribute to Capsid Peptide-MHC Class I Complexes
|
Hauck, Bernd
|
|
|
110 |
11 |
p. 3736
|
artikel
|
| 4943 |
Tracking the MDS Clone in Peripheral Blood (PB) Cells from Patients (pts) with Myelodysplastic Syndrome (MDS) Undergoing Azacitidine (AZAC)-Based Therapy.
|
Cozza, Amanda
|
|
|
110 |
11 |
p. 4600
|
artikel
|
| 4944 |
transCGH: Rapid Identification and High-Resolution Mapping of Balanced IgH Translocations in Archival DNA Using Custom Oligonucleotide Arrays.
|
Greisman, Harvey A.
|
|
|
110 |
11 |
p. 459
|
artikel
|
| 4945 |
Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.
|
Neumann, Frank
|
|
|
110 |
11 |
p. 4540
|
artikel
|
| 4946 |
Transcriptional Regulation of Hepcidin by Iron.
|
Lee, Pauline
|
|
|
110 |
11 |
p. 2664
|
artikel
|
| 4947 |
Transcriptional Regulation of NGAL by the Pro-Inflammatory Cytokines IL-17 and TNFα.
|
Karlsen, Joachim R.
|
|
|
110 |
11 |
p. 1339
|
artikel
|
| 4948 |
Transcription Factor Dosage: Maximal STAT5-Induced Proliferation and Stem Cell Self-Renewal at Intermediate STAT5 Activity Levels.
|
Wierenga, Albertus T.J.
|
|
|
110 |
11 |
p. 2242
|
artikel
|
| 4949 |
Transcription Factor NF-kB as a Biomarker for Disease Progression and Target for Treatment in Chronic Lymphocytic Leukaemia.
|
Hewamana, Saman
|
|
|
110 |
11 |
p. 3091
|
artikel
|
| 4950 |
Transfection with mRNA for CD19 Specific Chimeric Antigen Receptor Restores Natural Killer Cell Mediated Killing of CLL Cells.
|
Boissel, Laurent
|
|
|
110 |
11 |
p. 3110
|
artikel
|
| 4951 |
Transferrin Acts as an Iron Sensor Upstream of BMP2b in the Zebrafish.
|
Fraenkel, Paula G.
|
|
|
110 |
11 |
p. 704
|
artikel
|
| 4952 |
Transformation to Myelofibrosis and Blastic Transformation of PV Are Associated with Higher JAK2 Mutation Levels.
|
Koren-Michowitz, Maya
|
|
|
110 |
11 |
p. 1555
|
artikel
|
| 4953 |
Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.
|
Leitch, Heather A.
|
|
|
110 |
11 |
p. 4653
|
artikel
|
| 4954 |
Transgenic Expression of JAK2V617F Causes Myeloproliferative Disorders in Mice.
|
Xing, Shu
|
|
|
110 |
11 |
p. 2527
|
artikel
|
| 4955 |
Transient Association of the Endoplasmic Reticulum Protein, NogoB, with Integrin Complexes Provides a Novel Mechanism for Inducing Endothelial Cell Motility.
|
Bialkowska, Katarzyna
|
|
|
110 |
11 |
p. 3715
|
artikel
|
| 4956 |
Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.
|
Pungolino, Ester
|
|
|
110 |
11 |
p. 4577
|
artikel
|
| 4957 |
Transient Over-Expression of HOX-Regulating Genes CDX2 and MLL during Human Embryoid Body Differentiation Greatly Augments the Generation of Multipotent Hematopoietic Progenitors.
|
Levine, Michal A.
|
|
|
110 |
11 |
p. 3745.5
|
artikel
|
| 4958 |
Transient Over-Expression of HOX-Regulating Genes CDX2 and MLL during Human Embryoid Body Differentiation Greatly Augments the Generation of Multipotent Hematopoietic Progenitors.
|
Levine, Michal A.
|
|
|
110 |
11 |
p. 1243
|
artikel
|
| 4959 |
Translational Regulation of Gene Expression by Cytoplasmic Nucleophosmin in AML: A Global Evaluation of RNA's Differentially Recruited to Polyribosomes.
|
Funato, Kotaro
|
|
|
110 |
11 |
p. 720
|
artikel
|
| 4960 |
Translocation t(4;14) Is Not an Adverse Prognostic Factor in Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation.
|
Hansen, Timon
|
|
|
110 |
11 |
p. 4743
|
artikel
|
| 4961 |
Translocation t(14;19)(q32;q13) Is a Rare Abnormality in CLL and Associated with Trisomy 12, an Unmutated IgVH Status and a Distinct Gene Expression Profile.
|
Haferlach, Claudia
|
|
|
110 |
11 |
p. 4703
|
artikel
|
| 4962 |
Translocation (X;20)(q13;q13.3): Report of Three Additional Cases.
|
Sreekantaiah, Chandrika
|
|
|
110 |
11 |
p. 4264
|
artikel
|
| 4963 |
Transplantation in the Elderly: The Affect of Age on Clinical Course and Outcomes.
|
Canary, Marcy
|
|
|
110 |
11 |
p. 5114
|
artikel
|
| 4964 |
Transplantation of Multiple Cord Blood Units for Patients with Hematologic Malignancy.
|
Sun, Zimin
|
|
|
110 |
11 |
p. 5082
|
artikel
|
| 4965 |
Transplantation of Primary Human CD34+CD38 - Hematopoietic Stem Cells Recapitulates Idiopathic Myelofibrosis in the NOD/scid/IL2rgKO Mice.
|
Saito, Noriyuki
|
|
|
110 |
11 |
p. 260
|
artikel
|
| 4966 |
Transplantation of T-Cell Depleted Peripheral Blood Haematopoietic Stem Cells from an HLA-Disparate Family Donor for Children with Hematological Malignancies.
|
Locatelli, Franco
|
|
|
110 |
11 |
p. 3071
|
artikel
|
| 4967 |
Transplant Centre Experience and Patient Selection Are the Key Elements Associated with Outcome of RIC and MAC HSCT for CML.
|
Crawley, Charles R.
|
|
|
110 |
11 |
p. 478
|
artikel
|
| 4968 |
Transplant Outcome Is Not Affected by Body Mass Index (BMI) in Patients with Haematological Malignancies.
|
Nikolousis, Emmanouil
|
|
|
110 |
11 |
p. 1991
|
artikel
|
| 4969 |
Transvection Mediated by the Translocated Cyclin D1 Gene in Mantle Cell Lymphoma.
|
Epner, Elliot M.
|
|
|
110 |
11 |
p. 4156
|
artikel
|
| 4970 |
Traumatic Lumbar Puncture (TLP) Is Not Associated with Worse Outcome in Adults with Acute Lymphocytic Leukemia (ALL) or Burkitt-Type Leukemia/Lymphoma (BLL) Receiving Hyper-CVAD Regimens.
|
Atallah, Ehab
|
|
|
110 |
11 |
p. 4346
|
artikel
|
| 4971 |
Treatment Decisions for Young Women with Supra-Diaphragmatic, Limited-Stage Hodgkin Lymphoma: Exploration of Options Using a Markov Decision Analysis.
|
Hicks, Lisa
|
|
|
110 |
11 |
p. 369
|
artikel
|
| 4972 |
Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.
|
Fabre, Claire
|
|
|
110 |
11 |
p. 1849
|
artikel
|
| 4973 |
Treatment of Diffuse Large B-Cell Lymphoma of the Liver with Yttrium-90 Microsphere Embolization.
|
Benjamin, Heather L.
|
|
|
110 |
11 |
p. 4510
|
artikel
|
| 4974 |
Treatment of Diffuse Large B-Cell Lymphoma with Rituximab, Intensive Induction and High-Dose Consolidation: The Final Analysis of the Czech Lymphoma Study Group (CLSG) R-MegaCHOP-ESHAP-BEAM (R-MEB) Trial.
|
Trneny, Marek
|
|
|
110 |
11 |
p. 21
|
artikel
|
| 4975 |
Treatment of Donor Graft Failure with Autologous or Allogenenic Stem-Cell Boost or a Second Allogeneic Transplant Based on Chimerism Testing.
|
Shimoni, Avichai
|
|
|
110 |
11 |
p. 2998
|
artikel
|
| 4976 |
Treatment of Established Graft-Versus-Host Disease by PG490-88.
|
Chen, Benny J.
|
|
|
110 |
11 |
p. 3243
|
artikel
|
| 4977 |
Treatment of Extranodal Marginal Zone Lymphoma and Primary Cutaneous B Cell Lymphoma with Rituximab: A Single Institution Experience.
|
Chen, Robert
|
|
|
110 |
11 |
p. 4502
|
artikel
|
| 4978 |
Treatment of Idiopathic Myelofibrosis Employing siRNA for Heat Shock Protein 47 (siRNA/HSP47) Encapsulated in Liposomes.
|
Watanabe, Junichi
|
|
|
110 |
11 |
p. 4646
|
artikel
|
| 4979 |
Treatment of Indolent Non-Hodgkin's Lymphoma in Germany - Results of a Representative Population-Based Survey.
|
Dreyling, Martin
|
|
|
110 |
11 |
p. 1353
|
artikel
|
| 4980 |
Treatment of Infections in Patients with X-Linked Chronic Granulomatous Disease (XCGD) with Gene Therapy.
|
Kang, Elizabeth M.
|
|
|
110 |
11 |
p. 504
|
artikel
|
| 4981 |
Treatment of Intractable Graft-Versus-Host Disease with Bone Marrow Derived Mesenchymal Stem Cells - A Pilot Clinical Trial.
|
Lee, Je-Hwan
|
|
|
110 |
11 |
p. 4974
|
artikel
|
| 4982 |
Treatment of Iron-Deficiency Anemia with IV Ferumoxytol in CKD Patients: Efficacy Compared with Oral Iron across Different Age Groups.
|
Brenner, Louis
|
|
|
110 |
11 |
p. 2679
|
artikel
|
| 4983 |
Treatment of Light Chain (AL) Amyloidosis and Light Chain Deposition Disease (LCDD) with the Combination of Bortezomib and Dexamethasone.
|
Kastritis, Efstathios
|
|
|
110 |
11 |
p. 191
|
artikel
|
| 4984 |
Treatment of MDS Related Transfusion-Dependent Anemia with Epoetin alfa: A Meta-Analysis Perspective.
|
Mundle, Suneel
|
|
|
110 |
11 |
p. 1471
|
artikel
|
| 4985 |
Treatment of Myelodysplastic Syndrome (MDS) with Cytokine Immunotherapy for Low-Risk MDS.
|
Kadia, Tapan M.
|
|
|
110 |
11 |
p. 1463
|
artikel
|
| 4986 |
Treatment of Myelodysplastic Syndrome with Azacitidine and Erythropoietin.
|
Limaye, Sewanti
|
|
|
110 |
11 |
p. 4627
|
artikel
|
| 4987 |
Treatment of Patients with Multiple Myeloma Complicated by Renal Failure with Bortezomib - Based Regimens.
|
Roussou, Maria
|
|
|
110 |
11 |
p. 2739
|
artikel
|
| 4988 |
Treatment of Philadelphia Positive Chronic Myeloid Leukemia with Imatinib: Introducing the Concept of Confirmed Molecular Response.
|
Palandri, Francesca
|
|
|
110 |
11 |
p. 1933
|
artikel
|
| 4989 |
Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.
|
Issa, Samar
|
|
|
110 |
11 |
p. 1364
|
artikel
|
| 4990 |
Treatment of Relapsed and Refractory Acute Myeloid Leukemia with a Salvage FLAG-IDA Chemotherapy Regimen Followed by a HLA Matched Related Allogeneic PBSC Infusion without Additional Conditioning.
|
Chandy, Mammen
|
|
|
110 |
11 |
p. 5050
|
artikel
|
| 4991 |
Treatment of Relapsed or Refractory Lymphoma with the Oral Isotype-Selective Histone Deacetylase Inhibitor MGCD0103: Interim Results from a Phase II Study.
|
Younes, Anas
|
|
|
110 |
11 |
p. 2571
|
artikel
|
| 4992 |
Treatment of Relapse of AML and MDS after Allogeneic Stem Cell Transplantation Using Low-Dose Chemotherapy, Donor PBSC and GM-CSF: Final Results from a Prospective, Multicenter Phase II Trial by the German Cooperative Transplant Group.
|
Schmid, Christoph
|
|
|
110 |
11 |
p. 1651
|
artikel
|
| 4993 |
Treatment of T Cell Large Granular Lymphocyte Leukemia with Reduced-Intensity Allogeneic Stem Cell Transplantation.
|
Donato, Michele L.
|
|
|
110 |
11 |
p. 4931
|
artikel
|
| 4994 |
Treatment Outcome with Imatinib-Based Maintenance Therapy in Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ALL) Ineligible for Allogeneic Stem Cell Transplantation (SCT).
|
Pfeifer, Heike
|
|
|
110 |
11 |
p. 2817
|
artikel
|
| 4995 |
Treatment Success in Cancer.
|
Djulbegovic, Benjamin
|
|
|
110 |
11 |
p. 631
|
artikel
|
| 4996 |
Treatment Type Determines Gene Expression Changes from Pretreatment (PTx) to Relapse (Rel) in Acute Promyelocytic Leukemia (APL).
|
Cui, Qingping
|
|
|
110 |
11 |
p. 3167
|
artikel
|
| 4997 |
Treatment with hERG1 K+ Channel Inhibitors Reduces Acute Myeloid Leukemia Cell Lines Engraftment into Nonobese Diabetic/Severe Combined Immunodeficient Mice and Prolongs Survival of Injected Mice.
|
Pillozzi, Serena
|
|
|
110 |
11 |
p. 877
|
artikel
|
| 4998 |
Treatment with Natalizumab in Patients with Multiple Sclerosis Is Associated with Increased Numbers of Circulating CD34+ Cells in the Peripheral Blood.
|
Zohren, Fabian
|
|
|
110 |
11 |
p. 4916
|
artikel
|
| 4999 |
Treatment with Sequential Valproic Acid (VPA) +/− Low Doses All Trans Retinoic Acid (LoATRA) and Low Doses Ara-C (LoDAC) for “De Novo” or Relapsed Acute Myeloid Leukaemia (AML).
|
Fenu, Susanna
|
|
|
110 |
11 |
p. 4362
|
artikel
|
| 5000 |
Treatment with Valproic Acid Restores Differentiation in AML1/ETO-Positive Leukaemic Cells.
|
Zapotocky, Michal
|
|
|
110 |
11 |
p. 4295
|
artikel
|
Tijdschrift beschrijving